View Filing Data

Print Document View Excel Document

Document Entity Information Document - USD ($)	12 Months Ended
Document Entity Information Document - USD ($)	Dec. 31, 2012	Feb. 14, 2013	Jun. 30, 2012
Entity Information [Line Items]
Entity Registrant Name	DENTSPLY INTERNATIONAL INC /DE/
Entity Central Index Key	0000818479
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Trading Symbol	XRAY
Document Period End Date	Dec. 31, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	FY
Amendment Flag	false
Total outstanding shares		142,849,900
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 5,576,831,322

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Net sales	$ 2,928,429	$ 2,537,718	$ 2,221,014
Cost of products sold	1,372,042	1,264,278	1,090,856
Gross profit	1,556,387	1,273,440	1,130,158
Selling, general and administrative expenses	1,148,731	936,847	738,901
Restructuring and other costs	25,717	35,865	10,984
Operating income	381,939	300,728	380,273
Other income and expenses:
Interest expense	56,851	43,814	25,089
Interest income	(8,760)	(8,237)	(4,254)
Other expense (income), net	3,169	9,040	1,782
Income before income taxes	330,679	256,111	357,656
Provision for income taxes	8,920	11,016	89,225
Equity in net income (loss) of unconsolidated affilated company	(3,270)	2,351	(1,096)
Net income	318,489	247,446	267,335
Less: Net income attributable to noncontrolling interests	4,276	2,926	1,627
Net income attributable to DENTSPLY International	$ 314,213	$ 244,520	$ 265,708
Earnings per common share:
Basic	$ 2.22	$ 1.73	$ 1.85
Diluted	$ 2.18	$ 1.70	$ 1.82
Weighted average common shares outstanding:
Basic	141,850	141,386	143,980
Diluted	143,945	143,553	145,985

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 318,489	$ 247,446	$ 267,335
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	93,775	(208,009)	(54,111)
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net	(25,752)	9,258	(12,848)
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent	18,338	(11,545)	11,029
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax, Portion Attributable to Parent	(39,196)	(3,164)	(8,048)
Other Comprehensive Income (Loss), Net of Tax	47,165	(213,460)	(63,978)
Comprehensive Income	365,654	33,986	203,357
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	4,671	2,730	(2,965)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$ 360,983	$ 31,256	$ 206,322

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References + Details

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References + Details

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References + Details

- Definition

Amount after tax, before reclassification adjustments, resulting from the process of expressing in the reporting currency of the reporting entity those amounts that are denominated or measured in a different currency, and from transactions whose terms are denominated in a currency other than the entity's functional currency.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a-c)
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32022-110900

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32157-110900

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 45
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 17
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 52
-Paragraph 13, 20, 31
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=18733213&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A1, A4, A5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Current Assets:
Cash and cash equivalents	$ 80,132	$ 77,128
Accounts and notes receivable-trade, net	442,412	427,709
Inventories, net	402,940	361,762
Prepaid expenses and other current assets	185,612	146,304
Total Current Assets	1,111,096	1,012,903
Property, plant and equipment, net	614,705	591,445
Identifiable intangible assets, net	830,642	791,100
Goodwill, net	2,210,953	2,190,063
Other noncurrent assets, net	204,901	169,887
Total Assets	4,972,297	4,755,398
Current Liabilities:
Accounts payable	165,290	149,117
Accrued liabilities	424,336	289,201
Income taxes payable	39,191	9,054
Notes payable and current portion of long-term debt	298,963	276,701
Total Current Liabilities	927,780	724,073
Long-term debt	1,222,035	1,490,010
Deferred income taxes	232,641	249,822
Other noncurrent liabilities	340,398	407,342
Total Liabilities	2,722,854	2,871,247
Commitments and contingencies
Equity:
Preferred stock, $.01 par value; .25 million shares authorized; no shares issued	0	0
Common stock, $.01 par value; 200.0 million shares authorized; 162.8 million shares issued at December 31, 2011 and 2010, respectively	1,628	1,628
Capital in excess of par value	246,548	229,687
Retained earnings	2,818,461	2,535,709
Accumulated other comprehensive income	(144,200)	(190,970)
Treasury stock, at cost, 20.5 million shares at December 31, 2012 and 21.1 million shares at December 31, 2011	(713,739)	(727,977)
Total DENTSPLY International Equity	2,208,698	1,848,077
Noncontrolling Interests	40,745	36,074
Total Equity	2,249,443	1,884,151
Total Liabilities and Equity	$ 4,972,297	$ 4,755,398

CONSOLIDATED STATEMENTS OF EQUITY AND COMPREHENSIVE INCOME - USD ($) $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Total DENTSPLY International Equity	Noncontrolling Interests
Common Stock, Dividends, Per Share, Cash Paid	$ 0.200
Beginning Balance at Dec. 31, 2009	$ 1,906,958	$ 1,628	$ 195,495	$ 2,083,459	$ 83,542	$ (532,019)	$ 1,832,105	$ 74,853
Comprehensive Income:
Net income	267,335			265,708			265,708	1,627
Other Comprehensive Income (Loss), Net of Tax	(63,978)				(59,386)		(59,386)	(4,592)
Exercise of stock options	30,189		(10,107)			40,296	30,189
Tax benefit from stock options exercised	4,663		4,663				4,663
Share based compensation expense	18,803		18,803				18,803
Funding of Employee Stock Option Plan	1,340		208			1,132	1,340
Treasury shares purchased	(223,993)					(223,993)	(223,993)
Dividends from noncontrolling interests	(1,362)							(1,362)
RSU distributions	(1,379)		(4,313)			2,934	(1,379)
RSU dividends			153	(153)
Cash dividends ($0.220 in 2012,$0.205 in 2011 and $0.200 in 2010 per share)	(28,664)			(28,664)			(28,664)
Ending Balance at Dec. 31, 2010	$ 1,909,912	1,628	204,902	2,320,350	24,156	(711,650)	1,839,386	70,526
Common Stock, Dividends, Per Share, Cash Paid	$ 0.205
Comprehensive Income:
Net income	$ 247,446			244,520			244,520	2,926
Other Comprehensive Income (Loss), Net of Tax	(213,460)				(213,264)		(213,264)	(196)
Acquisition of noncontrolling interest	(16,088)		22,782		(1,862)		20,920	(37,008)
Exercise of stock options	42,275		(14,677)			56,952	42,275
Tax benefit from stock options exercised	1,039		1,039				1,039
Share based compensation expense	20,947		20,947				20,947
Funding of Employee Stock Option Plan	2,974		379			2,595	2,974
Treasury shares purchased	(79,500)					(79,500)	(79,500)
Dividends from noncontrolling interests	(174)							(174)
RSU distributions	(2,246)		(5,872)			3,626	(2,246)
RSU dividends	0		187	(187)		0	0
Cash dividends ($0.220 in 2012,$0.205 in 2011 and $0.200 in 2010 per share)	(28,974)			(28,974)			(28,974)
Ending Balance at Dec. 31, 2011	$ 1,884,151	1,628	229,687	2,535,709	(190,970)	(727,977)	1,848,077	36,074
Common Stock, Dividends, Per Share, Cash Paid	$ 0.220
Comprehensive Income:
Net income	$ 318,489			314,213			314,213	4,276
Other Comprehensive Income (Loss), Net of Tax	47,165				46,770		46,770	395
Exercise of stock options	34,183		(10,482)			44,665	34,183
Tax benefit from stock options exercised	13,009		13,009				13,009
Share based compensation expense	22,187		22,187				22,187
Funding of Employee Stock Option Plan	3,641		370			3,271	3,641
Treasury shares purchased	(38,837)					(38,837)	(38,837)
RSU distributions	(3,314)		(8,453)			5,139	(3,314)
RSU dividends	0		230	(230)		0	0
Cash dividends ($0.220 in 2012,$0.205 in 2011 and $0.200 in 2010 per share)	(31,231)			(31,231)			(31,231)
Ending Balance at Dec. 31, 2012	$ 2,249,443	$ 1,628	$ 246,548	$ 2,818,461	$ (144,200)	$ (713,739)	$ 2,208,698	$ 40,745

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Cash flows from operating activities:
Net income	$ 318,489	$ 247,446	$ 267,335
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	79,456	64,039	56,868
Amortization of intangible and other assets	49,743	20,996	9,044
Amortization of deferred financing costs	7,045	8,023	428
Deferred income taxes	(65,527)	(88,402)	15,119
Share based compensation expense	22,187	20,947	18,803
Restructuring and other costs - non-cash	20,229	2,460	379
Stock option income tax benefit	(13,009)	(1,039)	(4,663)
Net interest expense on derivatives with an other than insignificant financing element	1,108	3,853	1,635
Income (Loss) from Equity Method Investments	3,270	(2,351)	1,096
Other non-cash expense (income)	(15,564)	20,938	6,153
Loss (gain) on disposal of property, plant and equipment	808	570	113
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	(12,591)	1,469	5,115
Inventories, net	(36,792)	21,503	(9,309)
Prepaid expenses and other current assets	(15,126)	(933)	(3,705)
Other noncurrent assets	853	(1,560)	(1,154)
Accounts payable	12,843	10,816	2,165
Accrued liabilities	(2,084)	38,365	9,004
Income taxes	22,105	26,139	2,786
Other noncurrent liabilities	(7,758)	190	249
Net cash provided by operating activities	369,685	393,469	377,461
Cash flows from investing activities:
Cash paid for acquisitions of businesses and equity investments	(4,861)	(1,787,516)	(35,556)
Capital expenditures	(92,072)	(71,186)	(44,236)
Purchase of convertible debt issued by affiliate	0	0	(49,654)
Purchase of company owned life insurance policies	(1,577)	0	(2,000)
Payments on settlement of net investment hedges	(14,221)	(25,575)	(34,978)
Expenditures for identifiable intangible assets	(3,329)	(3,068)	(1,606)
Liquidations of short-term investments	0	6	0
Proceeds from sale of property, plant and equipment	1,039	497	3,562
Net cash used in investing activities	(115,021)	(1,886,842)	(164,468)
Cash flows from financing activities:
Proceeds from long-term borrowings, net of deferred financing costs	0	1,106,514	368,611
Payments on long-term borrowings	0	(251,932)	(242,137)
Increase (decrease) in short-term borrowings	(228,912)	270,209	(9,657)
Payments on terminated derivative instruments	0	(34,628)	0
Proceeds from exercise of stock options	34,183	42,275	30,189
Excess tax benefits from share based compensation	13,009	1,039	4,663
Cash paid for contingent consideration on prior acquisitions	(2,519)	(3,023)	0
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries	0	(16,088)	0
Cash paid for treasury stock	(38,837)	(79,500)	(223,993)
Cash dividends paid	(31,425)	(28,632)	(29,077)
Net interest payments on derivatives with an other-than-insignificant financing element	(1,108)	(3,853)	(1,635)
Net cash provided by (used in) financing activities	(255,609)	1,002,381	(103,036)
Effect of exchange rate changes on cash and cash equivalents	3,949	28,082	(20,267)
Net (decrease) increase in cash and cash equivalents	3,004	(462,910)	89,690
Cash and cash equivalents at beginning of period	77,128	540,038	450,348
Cash and cash equivalents at end of period	80,132	77,128	540,038
Supplemental disclosures of cash flow information:
Interest paid, net of amounts capitalized	60,166	34,048	21,856
Income taxes paid	$ 109,544	$ 58,646	$ 64,787

Balance Sheet (Parentheticals) - $ / shares shares in Thousands	Dec. 31, 2012	Dec. 31, 2011
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	250	250
Preferred Stock, Shares Issued	0	0
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	200,000	200,000
Common Stock, Shares, Issued	162,800	162,800
Treasury Stock, Shares	20,500	21,100

SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

Description of Business

DENTSPLY International Inc. (“DENTSPLY” or the “Company”), designs, develops, manufactures and markets a broad range of consumable dental products for the professional dental market. The Company believes that it is the world's leading manufacturer and distributor of dental prosthetics, endodontic instruments and materials, and ultrasonic scalers; the leading U.S. manufacturer and distributor of denture teeth, dental handpieces, dental x-ray film holders, film mounts and prophylaxis paste; and a leading worldwide manufacturer or distributor of dental injectable anesthetics, impression materials, orthodontic appliances, dental cutting instruments, dental implants and restorative dental materials, dental sealants, and crown and bridge materials. The Company also manufacturers and distributes consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company distributes its products in over 120 countries under some of the most well established brand names in the industry.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“US GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements.

Principles of Consolidation

The consolidated financial statements include the accounts of the Company. The Company also consolidates all variable interest entities (“VIE”) where the Company has determined that it has the power to direct the activities that most significantly impact the VIE's economic performance and shares in either the significant risks or rewards of the VIE. The Company continually reassesses its VIE to determine if consolidation is appropriate. All significant intercompany accounts and transactions are eliminated in consolidation.

Investments in nonconsolidated affiliates (20-50 percent owned companies, joint ventures and partnerships as well as less than 20 percent ownership positions where the Company maintains significant influence over the subsidiary) are accounted for using the equity method.

The accompanying audited consolidated statements of operations for the year ended December 31, 2011 include the results of operations for Astra Tech AB (“Astra Tech”) for the period September 1, 2011 to December 31, 2011.

Cash and Cash Equivalents

Cash and cash equivalents include deposits with banks as well as highly liquid time deposits with maturities at the date of purchase of ninety days or less.

Short-term Investments

Short-term investments are highly liquid time deposits with original maturities at the date of purchase greater than ninety days and with remaining maturities of one year or less.

Accounts and Notes Receivable-Trade

The Company sells dental and certain medical products through a worldwide network of distributors and directly to end users. For customers on credit terms, the Company performs ongoing credit evaluation of those customers' financial condition and generally does not require collateral from them. The Company establishes allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The Company records a provision for doubtful accounts, which is included in “Selling, general and administrative expenses" in the Consolidated Statements of Operations.

Accounts receivable – trade is stated net of these allowances that were $13.6 million and $14.9 million at December 31, 2012 and 2011, respectively. For the years ended December 31, 2012 and 2011, the Company wrote-off $3.8 million and $1.4 million, respectively, of accounts receivable that were previously reserved. The Company increased the provision for doubtful accounts by $2.4 million and $0.5 million during 2012 and 2011, respectively.

Additionally, notes receivable – trade is stated net of these allowances that were $0.9 million and $0.9 million at December 31, 2012 and 2011, respectively. The Company recorded provisions for doubtful accounts on notes receivable – trade of $0.1 million for 2012 and $1.0 million for 2011. Additionally, the Company wrote-off $0.2 million and $0.9 million in 2012 and 2011, respectively.

Inventories

Inventories are stated at the lower of cost or market. At December 31, 2012 and 2011, the cost of $6.3 million and $7.1 million, respectively, of inventories was determined by the last in, first-out (“LIFO”) method. The cost of other inventories was determined by the first-in, first-out (“FIFO”) or average cost methods. The Company establishes reserves for inventory estimated to be obsolete or unmarketable equal to the difference between the cost of inventory and estimated market value based upon assumptions about future demand and market conditions.

If the FIFO method had been used to determine the cost of LIFO inventories, the amounts at which net inventories are stated would be higher than reported at December 31, 2012 and 2011 by $5.9 million and $5.6 million, respectively.

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:



	December 31,
(in thousands)	2012	2011

Deferred taxes	80,903	67,159
Prepaid expenses	54,881	32,899
Other current assets	49,828	46,246
	185,612	146,304

Valuation of Goodwill and Other Long-Lived Assets

Assessment of the potential impairment of goodwill and other long-lived assets is an integral part of the Company's normal ongoing review of operations. Testing for potential impairment of these assets is significantly dependent on assumptions and reflects management's best estimates at a particular point in time. The dynamic economic environments in which the Company's businesses operate and key economic and business assumptions with respect to projected selling prices, increased competition and introductions of new technologies can significantly affect the outcome of impairment tests. Estimates based on these assumptions may differ significantly from actual results. Changes in factors and assumptions used in assessing potential impairments can have a significant impact on the existence and magnitude of impairments, as well as the time at which such impairments are recognized. If there are unfavorable changes in these assumptions, future cash flows, a key variable in assessing the impairment of these assets, may decrease and as a result the Company may be required to recognize impairment charges. Future changes in the environment and the economic outlook for the assets being evaluated could also result in additional impairment charges being recognized. The following information outlines the Company's significant accounting policies on long-lived assets by type.

Goodwill

Goodwill is the excess of the purchase price over the fair value of identifiable net assets acquired and liabilities assumed in a business combination. Goodwill is not amortized. Goodwill is tested for impairment annually, during the Company's second quarter, or when indications of potential impairment exist. The Company monitors for the existence of potential impairment throughout the year. This impairment assessment includes an evaluation of various reporting units, which is an operating segment or one reporting level below the operating segment. The Company performs impairment tests using a fair value approach. The Company compares the fair value of each reporting unit to its carrying amount to determine if there is potential goodwill impairment. If impairment is identified on goodwill, the resulting charge is determined by recalculating goodwill through a hypothetical purchase price allocation of the fair value and reducing the current carrying value to the extent it exceeds the recalculated goodwill.

The Company's fair value approach involves using a discounted cash flow model with market-based support as its valuation technique to measure the fair value for its reporting units. The discounted cash flow model uses five-year forecasted cash flows plus a terminal value based on a multiple of earnings. In addition, the Company applies gross profit and operating expense assumptions consistent with its historical trends. The total cash flows were discounted based on market participant data, which included the Company's weighted-average cost of capital. The Company considered the current market conditions when determining its assumptions. Lastly, the Company reconciled the aggregate fair values of its reporting units to its market capitalization, which included a reasonable control premium based on market conditions. Additional information related to the testing for goodwill impairment is provided in Note 8, Goodwill and Intangible Assets.

Indefinite-Lived Intangible Assets

Indefinite-lived intangible assets consist of tradenames and are not subject to amortization. Valuations of identifiable intangibles assets acquired are based on information and assumptions available at the time of acquisition, using income and market model approaches to determine fair value. In-process research and development assets are not subject to amortization until the product associated with the research and development is substantially complete and is a viable product. At that time, the useful life to amortize the intangible asset is determined by identifying the period in which substantially all the cash flows are expected to be generated and the asset is moved to definite-lived.

These assets are reviewed for impairment annually or whenever events or circumstances suggest that the carrying amount of the asset may not be recoverable. The Company uses an income approach, more specifically a relief from royalty method. Significant management judgment is necessary to determine key assumptions, including projected revenue, royalty rates and appropriate discount rates. Royalty rates used are consistent with those assumed for the original purchase accounting valuation. Other assumptions are consistent with those applied to goodwill impairment testing. If the carrying value exceeds the fair value, an impairment loss in the amount equal to the excess is recognized.

Identifiable Definite-Lived Intangible Assets

Identifiable definite-lived intangible assets, which primarily consist of patents, trademarks, brand names, non-compete agreements and licensing agreements, are amortized on a straight-line basis over their estimated useful lives. Valuations of identifiable intangibles assets acquired are based on information and assumptions available at the time of acquisition, using income and market model approaches to determine fair value.

These assets are reviewed for impairment whenever events or circumstances suggest that the carrying amount of the asset may not be recoverable. The Company closely monitors certain intangible assets related to new and existing technologies for indicators of impairment as these assets have more risk of becoming impaired. Impairment is based upon an initial evaluation of the identifiable undiscounted cash flows. If the initial evaluation identifies a potential impairment, a fair value is determined by using a discounted cash flows valuation. If impaired, the resulting charge reflects the excess of the asset’s carrying cost over its fair value.

Property, Plant and Equipment

Property, plant and equipment are stated at cost, net of accumulated depreciation. Except for leasehold improvements, depreciation for financial reporting purposes is computed by the straight-line method over the following estimated useful lives: buildings - generally 40 years and machinery and equipment - 4 to 15 years. The cost of leasehold improvements is amortized over the shorter of the estimated useful life or the term of the lease. Maintenance and repairs are expensed as incurred to the statement of operations; replacements and major improvements are capitalized. These assets groups are reviewed for impairment whenever events or circumstances suggest that the carrying amount of the asset group may not be recoverable. Impairment is based upon an evaluation of the identifiable undiscounted cash flows. If impaired, the resulting charge reflects the excess of the asset group’s carrying cost over its fair value.

Marketable Securities

The Company's marketable securities consist of debt instruments that are classified as available-for-sale in “Other noncurrent assets, net” on the Consolidated Balance Sheets as the instruments mature in December 2015. The Company determined the appropriate classification at the time of purchase and will re-evaluate such designation as of each balance sheet date. In addition, the Company reviews the securities each quarter for indications of possible impairment. Once identified, the determination of whether the impairment is temporary or other-than-temporary requires significant judgment. The primary factors that the Company considers in classifying the impairment include the extent and time the fair value of each investment has been below cost and the existence of a credit loss. If a decline in fair value is judged other-than-temporary, the basis of the securities is written down to fair value and the amount of the write-down is included as a realized loss.

Derivative Financial Instruments

The Company records all derivative instruments on the consolidated balance sheet at fair value and changes in fair value are recorded each period in the consolidated statements of operations or accumulated other comprehensive income (“AOCI”).

The Company employs derivative financial instruments to hedge certain anticipated transactions, firm commitments, and assets and liabilities denominated in foreign currencies. Additionally, the Company utilizes interest rate swaps to convert floating rate debt to fixed rate, fixed rate debt to floating rate, cross currency basis swaps to convert debt denominated in one currency to another currency, and commodity swaps to fix its variable raw materials costs.

Pension and Other Postretirement Benefits

Some of the employees of the Company and its subsidiaries are covered by government or Company-sponsored defined benefit plans. Many of the employees have available to them defined contribution plans. Additionally, certain union and salaried employee groups in the United States are covered by postretirement healthcare plans. Costs for Company-sponsored defined benefit and postretirement benefit plans are based on expected return on plan assets, discount rates, employee compensation increase rates and health care cost trends. Expected return on plan assets, discount rates and health care cost trend assumptions are particularly important when determining the Company’s benefit obligations and net periodic benefit costs associated with postretirement benefits. Changes in these assumptions can impact the Company’s earnings before income taxes. In determining the cost of postretirement benefits, certain assumptions are established annually to reflect market conditions and plan experience to appropriately reflect the expected costs as actuarially determined. These assumptions include medical inflation trend rates, discount rates, employee turnover and mortality rates. The Company predominantly uses liability durations in establishing its discount rates, which are observed from indices of high-grade corporate bond yields in the respective economic regions of the plans. The expected return on plan assets is the weighted average long-term expected return based upon asset allocations and historic average returns for the markets where the assets are invested, principally in foreign locations. The Company reports the funded status of its defined benefit pension and other postretirement benefit plans on its consolidated balance sheets as a net liability or asset. Additional information related to the impact of changes in these assumptions is provided in Note 13, Benefit Plans.

Accruals for Self-Insured Losses

The Company maintains insurance for certain risks, including workers’ compensation, general liability, product liability and vehicle liability, and is self-insured for employee related healthcare benefits. The Company accrues for the expected costs associated with these risks by considering historical claims experience, demographic factors, severity factors and other relevant information. Costs are recognized in the period the claim is incurred, and the financial statement accruals include an estimate of claims incurred but not yet reported. The Company has stop-loss coverage to limit its exposure to any significant exposure on a per claim basis.

Litigation

The Company and its subsidiaries are from time to time parties to lawsuits arising out of their respective operations. The Company records liabilities when a loss is probable and can be reasonably estimated. These estimates are typically in the form of ranges, and the Company records the liabilities at the low point of the ranges, when no other point within the ranges are a better estimate of the probable loss. The ranges established by management are based on analysis made by internal and external legal counsel who considers information known at the time. If the Company determines a liability to be only reasonably possible, it considers the same information to estimate the possible exposure and discloses any material potential liability. These loss contingencies are monitored regularly for a change in fact or circumstance that would require an accrual adjustment. The Company believes it has estimated liabilities for probable losses appropriately in the past; however, the unpredictability of litigation and court decisions could cause a liability to be incurred in excess of estimates. Legal costs related to these lawsuits are expensed as incurred.

Accumulated Other Comprehensive Income

AOCI includes foreign currency translation adjustments related to the Company’s foreign subsidiaries, net of the related changes in certain financial instruments hedging these foreign currency investments. In addition, changes in the Company’s fair value of certain derivative financial instruments, net unrealized holding gain on available-for-sale securities and pension liability adjustments and prior service costs, net are recorded in AOCI. These changes are recorded in AOCI net of any related tax adjustments. For the years ended December 31, 2012, 2011 and 2010, these tax adjustments were $185.6 million, $167.5 million and $158.7 million, respectively, primarily related to foreign currency translation adjustments.

The balances included in AOCI in the consolidated balance sheets are as follows:



	December 31,
(in thousands)	2012			2011

Foreign currency translation adjustments	$	54,302		$	(39,078	)
Net loss on derivative financial instruments	(143,142		)	(117,390		)
Net unrealized holding (loss) gain on available for-sale securities	17,822			(516		)
Pension liability adjustments	(73,182		)	(33,986		)
	$	(144,200	)	$	(190,970	)

The cumulative foreign currency translation adjustments included translation gains of $177.7 million and $94.4 million as of December 31, 2012 and 2011, respectively, were offset by losses of $123.4 million and $133.5 million, respectively, on loans designated as hedges of net investments.

Foreign Currency Translation

The functional currency for foreign operations, except for those in highly inflationary economies, generally has been determined to be the local currency.

Assets and liabilities of foreign subsidiaries are translated at foreign exchange rates on the balance sheet date; revenue and expenses are translated at the average year-to-date foreign exchange rates. The effects of these translation adjustments are reported in Equity within AOCI of the consolidated balance sheets. During the year ended December 31, 2012, the Company had gains of $10.1 million on its loans designated as hedges of net investments and translation gains of $83.3 million. During the year ended December 31, 2011, the Company had losses of $9.6 million on its loans designated as hedges of net investments and translation losses of $200.1 million.

Foreign exchange gains and losses arising from transactions denominated in a currency other than the functional currency of the entity involved and remeasurement adjustments in countries with highly inflationary economies are included in income. Net foreign exchange transaction losses of $2.7 million, $1.7 million and $3.3 million in 2012, 2011, and 2010, respectively, are included in “Other expense (income), net” on the Consolidated Statements of Operations.

Revenue Recognition

Revenue, net of related discounts and allowances, is recognized when the earnings process is complete. This occurs when products are shipped to or received by the customer in accordance with the terms of the agreement, title and risk of loss have been transferred, collectability is reasonably assured and pricing is fixed or determinable. Net sales include shipping and handling costs collected from customers in connection with the sale. Sales taxes, value added taxes and other similar types of taxes collected from customers in connection with the sale are recorded by the Company on a net basis and are not included in the consolidated statement of operations.

Certain of the Company's customers are offered cash rebates based on targeted sales increases. Estimates of rebates are based on the forecasted performance of the customer and their expected level of achievement within the rebate programs. In accounting for these rebate programs, the Company records an accrual as a reduction of net sales as sales take place over the period the rebate is earned. The Company revises the accruals for these rebate programs as actual results and revised forecasts impact the estimated achievement for customers within the rebate programs.

A portion of the Company’s net sales is comprised of sales of precious metals generated through its precious metal dental alloy product offerings. As the precious metal content of the Company’s sales is largely a pass-through to customers, the Company uses its cost of precious metal purchased as a proxy for the precious metal content of sales, as the precious metal content of sales is not separately tracked and invoiced to customers. The Company believes that it is reasonable to use the cost of precious metal content purchased in this manner since precious metal alloy sale prices are typically adjusted when the prices of underlying precious metals change. The precious metals content of sales was $213.7 million, $205.1 million and $189.2 million for 2012, 2011 and 2010, respectively.

Cost of Products Sold

Cost of products sold represents costs directly related to the manufacture and distribution of the Company’s products. Primary costs include raw materials, packaging, direct labor, overhead, shipping and handling, warehousing and the depreciation of manufacturing, warehousing and distribution facilities. Overhead and related expenses include salaries, wages, employee benefits, utilities, lease costs, maintenance and property taxes.

Warranties

The Company provides warranties on certain equipment products. Estimated warranty costs are accrued when sales are made to customers. Estimates for warranty costs are based primarily on historical warranty claim experience. Warranty costs are included in “Cost of products sold” in the Consolidated Statements of Operations.

Selling, General and Administrative Expenses

Selling, general and administrative expenses represent costs incurred in generating revenues and in managing the business of the Company. Such costs include advertising and other marketing expenses, salaries, employee benefits, incentive compensation, research and development, travel, office expenses, lease costs, amortization of capitalized software and depreciation of administrative facilities.

Research and Development Costs

Research and development (“R&D”) costs relate primarily to internal costs for salaries and direct overhead expenses. In addition, the Company contracts with outside vendors to conduct R&D activities. All such R&D costs are charged to expense when incurred. The Company capitalizes the costs of equipment that have general R&D uses and expenses such equipment that is solely for specific R&D projects. The depreciation expense related to this capitalized equipment is included in the Company’s R&D costs. R&D costs are included in “Selling, general and administrative expenses” in the Consolidated Statements of Operations and amounted to $85.4 million, $66.7 million and $49.4 million for 2012, 2011 and 2010, respectively.

Stock Compensation

The Company recognizes the compensation cost relating to share-based payment transactions in the financial statements. The cost of share-based payment transactions is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the employee’s requisite service period (generally the vesting period of the equity awards). The compensation cost is only recognized for the portion of the awards that are expected to vest.

Income Taxes

The Company’s tax expense includes U.S. and international income taxes plus the provision for U.S. taxes on undistributed earnings of international subsidiaries not deemed to be permanently invested. Tax credits and other incentives reduce tax expense in the year the credits are claimed. Certain items of income and expense are not reported in tax returns and financial statements in the same year. The tax effect of such temporary differences is reported as deferred income taxes. Deferred tax assets are recognized if it is more likely than not that the assets will be realized in future years. The Company establishes a valuation allowance for deferred tax assets for which realization is not likely.

The Company applies a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company recognizes in the financial statements, the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.

Earnings Per Share

Basic earnings per share are calculated by dividing net earnings by the weighted average number of shares outstanding for the period. Diluted earnings per share is calculated by dividing net earnings by the weighted average number of shares outstanding for the period, adjusted for the effect of an assumed exercise of all dilutive options outstanding at the end of the period.

Business Acquisitions

The Company acquires businesses as well as partial interests in businesses. Acquired businesses are accounted for using the acquisition method of accounting which requires the Company to record assets acquired and liabilities assumed at their respective fair values with the excess of the purchase price over estimated fair values recorded as goodwill. The assumptions made in determining the fair value of acquired assets and assumed liabilities as well as asset lives can materially impact the results of operations.

The Company obtains information during due diligence and through other sources to establish respective fair values. Examples of factors and information that the Company uses to determine the fair values include: tangible and intangible asset evaluations and appraisals; evaluations of existing contingencies and liabilities and product line information. If the initial valuation for an acquisition is incomplete by the end of the quarter in which the acquisition occurred, the Company will record a provisional estimate in the financial statements. The provisional estimate will be finalized as soon as information becomes available but will only occur up to one year from the acquisition date.

Equity Method Investments

Investments in partnerships, joint ventures and less-than-majority-owned subsidiaries in which the Company has significant influence are accounted for under the equity method.

Equity investments are carried at original cost adjusted for the proportionate share of the investees’ income, losses and distributions. The Company assesses the carrying value of its equity investments when an indicator of a loss in value is present and record a loss in value of the investment when the assessment indicates that an other-than-temporary decline in the investment exists.

The Company classifies its equity in net earnings of unconsolidated affiliates in the Consolidated Statements of Operations under the title of “Equity in net income (loss) of unconsolidated affiliated company.”

Noncontrolling Interests

The Company reports noncontrolling interest (“NCI”) in a subsidiary as a separate component of Equity in the Consolidated Balance Sheets. Additionally, the Company reports the portion of net income and comprehensive income (loss) attributed to the Company and NCI separately in the Consolidated Statements of Operations. The Company also includes a separate column for NCI in the Consolidated Statements of Changes in Equity.

Variable Interest Entities

The Company consolidates all VIE where the Company has determined that it has the power to direct the activities that most significantly impact the VIE’s economic performance and shares in either the significant risks or rewards of the VIE. The Company continually reassesses VIE to determine if consolidation is appropriate. The Company continues to believe that it is the primary beneficiary of one entity under the accounting guidance.

Segment Reporting

The Company has numerous operating businesses covering a wide range of products and geographic regions, primarily serving the professional dental market and to a lesser extent the consumable medical device market. Professional dental products represented approximately 89%, 93%, and 97% of sales in 2012, 2011 and 2010, respectively. The Company has four reportable segments and a description of the activities of these segments is included in Note 4, Segment and Geographic Information.

During the first quarter of 2012, the Company realigned reporting responsibilities for multiple locations as a result of changes to the management structure. These changes also helped the Company gain operating efficiencies and effectiveness. The segment information below reflects the revised structure for all periods shown.

Fair Value Measurement

Recurring Basis

The Company records certain financial assets and liabilities at fair value in accordance with the accounting guidance, which defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The accounting guidance establishes a hierarchal disclosure framework associated with the level of pricing observability utilized in measuring financial instruments at fair value. The three broad levels defined by the fair value hierarchy are as follows:

Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reported date.

Level 2 - Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reported date. The nature of these financial instruments include, derivative instruments whose fair value have been derived using a model where inputs to the model are directly observable in the market, or can be derived principally from, or corroborated by observable market data.

Level 3 - Instruments that have little to no pricing observability as of the reported date. These financial instruments do not have two-way markets and are measured using management's best estimate of fair value, where the inputs into the determination of fair value require significant management judgment or estimation.

The degree of judgment utilized in measuring the fair value of certain financial assets and liabilities generally correlates to the level of pricing observability. Pricing observability is impacted by a number of factors, including the type of financial instrument. Financial assets and liabilities with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of pricing observability and a lesser degree of judgment utilized in measuring fair value. Conversely, financial assets and liabilities rarely traded or not quoted will generally have less, or no pricing observability and a higher degree of judgment utilized in measuring fair value.

The Company primarily applies the market approach for recurring fair value measurements and endeavors to utilize the best available information. Accordingly, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. Additionally, the Company considers its credit risks and its counterparties' credit risks when determining the fair values of its financial assets and liabilities. The Company has presented the required disclosures in Note 16, Fair Value Measurement.

Non-Recurring Basis

When events or circumstances require an asset or liability to be fair valued that otherwise is generally recorded based on another valuation method, such as, net realizable value, the Company will utilize the valuation techniques described above.

Reclassification of Prior Year Amounts

Certain reclassifications have been made to prior years' data in order to conform to current year presentation.

New Accounting Pronouncements

In June 2011, the Financial Accounting Standards Board (“FASB”) amended its rules regarding the presentation of comprehensive income. The objective of this amendment was to improve the comparability, consistency and transparency of financial reporting and to increase the prominence of items reported in other comprehensive income. Specifically, this amendment requires that all non-owner changes in shareholders' equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The new rules became effective during interim and annual periods beginning after December 15, 2011, with the exception of the requirement to present reclassification adjustments from other comprehensive income to net income on the face of the financial statements, which has been deferred pending further deliberation by the FASB. Because the standard only impacted the presentation of comprehensive income and does not impact what is included in comprehensive income, the standard did not have a significant impact on the Company's consolidated financial statements. The Company adopted this accounting standard during the quarter ended March 31, 2012.

In September 2011, the FASB issued Accounting Standards Update (ASU) No. 2011-08, “Intangibles - Goodwill and Other (Topic 350): Testing Goodwill for Impairment”. This newly issued accounting standard is intended to reduce the cost and complexity of the annual goodwill impairment test by providing entities an option to perform a "qualitative" assessment to determine whether further impairment testing is necessary. Under the revised standard, an entity has the option to first assess qualitative factors to determine whether it is necessary to perform the current two-step impairment test. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount, the quantitative impairment test is required; otherwise, no further testing is required. Prior to the issuance of the revised standard, an entity was required to perform step one of the impairment test at least annually by calculating and comparing the fair value of a reporting unit to its carrying amount. Under the revised standard, if an entity determines that step one is necessary and the fair value of the reporting unit is less than its carrying amount, then step two of the test will continue to be required to measure the amount of the impairment loss, if any. These amendments do not change the current guidance for testing other indefinite-lived intangible assets for impairment. This ASU is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The Company adopted this standard for the quarter ended June 30, 2012 and it did not impact the Company's financial position or results from operations.

In July 2012, the FASB issued ASU No. 2012-02, "Intangibles - Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment". This newly issued accounting standard is intended to reduce the cost and complexity of the annual indefinite-lived intangible asset impairment test by providing entities an option to perform a qualitative assessment to determine whether further impairment testing is necessary. Under the revised standard, an entity has the option to first assess qualitative factors to determine whether it is necessary to perform the current two-step impairment test. If an entity believes, as a result of its qualitative assessment, that it is more-likely-than-not that an indefinite-lived intangible asset is less than its carrying amount, the quantitative impairment test is required; otherwise, no further testing is required. Prior to the issuance of the revised standard, an entity was required to perform step one of the impairment test at least annually by calculating and comparing the fair value of an indefinite-lived intangible asset to its carrying amount. Under the revised standard, if an entity determines that step one is necessary and the indefinite-lived intangible asset is less than its carrying amount, then step two of the test will continue to be required to measure the amount of the impairment loss, if any. This ASU is effective for annual and interim indefinite-lived intangible asset impairment tests performed for fiscal years beginning after September 15, 2012. The Company expects to adopt this standard for the quarter ended March 31, 2013. The adoption of this standard is not expected to impact the Company's financial position or results from operations.

EARNINGS PER COMMON SHARE

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

EARNINGS PER COMMON SHARE

The following table sets forth the computation of basic and diluted earnings per common share:



(in thousands, except for per share amounts)	Net income attributable to DENTSPLY International		Shares	Earnings per common share

Year Ended December 31, 2012
Basic	$	314,213	141,850	$	2.22
Incremental shares from assumed exercise of dilutive options	—		2,095

Diluted	$	314,213	143,945	$	2.18

Year Ended December 31, 2011
Basic	$	244,520	141,386	$	1.73
Incremental shares from assumed exercise of dilutive options	—		2,167

Diluted	$	244,520	143,553	$	1.70

Year Ended December 31, 2010
Basic	$	265,708	143,980	$	1.85
Incremental shares from assumed exercise of dilutive options	—		2,005

Diluted	$	265,708	145,985	$	1.82

Options to purchase 4.1 million, 3.2 million and 3.1 million shares of common stock that were outstanding during the years ended 2012, 2011 and 2010, respectively, were not included in the computation of diluted earnings per common share since the options' exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.

BUSINESS ACQUISITIONS AND INVESTMENTS IN AFFILIATES

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

BUSINESS ACQUISITIONS AND INVESTMENTS IN AFFILIATES

Business Acquisitions

2012 Acquisitions

The acquisition related activity for the year ended December 31, 2012 was $7.4 million, which was related to one acquisition and one earn-out payment for a prior period acquisition.

The Company had one acquisition for the year ended December 31, 2012. The results of operations for this business have been included in the accompanying financial statements as of the effective date of the respective transactions. The purchase price has been assigned on the basis of preliminary estimates of the fair values of assets acquired and liabilities assumed. This transaction was immaterial to the Company's net sales and net income attributable to DENTSPLY.

2011 Acquisitions

The acquisition related activity for the year ended December 31, 2011 was $1.8 billion, net of cash acquired of $23.4 million, was related to six acquisitions and two earn-out payments for prior period acquisitions.

On August 31, 2011, the Company acquired 100% of the outstanding common shares of Astra Tech using the available cash on hand and debt financing discussed in Note 10, Financing Arrangements. Astra Tech is a leading developer, manufacturer and marketer of dental implants, customized implant abutments and consumable medical devices in the urology and surgery market segments. The Astra Tech acquisition was recorded in accordance with the business combinations provisions of US GAAP.

The following table summarizes the final fair value of identifiable assets and liabilities assumed at the date of the acquisition. This table has been updated in 2012 to reflect the final fair value. The final valuation change resulted in increases to identifiable intangible assets relating mostly to customer relationships and deferred tax liabilities with a decrease to goodwill. During the fourth quarter of 2012, the Company increased goodwill by $5.0 million primarily due to an increase to the purchase price of $4.3 million resulting from the finalization of the purchase price with the seller. The Company determined that it was not necessary to retroactively revise prior period financial statements as the changes were not material to the Company's consolidated financial statements.



(in thousands)

Inventory	$	84,659
Other current assets	140,546
Property, plant, and equipment	178,495
Identifiable intangible assets	844,100
Goodwill	952,108
Other long-term assets	15,969
Total assets	2,215,877
Current liabilities	107,243
Long-term liabilities	313,594
Total liabilities	420,837
Net assets	$	1,795,040

Other current assets consist primarily of trade accounts receivable of $101.2 million. Current liabilities assumed are primarily comprised of accrued and other current liabilities of $80.1 million and trade accounts payable of $27.1 million. Long-term liabilities assumed are primarily comprised of noncurrent deferred tax liabilities of $260.3 million and pension obligations of $53.3 million.

Inventory held by Astra Tech includes a fair value adjustment of $32.8 million. The Company expensed this amount by December 31, 2011 as the acquired inventory was sold.

Property, plant and equipment include a fair value adjustment of $28.7 million and consist of land, buildings, plant and equipment. Depreciable lives range 40 years for buildings and from 5 to 15 years for plant and equipment.

The fair values assigned to identifiable intangible assets were determined through the use of the income approach, specifically the relief from royalty method and the multi-period excess earnings method. Both valuation methods rely on management’s judgments, including expected future cash flows resulting from existing customer relationships, customer attrition rates, contributory effects of other assets utilized in the business, peer group cost of capital and royalty rates as well as other factors.

Useful lives for identifiable intangible assets were determined based upon the remaining useful economic lives of the identifiable intangible assets that are expected to contribute to future cash flows. The acquired identifiable intangible assets are being amortized on a straight-line basis over their expected useful lives. Identifiable indefinite-lived intangible and in-process research and development ("In-process R&D") assets were not assigned lives.

Intangible assets acquired consist of the following:



(in thousands, except for useful life)			Useful Life
	Amount		(in years)

Customer relationships	$	494,700	15 - 18
Developed technology and patents	116,500		10
Trade names and Trademarks	229,100		Indefinite
In-process R&D	3,800		—
Total	$	844,100

The $952.1 million of goodwill is attributable to the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The goodwill recognized is primarily attributable to cost savings and other synergies that the Company expects to realize through operational efficiencies. All of the goodwill has been assigned to the Company's Implants/Endodontics/Healthcare/Pacific Rim segment and is not expected to be deductible for tax purposes.

Astra Tech contributed net sales of $207.1 million and an operating loss of $18.5 million to the Company's consolidated statements of operations during the period from September 1, 2011 to December 31, 2011 and is included in the Implants/Endodontics/Healthcare/Pacific Rim segment.

The following unaudited pro forma financial information reflects the consolidated results of operations of the Company had the Astra Tech acquisition occurred on January 1, 2010. These amounts were calculated after conversion to US GAAP, applying the Company's accounting policies and adjusting Astra Tech's results to reflect the additional depreciation and amortization that would have been charged assuming the fair value adjustments to property, plant and equipment, inventory and intangible assets had been applied from January 1, 2010, together with the consequential tax effects at the statutory rate. These adjustments also reflect the additional interest expense incurred on the debt to finance the acquisition.



(in thousands, except per share data)	Year Ended December 31,
	2011		2010

Net Sales	$	2,918,347	$	2,755,300
Net income attributable to DENTSPLY	250,363		274,962
Diluted earnings per common share	$	1.74	$	1.88

The pro forma financial information is based on the Company's final assignment of purchase price of the fair value of identifiable assets acquired and liabilities assumed. The Astra Tech financial information has been compiled in a manner consistent with the accounting policies adopted by DENTSPLY. Pro forma results do not include any anticipated synergies or other anticipated benefits of the acquisition. Accordingly, the unaudited pro forma financial information is not necessarily indicative of either future results of operations or results that might have been achieved had the acquisition occurred on January 1, 2010. While the Company completed other transactions during the pro forma periods presented above, these transactions were immaterial to the Company's net sales and net income attributable to DENTSPLY.

The Company had additional acquisition related activity for the year ended December 31, 2011. The results of operations for this business have been included in the accompanying financial statements as of the effective date of the respective transactions. The purchase prices have been assigned on the basis of preliminary estimates of the fair values of assets acquired and liabilities assumed. At December 31, 2011, the Company recorded a total of $9.7 million in goodwill related to the difference between the fair value of assets acquired and liabilities assumed and the consideration given. The goodwill is primarily associated with the Implants/Endodontics/Healthcare/Pacific Rim segment.

For the year ended December 31, 2011, in connection with pending or completed acquisitions, the Company had incurred $44.2 million of transaction related costs, primarily banking fees and amounts paid to third party advisers.

Investment in Affiliates

On December 9, 2010, the Company purchased an initial ownership interest of 17% of the outstanding shares of DIO Corporation (DIO). The Company accounts for the ownership in DIO under the equity method of accounting as it has significant influence over DIO. In addition, on December 9, 2010, the Company invested $49.7 million in the corporate convertible bonds of DIO, which may be converted into common shares at any time. The contractual maturity of the bond is in December 2015. The bonds are designated by the Company as available-for-sale securities which are reported in, “Other noncurrent assets, net,” on the Consolidated Balance Sheets and the changes in fair value are reported in AOCI. The convertible feature of the bond has not been bifurcated from the underlying bond as the feature does not contain a net-settlement feature, nor would the Company be able to achieve a hypothetical net-settlement that would substantially place the Company in a comparable cash settlement position. As such, the derivative is not accounted for separately from the bond. The cash paid by the Company is equal to the face value of the bonds issued by DIO, and therefore, the Company has not recorded any bond premium or discount on acquiring the bonds. The fair value of the DIO bond was $75.1 million and $47.8 million at December 31, 2012 and 2011, respectively. At December 31, 2012, an unrealized holding gain of $17.8 million on available-for-sale securities, net of tax, had been recorded in AOCI. At December 31, 2011 and 2010, an unrealized holding loss of $11.5 million and an unrealized holding gain of $11.0 million, respectively, was recorded on available-for-sale securities, net of tax, in AOCI.

Variable Interest Entities

During 2011, the Company completed the acquisition of the remaining share of one VIE, in which it had acquired a minority interest in 2006. This transaction was immaterial to the Company's net sales and net income attributable to DENTSPLY.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1383-128463

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 88-16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph F4
-Subparagraph e
-Appendix F

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51, 52
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 67-73
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

SEGMENT AND GEOGRAPHIC INFORMATION

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

SEGMENT AND GEOGRAPHIC INFORMATION

The businesses are combined into operating groups, which have overlapping product offerings, geographical presence, customer bases, distribution channels and regulatory oversight. These operating groups are considered the Company’s reportable segments as the Company’s chief operating decision-maker regularly reviews financial results at the operating group level and uses this information to manage the Company’s operations. The accounting policies of the segments are consistent with those described for the consolidated financial statements in the summary of significant accounting policies (see Note 1, Significant Accounting Policies). The Company measures segment income for reporting purposes as net operating income before restructuring, impairments, and other costs, interest and taxes. Additionally, the operating groups are measured on net third party sales, excluding precious metal content. A description of the services provided within each of the Company’s four reportable segments is provided below. The disclosure below reflects the Company’s segment reporting structure.

Dental Consumable and Laboratory Businesses

This segment includes responsibility for the design, manufacturing, sales and distribution of certain small equipment and chairside consumable products in the United States, Germany and certain other European regions. It also has responsibility for the sales and distribution of certain Endodontic products in Germany. This segment also includes the responsibility for the design, manufacture, sales and distribution of most dental laboratory products, excluding certain countries. This segment is also responsible for most of the Company’s non-dental business excluding medical products.

Orthodontics/Canada/Mexico/Japan

This segment is responsible for the world-wide manufacturing, sales and distribution of the Company’s Orthodontic products. It also has responsibility for the sales and distribution of most of the Company’s dental products sold in Japan, Canada and Mexico.

Select Distribution Businesses

This segment includes responsibility for the sales and distribution for most of the Company's dental products sold in France, United Kingdom, Italy, Austria and certain other European countries, Middle Eastern countries, India and Africa. Operating margins of the segment are reflective of the intercompany transfer price of products manufactured by other operating segments. Operating margins derived by the intercompany manufacture of the products are retained in those operating segments, and are not included in this group.

Implants/Endodontics/Healthcare/Pacific Rim

This segment includes the responsibility for the design, manufacture, sales and distribution of most of the Company’s dental implant and related products. This segment also includes the responsibility for the design and manufacturing of Endodontic products and is responsible for the sales and distribution of the Company’s Endodontic products in the United States, Switzerland, and locations not covered by other selling divisions. In addition, this business group is also responsible for sales and distribution of certain Endodontic products in Germany, Asia and other parts of the world. Additionally, this segment is responsible for the design and manufacture of certain dental consumables and dental laboratory products and the sales and distribution of most dental products sold in Brazil, Latin America (excluding Mexico), Australia and most of Asia (excluding India and Japan). This segment is also responsible for the world-wide design, manufacturing, sales and distribution of the Company's medical products (non-dental) throughout most of the world.

Significant interdependencies exist among the Company’s operations in certain geographic areas. Inter-group sales are at prices intended to provide a reasonable profit to the manufacturing unit after recovery of all manufacturing costs and to provide a reasonable profit for purchasing locations after coverage of marketing and general and administrative costs.

Generally, the Company evaluates performance of the segments based on the groups’ operating income, excluding restructuring and other costs, and net third party sales, excluding precious metal content.

The following table sets forth information about the Company’s segments for the years ended December 31, 2012, 2011 and 2010.



Third Party Net Sales
(in thousands)	2012			2011			2010

Dental Consumable and Laboratory Businesses	$	958,266		$	946,464		$	890,499
Orthodontics/Canada/Mexico/Japan	331,811			322,444			359,780
Select Distribution Businesses	294,643			300,544			272,622
Implants/Endodontics/Healthcare/Pacific Rim	1,347,380			973,296			701,417
All Other (a)	(3,671		)	(5,030		)	(3,304		)
Total net sales	$	2,928,429		$	2,537,718		$	2,221,014


(a)	Includes amounts recorded at Corporate headquarters.



Third Party Net Sales, Excluding Precious Metal Content
(in thousands)	2012			2011			2010

Dental Consumable and Laboratory Businesses	$	792,035		$	794,736		$	750,924
Orthodontics/Canada/Mexico/Japan	297,877			289,529			331,971
Select Distribution Businesses	288,348			292,087			264,743
Implants/Endodontics/Healthcare/Pacific Rim	1,340,109			961,267			687,422
All Other (b)	(3,671		)	(5,030		)	(3,304		)
Total net sales, excluding precious metal content	$	2,714,698		$	2,332,589		$	2,031,756
Precious metal content of sales	213,731			205,129			189,258
Total net sales, including precious metal content	$	2,928,429		$	2,537,718		$	2,221,014


(b)	Includes amounts recorded at Corporate headquarters



Intersegment Net Sales
(in thousands)	2012			2011			2010

Dental Consumable and Laboratory Businesses	$	220,229		$	220,671		$	223,504
Orthodontics/Canada/Mexico/Japan	4,000			4,065			4,105
Select Distribution Businesses	12,231			16,036			13,515
Implants/Endodontics/Healthcare/Pacific Rim	154,127			148,241			126,597
All Other (c)	221,867			211,658			179,780
Eliminations	(612,454		)	(600,671		)	(547,501		)
Total	$	—		$	—		$	—


(c)	Includes amounts recorded at Corporate headquarters and one distribution warehouse not managed by named segments.



Depreciation and Amortization
(in thousands)	2012		2011		2010

Dental Consumable and Laboratory Businesses	$	33,022	$	34,874	$	30,960
Orthodontics/Canada/Mexico/Japan	5,076		4,473		4,447
Select Distribution Businesses	1,311		1,203		1,476
Implants/Endodontics/Healthcare/Pacific Rim	87,324		41,886		22,297
All Other (d)	2,466		2,599		6,732
Total	$	129,199	$	85,035	$	65,912


(d)	Includes amounts recorded at Corporate headquarters.



Segment Operating Income (Loss)
(in thousands)	2012			2011			2010

Dental Consumable and Laboratory Businesses	$	227,912		$	210,239		$	208,873
Orthodontics/Canada/Mexico/Japan	16,596			15,753			42,106
Select Distribution Businesses	(339		)	2,496			12,197
Implants/Endodontics/Healthcare/Pacific Rim	282,436			210,900			209,384
All Other (e)	(118,949		)	(102,795		)	(81,303		)
Segment Operating Income	$	407,656		$	336,593		$	391,257

Reconciling Items:
Restructuring and other costs	25,717			35,865			10,984
Interest expense	56,851			43,814			25,089
Interest income	(8,760		)	(8,237		)	(4,254		)
Other expense (income), net	3,169			9,040			1,782
Income before income taxes	$	330,679		$	256,111		$	357,656


(e)	Includes results of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments. Amount recorded in 2011 includes $31.9 million of Astra Tech acquisition costs.



Capital Expenditures
(in thousands)	2012		2011		2010

Dental Consumable and Laboratory Businesses	$	18,912	$	20,391	$	15,639
Orthodontics/Canada/Mexico/Japan	9,071		7,494		2,432
Select Distribution Businesses	724		1,439		1,352
Implants/Endodontics/Healthcare/Pacific Rim	58,367		32,949		21,297
All Other (f)	4,998		8,913		3,516
Total	$	92,072	$	71,186	$	44,236


(f)	Includes capital expenditures of Corporate headquarters.



Assets
(in thousands)	2012		2011

Dental Consumable and Laboratory Businesses	$	1,007,307	$	1,180,001
Orthodontics/Canada/Mexico/Japan	294,348		328,376
Select Distribution Businesses	192,684		168,500
Implants/Endodontics/Healthcare/Pacific Rim	3,195,382		2,881,591
All Other (g)	282,576		196,930
Total	$	4,972,297	$	4,755,398


(g)	Includes assets of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments.

Geographic Information

The following table sets forth information about the Company's operations in different geographic areas for the years ended December 31, 2012, 2011 and 2010. Net sales reported below represent revenues for shipments made by operating businesses located in the country or territory identified, including export sales. Property, plant and equipment, net, represents those long-lived assets held by the operating businesses located in the respective geographic areas.



(in thousands)	United States		Germany		Sweden		Other Foreign		Consolidated

2012
Net sales	$	993,980	$	546,092	$	54,507	$	1,333,850	$	2,928,429
Property, plant and equipment, net	148,950		122,310		133,502		209,943		614,705

2011
Net sales	$	875,471	$	515,819	$	20,383	$	1,126,045	$	2,537,718
Property, plant and equipment, net	137,871		118,229		150,167		185,178		591,445

2010
Net sales	$	846,834	$	470,953	$	—	$	903,227	$	2,221,014
Property, plant and equipment, net	119,599		116,951		—		186,555		423,105

Product and Customer Information

The following table presents net sales information by product category:



	December 31,
(in thousands)	2012		2011		2010

Dental consumables products	$	768,098	$	766,385	$	717,718
Dental laboratory products	518,668		525,008		511,061
Dental specialty products	1,306,217		1,078,034		925,317
Consumable medical device products	335,446		168,291		66,918
Total net sales	$	2,928,429	$	2,537,718	$	2,221,014

Dental consumable products consist of dental sundries and small equipment products used in dental offices for the treatment of patients. DENTSPLY’s products in this category include dental anesthetics, infection control products, prophylaxis paste, dental sealants, impression materials, restorative materials, bone grafting materials, tooth whiteners and topical fluoride. The Company manufactures thousands of different consumable products marketed under more than a hundred brand names. Small equipment products consist of various durable goods used in dental offices for treatment of patients. DENTSPLY’s small equipment products include high and low speed handpieces, intraoral curing light systems and ultrasonic scalers and polishers.

Dental laboratory products are used in dental laboratories in the preparation of dental appliances. DENTSPLY’s products in this category include dental prosthetics, including artificial teeth, precious metal dental alloys, dental ceramics, crown and bridge materials, and equipment products used in laboratories consisting of computer aided machining (CAM) ceramic systems and porcelain furnaces.

Dental specialty products are specialized treatment products used within the dental office and laboratory settings. DENTSPLY’s products in this category include endodontic (root canal) instruments and materials, implants and related products, bone grafting material, 3D digital implantology, dental lasers and orthodontic appliances and accessories.

Consumable medical device products consist mainly of urological catheters, certain surgical products, medical drills and other non-medical products.

During 2012, the Company did not have any single customer that represented ten percent or more of DENTSPLY's consolidated net sales. In both 2011 and 2010, one customer, Henry Schein Incorporated, accounted for11% of DENTSPLY's consolidated net sales. Third party export sales from the U.S. are less than ten percent of consolidated net sales.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 131
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

OTHER EXPENSE (INCOME), NET

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

OTHER EXPENSE (INCOME), NET

Other expense (income), net, consists of the following:



	December 31,
(in thousands)	2012		2011		2010

Foreign exchange transaction losses	$	2,679	$	1,713	$	3,331
Other expense (income), net	490		7,327		(1,549		)
Total other expense (income), net	$	3,169	$	9,040	$	1,782

Other expense (income), net in 2011 included approximately $2.9 million of interest rate swap terminations, $3.8 million of Treasury rate lock ineffectiveness, and $0.6 million of other non-operating expense.

INVENTORIES, NET

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

INVENTORIES, NET

Inventories, net, consist of the following:



	December 31,
(in thousands)	2012		2011

Finished goods	$	248,870	$	218,814
Work-in-process	72,533		66,952
Raw materials and supplies	81,537		75,996
Inventories, net	$	402,940	$	361,762

The Company’s inventory valuation reserve was $32.6 million and $35.1 million at December 31, 2012 and 2011, respectively.

PROPERTY, PLANT AND EQUIPMENT, NET

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net, consist of the following:



	December 31,
(in thousands)	2012		2011

Assets, at cost:
Land	$	45,561	$	45,840
Buildings and improvements	409,451		372,156
Machinery and equipment	848,331		680,240
Construction in progress	50,647		42,648
	1,353,990		1,140,884
Less: Accumulated depreciation	739,285		549,439
Property, plant and equipment, net	$	614,705	$	591,445

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details

GOODWILL AND INTANGIBLE ASSETS

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

GOODWILL AND INTANGIBLE ASSETS

The Company performed the required annual impairment tests of goodwill as of April 30, 2012 on thirteen reporting units. To determine the fair value of the Company’s reporting units, the Company uses a discounted cash flow model with market-based support as its valuation technique to measure the fair value for its reporting units. The discounted cash flow model uses five-year forecasted cash flows plus a terminal value based on a multiple of earnings. In addition, the Company applies gross margin and operating expense assumptions consistent with historical trends. The total cash flows were discounted based on a range between 8.5% to 10.5%, which included assumptions regarding the Company’s weighted-average cost of capital. The Company considered the current market conditions both in the U.S. and globally, when determining its assumptions. Lastly, the Company reconciled the aggregated fair values of its reporting units to its market capitalization, which included a reasonable control premium based on market conditions. As a result of the annual impairment tests of goodwill, no impairment was identified.

Impairments of identifiable definite-lived and indefinite-lived intangible assets for the years ended December 31, 2012, 2011 and 2010 were $5.2 million, $1.5 million and $0.4 million, respectively.

A reconciliation of changes in the Company’s goodwill is as follows:



	December 31,
(in thousands)	2012			2011

Balance, beginning of the year	$	2,190,063		$	1,303,055
Acquisition activity	867			978,191
Additional consideration for post closing adjustments	6,574			2,833
Adjustment of provisional amounts on prior acquisition	(22,516		)	—
Effect of exchange rate changes	35,965			(94,016		)
Balance, end of the year	$	2,210,953		$	2,190,063

Goodwill by reportable segment is as follows:



	December 31,
(in thousands)	2012		2011

Dental Consumable and Laboratory Businesses	$	488,206	$	484,779
Orthodontics/Canada/Mexico/Japan	102,065		102,950
Select Distribution Businesses	92,473		108,566
Implants/Endodontics/Healthcare/Pacific Rim	1,528,209		1,493,768
Total	$	2,210,953	$	2,190,063

During 2012, the Company transferred goodwill of approximately $13.2 million from the Select Distribution Businesses segment to the Implants/Endodontics/Healthcare/Pacific Rim segment due to changes in reporting units resulting from the integration of the implant businesses.

Identifiable definite-lived and indefinite-lived intangible assets consist of the following:



	December 31, 2012							December 31, 2011
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount

Patents	$	179,512	$	(81,390	)	$	98,122	$	131,252	$	(17,393	)	$	113,859
Trademarks	83,073		(33,129		)	49,944		73,413		(23,885		)	49,528
Licensing agreements	30,695		(18,966		)	11,729		30,444		(17,277		)	13,167
Customer relationships	491,859		(50,632		)	441,227		411,626		(19,066		)	392,560
Total definite-lived	$	785,139	$	(184,117	)	$	601,022	$	646,735	$	(77,621	)	$	569,114

Trademarks and In-process R&D	$	229,620	$	—		$	229,620	$	221,986	$	—		$	221,986

Total identifiable intangible assets	$	1,014,759	$	(184,117	)	$	830,642	$	868,721	$	(77,621	)	$	791,100

Amortization expense for identifiable definite-lived intangible assets for 2012, 2011 and 2010 was $49.7 million, $21.0 million and $9.0 million, respectively. The annual estimated amortization expense related to these intangible assets for each of the five succeeding fiscal years is $46.4 million, $45.6 million, $45.5 million, $45.1 million and $44.4 million for 2013, 2014, 2015, 2016 and 2017, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

ACCRUED LIABILITIES

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

ACCRUED LIABILITIES

Accrued liabilities consist of the following:



	December 31,
(in thousands)	2012		2011

Payroll, commissions, bonuses, other cash compensation and employee benefits	$	96,206	$	85,855
General insurance	12,204		12,164
Sales and marketing programs	32,742		34,528
Professional and legal costs	12,202		10,269
Restructuring costs	14,452		4,787
Warranty liabilities	3,693		3,765
Deferred income	5,514		6,304
Accrued vacation and holidays	29,804		28,169
Third party royalties	11,288		10,174
Current portion of derivatives	144,195		18,143
Other	62,036		75,043
	$	424,336	$	289,201

FINANCING ARRANGEMENTS

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

FINANCING ARRANGEMENTS

Short-Term Debt

Short-term debt consisted of the following:



	December 31,
	2012					2011
	Principal			Interest		Principal			Interest
(in thousands)	Balance			Rate		Balance			Rate

Bank overdrafts	$	123				$	192
Corporate commercial paper facility	45,000			0.5	%	266,828			0.5	%
European short-term loan	1,962			3.9	%	2,438			3.4	%
Brazil short-term loan	1,000			2.0	%	5,834			12.9	%
Add: Current portion of long-term debt	250,878					1,409
Total short-term debt	$	298,963				$	276,701

	2012					2011
Maximum month-end outstanding during the year	$	399,931				$	355,304
Average amount outstanding during the year	$	248,318				$	225,498
Weighted-average interest rate at year-end	0.6		%			0.8		%

Short-Term Borrowings

The Company has a $500.0 million commercial paper facility, at December 31, 2012 and 2011 amounts outstanding were $45.0 million and $266.8 million, respectively. The Company has a $500.0 million five-year revolving credit agreement that expires in July 2016, that serves as back-up credit to this commercial paper facility. Amounts outstanding under the commercial paper, if any, reduce amounts available under the revolving credit agreement. Average outstanding issued commercial paper during 2012 was $267.1 million. As of December 31, 2012, the Company has classified the commercial paper as short-term debt, reflecting the Company's intent to repay over the next year.

On August 21, 2012 the Company's unused $250.0 million 364-day revolving credit facility expired.

Long-Term Debt

Long-term debt consisted of the following:



	December 31,
	2012				2011
	Principal		Interest		Principal		Interest
(in thousands)	Balance		Rate		Balance		Rate

Floating rate senior notes $250 million due August 2013	$	250,000	1.8	%	$	250,000	2.0	%
Term loan Japanese yen denominated expiring September 2014	144,681		1.1	%	162,956		1.1	%
Private placement notes $250 million expiring March 2016	254,560		4.1	%	254,512		4.1	%
Fixed rate senior notes $300 million due August 2016	299,689		2.8	%	299,603		2.8	%
Term loan Swiss francs denominated expiring September 2016	71,027		1.2	%	69,197		1.2	%
Fixed rate senior notes $450 million due August 2021	448,653		4.1	%	448,497		4.1	%
Other borrowings, various currencies and rates	4,303				6,654
	$	1,472,913			$	1,491,419
Less: Current portion
(included in notes payable and current portion of long-term debt)	250,878				1,409
Long-term portion	$	1,222,035			$	1,490,010

The Company has a $500.0 million five-year revolving credit agreement with participation from sixteen banks, which expires in July 2016. The revolving credit agreement contains a number of covenants and two financial ratios, which the Company is required to satisfy. The most restrictive of these covenants pertain to asset dispositions and prescribed ratios of indebtedness to total capital and operating income excluding depreciation and amortization to interest expense. Any breach of any such covenants or restrictions would result in a default under the existing borrowing documentation that would permit the lenders to declare all borrowings under such documentation to be immediately due and payable and, through cross default provisions, would entitle the Company's other lenders to accelerate their loans. At December 31, 2012, the Company was in compliance with these covenants.

The term loans and private placement notes ("PPN") contain certain affirmative and negative covenants relating to the Company's operations and financial condition. At December 31, 2012, the Company was in compliance with all debt covenants.

At December 31, 2012, the Company had total unused lines of credit, including lines available under its short-term arrangements and revolving credit agreement, of $527.4 million.

The table below reflects the contractual maturity dates of the various borrowings at December 31, 2012:



(in thousands)

2013	$	250,878
2014	221,865
2015	102,230
2016	448,440
2017	442
2018 and Beyond	449,058
	$	1,472,913

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References + Details

EQUITY

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

EQUITY

At December 31, 2012, the Company had authorization to maintain up to 34.0 million shares of treasury stock under its stock repurchase program as approved by the Board of Directors. Under its stock repurchase program, the Company purchased 998,356 shares and 2,187,382 shares during 2012 and 2011, respectfully, at an average price of $38.90 and $36.34, respectively. As of December 31, 2012 and 2011, the Company held 20.5 million and 21.1 million of treasury stock shares, respectively. During 2012, the Company repurchased outstanding shares at a value of $38.8 million. The Company also received proceeds of $34.2 million primarily as a result of 1.8 million stock options exercised during the year ended December 31, 2012. During 2011, the Company repurchased outstanding shares at a value of $79.5 million. The Company also received proceeds of $42.3 million primarily as a result of 2.1 million stock options exercised during the year ended December 31, 2011. It is the Company’s practice to issue shares from treasury stock when options are exercised. The tax benefit realized for the options exercised during the year ended December 31, 2012 and 2011 is $6.8 million and $9.2 million, respectively.

The following table represents total outstanding shares for the years ended December 31:



(in thousands)	Common Shares	Treasury Shares		Outstanding Shares

Balance at December 31, 2009	162,776	(15,815	)	146,961
Shares issued	—	1,489		1,489
Repurchase of common stock at cost	—	(6,715	)	(6,715	)

Balance at December 31, 2010	162,776	(21,041	)	141,735
Shares issued	—	2,084		2,084
Repurchase of common stock at cost	—	(2,187	)	(2,187	)

Balance at December 31, 2011	162,776	(21,144	)	141,632
Shares issued	—	1,688		1,688
Repurchase of common stock at cost	—	(998	)	(998	)

Balance at December 31, 2012	162,776	(20,454	)	142,322

The Company maintains the 2010 Equity Incentive Plan (the “Plan”) under which it may grant non-qualified stock options ("NQSO"), incentive stock options, restricted stock, restricted stock units (“RSU”) and stock appreciation rights, collectively referred to as “Awards.” Awards are granted at exercise prices that are equal to the closing stock price on the date of grant. The Company authorized grants under the Plan of 13.0 million shares of common stock, plus any unexercised portion of cancelled or terminated stock options granted under the DENTSPLY International Inc. 2002 Equity Incentive Plan, as amended, subject to adjustment as follows: each January, if 7% of the total outstanding common shares of the Company exceed 13.0 million, the excess becomes available for grant under the Plan. No more than 2.5 million shares may be awarded as restricted stock and RSU, and no key employee may be granted restricted stock and RSU in excess of approximately 0.2 million shares of common stock in any calendar year. The number of shares available for grant under the 2010 Plan as of December 31, 2012 is 10.5 million.

Stock options generally expire ten years after the date of grant under these plans and grants become exercisable over a period of three years after the date of grant at the rate of one-third per year, except when they become immediately exercisable upon death, disability or qualified retirement. RSU vest 100% on the third anniversary of the date of grant and are subject to a service condition, which requires grantees to remain employed by the Company during the three-year period following the date of grant. In addition to the service condition, certain key executives are subject to performance requirements. Similar to stock options, RSU become immediately exercisable upon death, disability or qualified retirement. The fair value of each RSU assumes that performance goals will be achieved. If such goals are not met, no compensation cost is recognized and any recognized compensation costs is reversed. Under the terms of the RSU, the three-year period is referred to as the restricted period. RSU and the rights under the award may not be sold, assigned, transferred, donated, pledged or otherwise disposed of during the three-year restricted period prior to vesting. Upon the expiration of the applicable restricted period and the satisfaction of all conditions imposed, all restrictions imposed on RSU will lapse, and one share of common stock will be issued as payment for each vested RSU.

The following table represents total stock based compensation expense and the tax related benefit for the years ended:



	December 31,
(in thousands)	2012		2011		2010

Stock option expense	$	11,126	$	10,369	$	10,420
RSU expense	9,644		9,243		7,227
Total stock based compensation expense	$	20,770	$	19,612	$	17,647

Related deferred income tax benefit	$	5,775	$	5,021	$	4,886

There were 2.3 million non-qualified stock options unvested as of December 31, 2012. The remaining unamortized compensation cost related to non-qualified stock options is $13.5 million, which will be expensed over the weighted average remaining vesting period of the options, or 1.6 years. The unamortized compensation cost related to RSU is $15.0 million, which will be expensed over the remaining weighted average restricted period of the RSU, or 1.3 years.

The Company uses the Black-Scholes option-pricing model to estimate the fair value of each option awarded. The following table sets forth the assumptions used to determine compensation cost for the Company’s NQSO issued during the years ended:



	December 31,
	2012			2011			2010 (a)

Weighted average fair value per share	$	8.91		$	8.86		$	9.06
Expected dividend yield	0.57		%	0.55		%	0.58		%
Risk-free interest rate	0.93		%	2.35		%	2.55		%
Expected volatility	26		%	24		%	22		%
Expected life (years)	5.10			5.07			6.42

(a)

In 2010, the Human Resources Committee of the Company’s Board of Directors reviewed the Company’s practices for NQSO grants and determined that it would be more appropriate to make all regular equity grants in the February time frame, after the Company’s financial results are known for the prior year. Accordingly, there were no grants of NQSO in December 2010, which had been the historic practice.

The total intrinsic value of options exercised for the years ended December 31, 2012, 2011 and 2010 was $21.1 million, $27.0 million and $16.5 million, respectively.

The following table summarizes the NQSO transactions for the year ended December 31, 2012:



	Outstanding						Exercisable
(in thousands, except per share amounts)	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Shares	Weighted Average Exercise Price		Aggregate Intrinsic Value

December 31, 2011	10,148		$	31.23	$	51,402	8,049	$	30.06	$	50,365
Granted	1,346		38.62
Exercised	(1,409	)	24.26
Cancelled	(85	)	33.26
Forfeited	(94	)	33.97
December 31, 2012	9,906		$	33.18	$	69,079	7,599	$	31.79	$	64,819

The weighted average remaining contractual term of all outstanding options is 5.7 years and the weighted average remaining contractual term of exercisable options is 4.8 years.

The following table summarizes information about NQSO outstanding for the year ended December 31, 2012:



			Outstanding				Exercisable
(in thousands, except per share amounts and life)			Number Outstanding at December 31,	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number Exercisable at December 31,	Weighted Average Exercise Price
Range of			Number Outstanding at December 31,				Number Exercisable at December 31,
Exercise Prices			2012				2012

10.01	-	20.00	6	0.4	$	18.02	6	$	18.02
20.01	-	30.00	3,525	3.7	26.45		3,522	26.45
30.01	-	40.00	5,366	7.2	35.40		3,065	35.40
40.01	-	50.00	1,009	4.9	44.99		1,006	44.90
			9,906	5.7	$	33.18	7,599	$	31.79

The following table summarizes the unvested RSU transactions for the year ended December 31, 2012:



	Unvested Restricted Stock Units
	Shares		Weighted Average Grant Date Fair Value
(in thousands, except per share amounts)


Unvested at December 31, 2011	897		$	32.50
Granted	422		38.65
Vested	(247	)	26.38
Forfeited	(38	)	35.97
Unvested at December 31, 2012	1,034		$	36.34

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Section B
-Paragraph 7, 11A
-Chapter 1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 21: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 22: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 2, 3, 4, 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 23: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

INCOME TAXES

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

INCOME TAXES

The components of income before income taxes from operations are as follows:



	December 31,
(in thousands)	2012		2011		2010

United States	$	67,668	$	7,041	$	104,424
Foreign	263,011		249,070		253,232
	$	330,679	$	256,111	$	357,656

The components of the provision for income taxes from operations are as follows:



	December 31,
(in thousands)	2012			2011			2010

Current:
U.S. federal	$	23,412		$	34,870		$	21,848
U.S. state	2,788			5,151			3,795
Foreign	69,954			59,397			62,196
Total	$	96,154		$	99,418		$	87,839

Deferred:
U.S. federal	$	(128,832	)	$	(29,664	)	$	3,067
U.S. state	11,730			(4,089		)	1,062
Foreign	29,868			(54,649		)	(2,743		)
Total	$	(87,234	)	$	(88,402	)	$	1,386

	$	8,920		$	11,016		$	89,225

The reconciliation of the U.S. federal statutory tax rate to the effective rate for the years ended is as follows:



	December 31,
	2012		2011		2010

Statutory U. S. federal income tax rate	35.0	%	35.0	%	35.0	%
Effect of:
State income taxes, net of federal benefit	0.7		0.3		0.9
Federal benefit of R&D and foreign tax credits	(7.2	)	(8.6	)	(6.9	)
Tax effect of international operations	(7.4	)	(7.9	)	(3.7	)
Net effect of tax audit activity	(0.6	)	2.1		1.0
Tax effect of enacted statutory rate changes	(3.7	)	0.2		—
Federal tax on unremitted earnings of certain foreign subsidiaries	0.1		0.1		0.2
Valuation allowance adjustments	12.0		(18.1	)	(1.0	)
Foreign outside basis differences	(26.5	)	—		—
Other	0.3		1.2		(0.5	)

Effective income tax rate on operations	2.7	%	4.3	%	25.0	%

The tax effect of significant temporary differences giving rise to deferred tax assets and liabilities are as follows:



	December 31, 2012					December 31, 2011
(in thousands)	Deferred Tax Asset			Deferred Tax Liability		Deferred Tax Asset			Deferred Tax Liability

Commission and bonus accrual	$	2,529		$	—	$	2,812		$	—
Employee benefit accruals	44,266			—		38,061			—
Foreign outside basis difference	189,125			—		—			—
Inventory	21,173			—		19,972			—
Identifiable intangible assets	—			359,303		—			336,822
Insurance premium accruals	4,381			—		4,533			—
Miscellaneous accruals	12,685			—		12,273			—
Other	15,844			—		13,166			—
Unrealized losses included in other
comprehensive income	39,879			—		28,424			—
Property, plant and equipment	—			51,020		—			52,251
Product warranty accruals	1,154			—		907			—
R&D and foreign tax credit carryforward	—			—		49,552			—
Restructuring and other cost accruals	1,048			—		1,439			—
Sales and marketing accrual	4,480			—		4,874			—
Taxes on unremitted earnings of foreign subsidiaries	—			2,556		—			2,273
Tax loss carryforwards and other tax attributes	187,449			—		152,999			—
Valuation allowance	(179,699		)	—		(71,758		)	—
	$	344,314		$	412,879	$	257,254		$	391,346

Deferred tax assets and liabilities are included in the following consolidated balance sheet line items:



	December 31,
(in thousands)	2012		2011

Prepaid expenses and other current assets	$	80,903	$	67,159
Income taxes payable	2,856		2,678
Other noncurrent assets	86,029		51,250
Deferred income taxes	232,641		249,822

The Company has fully utilized its foreign tax credit carryforwards as of December 31, 2012.

Certain foreign and domestic subsidiaries of the Company have tax loss carryforwards of $853.3 million at December 31, 2012. Of such losses, $497.1 million expire at various times through 2032, and $356.2 million may be carried forward indefinitely. Included in deferred income tax assets as of December 31, 2012 are tax benefits totaling $136.5 million (before valuation allowances) for these tax loss carryforwards. The Company has provided $118.0 million of valuation allowance to offset the tax benefit of net operating losses and $61.7 million of valuation allowance for other deferred tax assets. The Company has provided these valuation allowances totaling $179.7 million due to the uncertainty that these assets can be realized in the future.

The Company has provided federal income taxes on certain undistributed earnings of its foreign subsidiaries that the Company anticipates will be repatriated. Deferred federal income taxes have not been provided on $1.1 billion of cumulative earnings of foreign subsidiaries that the Company has determined to be permanently reinvested. It is not practicable to estimate the amount of tax that might be payable on these permanently reinvested earnings.

Tax Contingencies

The total amount of gross unrecognized tax benefits at December 31, 2012 is approximately $18.4 million, of this total, approximately $16.9 million represents the amount of unrecognized tax benefits that, if recognized, would affect the effective income tax rate. It is reasonably possible that certain amounts of unrecognized tax benefits will significantly increase or decrease within twelve months of the reporting date of the Company’s consolidated financial statements. Final settlement and resolution of outstanding tax matters in various jurisdictions during the next twelve months could include unrecognized tax benefits of approximately $1.4 million.

The total amount of accrued interest and penalties were $6.1 million and $6.9 million as of December 31, 2012 and 2011, respectively. The Company has consistently classified interest and penalties recognized in its consolidated financial statements as income taxes based on the accounting policy election of the Company. During the year ended December 31, 2012, the Company recognized income tax benefit of $0.9 million in interest and penalties. During the years ended December 31, 2011 and 2010, the company recognized income tax expense in the amount of $0.9 million and $0.6 million for interest and penalties.

The Company is subject to U.S. federal income tax as well as income tax of multiple state and foreign jurisdictions. The significant jurisdictions include the U.S., Germany and Switzerland. The Company has substantially concluded all U.S. federal income tax matters for years through 2009, resulting in the years 2010 and 2011 being subject to future potential tax audit adjustments while years prior to 2010 are settled. The Company has concluded audits in Germany through the tax year 2008. The taxable years that remain open for Switzerland are 2002 through 2011.

The Company had the following activity recorded for unrecognized tax benefits:



	December 31,
(in thousands)	2012			2011			2010

Unrecognized tax benefits at beginning of period	$	14,956		$	13,143		$	12,864
Gross change for prior period positions	(3,029		)	1,425			47
Gross change for current year positions	268			640			1,036
Decrease due to settlements and payments	—			—			—
Decrease due to statute expirations	—			(123		)	(424		)
Increase due to effect of foreign currency translation	—			—			—
Decrease due to effect from foreign currency translation	69			(129		)	(380		)

Unrecognized tax benefits at end of period	$	12,264		$	14,956		$	13,143

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

+ Details

BENEFIT PLANS

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

BENEFIT PLANS

The Company has both U.S. and non-U.S. pension plans covering substantially all of our U.S. employees and a portion of our non-U.S. employees. Total costs for Company-sponsored defined benefit, defined contribution and employee stock ownership plans were $45.7 million, $34.6 million and $27.4 million in 2012, 2011 and 2010, respectively.

Defined Contribution Plans

The DENTSPLY Employee Stock Ownership Plan (“ESOP”) and 401(k) plans are designed to have contribution allocations of eligible compensation, with a targeted 3% going into the ESOP in Company stock and a targeted 3% going into the 401(k) as a non-elective contribution in cash. The Company sponsors an employee 401(k) savings plan for its U.S. workforce to which enrolled participants may contribute up to Internal Revenue Service defined limits. The annual expense and cash contribution to the 401(k) is expected to be $7.6 million for 2012 (of which $5.3 million will be contributed in the first quarter of 2013), and was $5.8 million for 2011 (of which $4.9 million was contributed in the first quarter of 2012), and $4.6 million for 2010 (of which $4.6 million was contributed in the first quarter of 2011).

The ESOP is a non-contributory defined contribution plan that covers substantially all of the U.S. based non-union employees of the Company. Contributions to the ESOP, net of forfeitures, are expected to be $4.6 million for 2012 (to be contributed in the first quarter of 2013), and were $3.6 million for 2011 (contributed in the first quarter of 2012), and were $3.0 million for 2010 (contributed in the first quarter of 2011). All future ESOP allocations will come from a combination of forfeited shares and shares acquired in the open market. The Company has targeted future ESOP allocations at 3% of eligible compensation. The share allocation will be accounted at fair value at the point of allocation, which is normally year-end.

In addition to the ESOP and 401(k) plans in the U.S., the Company also maintains various other U.S. and non-U.S. defined contribution and non-qualified deferred compensation plans. Total costs for these plans amounted to $13.9 million, $8.1 million and $6.7 million in 2012, 2011 and 2010, respectively.

Defined Benefit Plans

The Company maintains a number of separate contributory and non-contributory qualified defined benefit pension plans for certain union and salaried employee groups in the United States. Pension benefits for salaried plans are based on salary and years of service; hourly plans are based on negotiated benefits and years of service. Annual contributions to the pension plans are sufficient to satisfy minimum funding requirements. Pension plan assets are held in trust and consist mainly of common stock and fixed income investments. The U.S. plans are funded in excess of the funding required by the U.S. Department of Labor.

In addition to the U.S. plans, the Company maintains defined benefit pension plans for its employees in Austria, France, Germany, Italy, Japan, the Netherlands, Norway, Spain, Sweden, Switzerland and Taiwan. These plans provide benefits based upon age, years of service and remuneration. Substantially all of the German and Sweden plans are unfunded book reserve plans. Other foreign plans are not significant individually or in the aggregate. Most employees and retirees outside the U.S. are covered by government health plans.

Defined Benefit Pension Plan Assets

The primary investment strategy is to ensure that the assets of the plans, along with anticipated future contributions, will be invested in order that the benefit entitlements of employees, pensioners and beneficiaries covered under the plan can be met when due with high probability. Pension plan assets consist mainly of common stock and fixed income investments. The target allocations for defined benefit plan assets are 30% to 65% equity securities, 30% to 65% fixed income securities, 0% to 15% real estate, and 0% to 25% in all other types of investments. Equity securities include investments in companies located both in and outside the U.S. Equity securities do not include common stock of the Company. Fixed income securities include corporate bonds of companies from diversified industries, government bonds, mortgage notes and pledge letters. Other types of investments include investments in mutual funds, common trusts, insurance contracts, hedge funds and real estate. These plan assets are not recorded on the Company’s Consolidated Balance Sheet as they are held in trust or other off-balance sheet investment vehicles.

The defined benefit pension plan assets in the U.S. are held in trust and the investment policies of the plans are generally to invest the plans assets in equities and fixed income investments. The objective is to achieve a long-term rate of return in excess of 5% while at the same time mitigating the impact of investment risk associated with investment categories that are expected to yield greater than average returns. In accordance with the investment policies of the U.S. plans, the plans assets were invested in the following investment categories: interest-bearing cash, registered investment companies (e.g. mutual funds), common/collective trusts, master trust investment accounts and insurance company general accounts. The investment objective is for assets to be invested in a manner consistent with the fiduciary standards of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).

The defined benefit pension plan assets maintained in Austria, Germany, Japan, Norway, the Netherlands, Switzerland and Taiwan all have separate investment policies but generally have an objective to achieve a long-term rate of return in excess 4% while at the same time mitigating the impact of investment risk associated with investment categories that are expected to yield greater than average returns. In accordance with the investment policies for the plans outside the U.S., the plans’ assets were invested in the following investment categories: interest-bearing cash, U.S. and foreign equities, foreign fixed income securities (primarily corporate and government bonds), insurance company contracts, real estate and hedge funds.

Postretirement Healthcare

The Company sponsors postretirement healthcare plans that cover certain union and salaried employee groups in the U.S. and is contributory, with retiree contributions adjusted annually to limit the Company’s contribution for participants who retired after June 1, 1985. The plans for postretirement healthcare have no plan assets. The Company also sponsors unfunded non-contributory postretirement medical plans for a limited number of union employees and their spouses and retirees of a discontinued operation.

Reconciliations of changes in the defined benefit and postretirement healthcare plans’ benefit obligations, fair value of assets and statement of funded status are as follows:



							Other Postretirement
	Pension Benefits						Benefits
	December 31,						December 31,
(in thousands)	2012			2011			2012			2011

Change in Benefit Obligation
Benefit obligation at beginning of year	$	270,607		$	211,504		$	12,217		$	11,607
Service cost	12,178			10,950			195			61
Interest cost	10,600			9,633			490			553
Participant contributions	3,638			3,562			535			583
Actuarial losses	59,461			2,991			1,601			537
Plan amendments	(93		)	(3,034		)	—			—
Acquisitions/Divestitures	3,745			52,282			—			—
Effect of exchange rate changes	8,100			(8,355		)	—			—
Foreign plan additions	540			—			—			—
Plan curtailments	(310		)	—			—			—
Benefits paid	(12,700		)	(8,926		)	(820		)	(1,124		)
Benefit obligation at end of year	$	355,766		$	270,607		$	14,218		$	12,217

Change in Plan Assets
Fair value of plan assets at beginning of year	$	108,708		$	99,546		$	—		$	—
Actual return on assets	10,732			(889		)	—			—
Acquisitions/Divestitures	—			7,006			—			—
Effect of exchange rate changes	2,362			(1,238		)	—			—
Employer contributions	12,144			9,647			285			541
Participant contributions	3,638			3,562			535			583
Benefits paid	(12,700		)	(8,926		)	(820		)	(1,124		)
Fair value of plan assets at end of year	$	124,884		$	108,708		$	—		$	—

Funded status at end of year	$	(230,882	)	$	(161,899	)	$	(14,218	)	$	(12,217	)

The amounts recognized in the accompanying Consolidated Balance Sheets, net of tax effects, are as follows:



	Pension Benefits						Other Postretirement Benefits
	December 31,						December 31,
(in thousands)	2012			2011			2012			2011

Other noncurrent assets, net	$	263		$	355		$	—		$	—
Deferred tax asset	26,421			10,972			1,764			1,247
Total assets	$	26,684		$	11,327		$	1,764		$	1,247

Current liabilities	(4,561		)	(4,411		)	(654		)	(977		)
Other noncurrent liabilities	(226,584		)	(157,843		)	(13,564		)	(11,240		)
Deferred tax liability	(449		)	(269		)	—			—
Total liabilities	$	(231,594	)	$	(162,523	)	$	(14,218	)	$	(12,217	)

Accumulated other comprehensive income	70,377			32,002			2,805			1,984
Net amount recognized	$	(134,533	)	$	(119,194	)	$	(9,649	)	$	(8,986	)

Amounts recognized in AOCI consist of:



							Other Postretirement
	Pension Benefits						Benefits
	December 31,						December 31,
(in thousands)	2012			2011			2012		2011

Net actuarial loss	$	99,129		$	45,462		$	4,569	$	3,232
Net prior service cost	(2,780		)	(2,757		)	—		—
Before tax AOCI	$	96,349		$	42,705		$	4,569	$	3,232
Less: Deferred taxes	25,972			10,703			1,764		1,248
Net of tax AOCI	$	70,377		$	32,002		$	2,805	$	1,984

Information for pension plans with an accumulated benefit obligation in excess of plan assets:



	December 31,
(in thousands)	2012		2011

Projected benefit obligation	$	344,653	$	268,391
Accumulated benefit obligation	315,963		246,515
Fair value of plan assets	117,413		106,137

Components of net periodic benefit cost:



	Pension Benefits									Other Postretirement Benefits
(in thousands)	2012			2011			2010			2012		2011		2010

Service cost	$	12,178		$	10,950		$	8,108		$	195	$	61	$	58
Interest cost	10,600			9,633			8,415			490		553		605
Expected return on assets	(4,727		)	(5,184		)	(4,662		)	—		—		—
Amortization of transition obligation	—			—			124			—		—		—
Amortization of prior service cost (credit)	(138		)	80			86			—		—		—
Amortization of net actuarial loss	1,995			1,584			1,002			264		189		265
Curtailment and settlement gains	(303		)	4			—			—		—		—
Net periodic benefit cost	$	19,605		$	17,067		$	13,073		$	949	$	803	$	928

Other changes in plan assets and benefit obligations recognized in AOCI:



	Pension Benefits									Other Postretirement Benefits
(in thousands)	2012			2011			2010			2012			2011			2010

Net actuarial (gain) loss	$	55,662		$	8,352		$	12,640		$	1,601		$	537		$	(548	)
Net prior service (credit)	(161		)	(2,845		)	(8		)	—			—			—
Net transition obligation	—			—			(1		)	—			—			—
Amortization	(1,857		)	(1,664		)	(1,212		)	(264		)	(189		)	(265		)
Total recognized in AOCI	$	53,644		$	3,843		$	11,419		$	1,337		$	348		$	(813	)
Total recognized in net periodic benefit cost and AOCI	$	73,249		$	20,910		$	24,492		$	2,286		$	1,151		$	115

The estimated net loss, prior service cost and transition obligation for the defined benefit plans that will be amortized from AOCI into net periodic benefit cost over the next fiscal year are $5.0 million. The estimated net loss and prior service credit for the other postretirement plans that will be amortized from AOCI into net periodic benefit cost over the next fiscal year is $0.4 million.

The amounts in AOCI that are expected to be amortized as net expense (income) during fiscal year 2013 are as follows:



(in thousands)	Pension Benefits			Other Postretirement Benefits

Amount of net prior service cost	$	(139	)	$	—
Amount of net loss	5,144			352

The weighted average assumptions used to determine benefit obligations for the Company's plans, principally in foreign locations, at December 31, 2012, 2011 and 2010 are as follows:



	Pension Benefits						Other Postretirement Benefits
	2012		2011		2010		2012		2011		2010

Discount rate	2.8	%	4.0	%	4.1	%	3.5	%	4.0	%	5.0	%
Rate of compensation increase	2.7	%	2.8	%	2.6	%	n/a		n/a		n/a
Health care cost trend	n/a		n/a		n/a		8.0	%	7.5	%	8.0	%
Ultimate health care cost trend	n/a		n/a		n/a		5.0	%	5.0	%	5.0	%
Years until ultimate trend is reached	n/a		n/a		n/a		7.0		6.0		7.0

The weighted average assumptions used to determine net periodic benefit cost for the Company's plans, principally in foreign locations, for the years ended December 31, 2012, 2011 and 2010 are as follows:



	Pension Benefits						Other Postretirement Benefits
	2012		2011		2010		2012		2011		2010

Discount rate	4.0	%	4.1	%	4.7	%	4.0	%	5.0	%	5.5	%
Expected return on plan assets	4.1	%	4.8	%	5.2	%	n/a		n/a		n/a
Rate of compensation increase	2.8	%	2.6	%	2.7	%	n/a		n/a		n/a
Health care cost trend	n/a		n/a		n/a		8.0	%	7.5	%	8.0	%
Ultimate health care cost trend	n/a		n/a		n/a		5.0	%	5.0	%	5.0	%
Years until ultimate trend is reached	n/a		n/a		n/a		7.0		6.0		7.0

Measurement Date	12/31/2012		12/31/2011		12/31/2010		12/31/2012		12/31/2011		12/31/2010

To develop the assumptions for the expected long-term rate of return on assets, the Company considered the current level of expected returns on risk free investments (primarily government bonds), the historical level of the risk premium associated with the other asset classes in which the assets are invested and the expectations for future returns of each asset class. The expected return for each asset class was then weighted based on the target asset allocations to develop the assumptions for the expected long-term rate of return on assets.

Assumed health care cost trend rates have an impact on the amounts reported for postretirement benefits. A one percentage point change in assumed healthcare cost trend rates would have the following effects for the year ended December 31, 2012:



	Other Postretirement Benefits
(in thousands)	1% Increase		1% Decrease

Effect on total of service and interest cost components	$	140	$	(108	)
Effect on postretirement benefit obligation	2,503		(1,976		)

Fair Value Measurements of Plan Assets

The fair value of the Company's pension plan assets at December 31, 2012 is presented in the table below by asset category. Approximately 80% of the total plan assets are categorized as Level 1, and therefore, the values assigned to these pension assets are based on quoted prices available in active markets. For the other category levels, a description of the valuation is provided in Note 1, Significant Accounting Policies, under the “Fair Value Measurement” heading.



	December 31, 2012
(in thousands)	Total		Level 1		Level 2		Level 3

Assets Category
Cash and cash equivalents	$	5,930	$	5,930	$	—	$	—
Equity securities:
U. S.	1,015		1,015		—		—
International	34,197		34,197		—		—
Fixed income securities:
Fixed rate bonds (a)	48,450		48,450		—		—
Other types of investments:
Mutual funds (b)	8,994		—		8,994		—
Real estate mutual funds	9,713		9,713		—		—
Common trusts (c)	2,708		—		—		2,708
Insurance contracts	12,199		—		3,865		8,334
Hedge funds	1,311		—		—		1,311
Real estate	367		—		—		367
Total	$	124,884	$	99,305	$	12,859	$	12,720



	December 31, 2011
(in thousands)	Total		Level 1		Level 2		Level 3

Assets Category
Cash and cash equivalents	$	5,165	$	5,001	$	164	$	—
Equity securities:
U. S.	2,036		2,036		—		—
International	27,982		27,982		—		—
Fixed income securities:
Fixed rate bonds (a)	44,499		44,499		—		—
Other types of investments:
Mutual funds (b)	8,065		—		8,065		—
Real estate mutual funds	8,307		8,307		—		—
Common trusts (c)	2,083		—		—		2,083
Insurance contracts	9,323		—		3,503		5,820
Hedge funds	891		—		—		891
Real estate	357		—		—		357
Total	$	108,708	$	87,825	$	11,732	$	9,151


(a)	This category includes fixed income securities invested primarily in Swiss bonds, foreign bonds denominated in Swiss francs, foreign currency bonds, mortgage notes and pledged letters.


(b)	This category includes mutual funds balanced between moderate-income generation and moderate capital appreciation with investment allocations of approximately 50% equities and 50% fixed income investments.


(c)	This category includes common/collective funds with investments in approximately 65% equities and 35% in fixed income investments.

The following table provides a reconciliation from December 31, 2011 to December 31, 2012 for the plans assets categorized as Level 3. No assets were transferred in or out of the Level 3 category during the year ended December 31, 2012.



	Changes within Level 3 Category for
	Year Ended December 31, 2012
(in thousands)	Common Trust		Insurance Contracts		Hedge Funds		Real Estate		Total

Balance at December 31, 2011	$	2,083	$	5,820	$	890	$	358	$	9,151
Actual return on plan assets:
Relating to assets still held at the reporting date	284		1,700		52		—		2,036
Relating to assets sold during the period	8		—		6		—		14
Purchases, sales and settlements, net	333		533		331		—		1,197
Effect of exchange rate changes	—		281		32		9		322
Balance at December 31, 2012	$	2,708	$	8,334	$	1,311	$	367	$	12,720

The following tables provide a reconciliation from December 31, 2010 to December 31, 2011 for the plans assets categorized as Level 3. No assets were transferred in or out of the Level 3 category during the year ended December 31, 2011.



	Changes within Level 3 Category for
	Year Ended December 31, 2011
(in thousands)	Common Trust		Insurance Contracts			Hedge Funds			Real Estate			Total

Balance at December 31, 2010	$	2,066	$	1,824		$	1,334		$	360		$	5,584
Actual return on plan assets:
Relating to assets still held at the reporting date	5		(1,355		)	(80		)	—			(1,430		)
Relating to assets sold during the period	5		—			—			—			5
Acquisitions/Divestitures	—		6,738			—			—			6,738
Purchases, sales and settlements, net	7		(1,144		)	(384		)	—			(1,521		)
Effect of exchange rate changes	—		(243		)	20			(2		)	(225		)
Balance at December 31, 2011	$	2,083	$	5,820		$	890		$	358		$	9,151

Fair values for Level 3 assets are determined as follows:

Common Trusts and Hedge Funds: The investments are valued using the net asset value provided by the administrator of the trust or fund, which is based on the fair value of the underlying securities.

Real Estate: Investment is stated by its appraised value.

Insurance Contracts: The value of the asset represents the mathematical reserve of the insurance policies and is calculated by the insurance firms using their own assumptions.

Cash Flows

In 2013, the Company expects to make contributions and direct benefit payments of $7.7 million to its defined benefit pension plans and $0.7 million to its postretirement medical plans.

Estimated Future Benefit Payments



(in thousands)	Pension Benefits		Other Postretirement Benefits

2013	$	9,229	$	665
2014	10,619		634
2015	10,899		612
2016	10,999		633
2017	12,512		614
2018-2022	70,668		3,058

RESTRUCTURING AND OTHER COSTS

12 Months Ended

Dec. 31, 2012

RESTRUCTURING AND OTHER COSTS

Restructuring Costs

Restructuring costs of $17.8 million and $3.1 million for 2012 and 2011, respectively, are reflected in "Restructuring and other costs" in the Consolidated Statement of Operations and the associated liabilities are recorded in "Accrued liabilities" and "Other noncurrent liabilities" in the Consolidated Balance Sheet. These costs consist of employee severance benefits, payments due under operating contracts, and other restructuring costs.

During 2012, the Company initiated several restructuring plans primarily related to the closure and/or consolidation of certain production and selling facilities in Europe to better leverage the Company’s resources by reducing costs and obtaining operational efficiencies. These restructuring costs were offset by changes in estimates of $0.8 million, related to adjustments to 2011 and 2010 and prior plans.

During 2011, as a result of the impact of the Japan natural disaster, the Company initiated a restructuring plan related to the Orthodontic business during the second quarter. The restructuring plan addressed overhead costs related to the business and has reduced those costs as the Orthodontic business continues to be impacted by the lack of product supply. The Company recorded $1.7 million of charges for the year ended December 31, 2011 for this plan. In addition to the restructuring charges, for the year ended December 31, 2011, the Company incurred approximately $3.3 million of selling, general and administrative expenses related to costs of maintaining the critical Orthodontic business processes and structures during the lack of product supply.

In addition to the Orthodontic restructuring plans during 2011, the Company also initiated several restructuring plans primarily related to the closure and/or consolidation of certain production and selling facilities in Europe and South America to better leverage the Company’s resources by reducing costs and obtaining operational efficiencies. The Company incurred $1.9 million of costs related to other restructuring plans, offset by income of $0.5 million for adjustments to 2010 plans and 2009 and prior plans. These adjustments were primarily related to revised estimates of severance costs.

The benefits associated with the 2011 and 2012 restructuring plans were immaterial to the current period. The Company estimates the future annual savings related to these plans to be in the range of $10 million to $15 million to be realized over the next three to five years. There is no assurance that future savings will be fully achieved.

At December 31, 2012, the Company’s restructuring accruals were as follows:



	Severances
(in thousands)	2010 and Prior Plans			2011 Plans			2012 Plans			Total

Balance at December 31, 2011	$	3,380		$	1,281		$	—		$	4,661
Provisions and adjustments	—			556			15,540			16,096
Amounts applied	(1,511		)	(1,392		)	(4,143		)	(7,046		)
Change in estimates	(720		)	(99		)	—			(819		)
Balance at December 31, 2012	$	1,149		$	346		$	11,397		$	12,892



	Lease/Contract Terminations
(in thousands)	2010 and Prior Plans			2012 Plans			Total

Balance at December 31, 2011	$	1,011		$	—		$	1,011
Provisions and adjustments	—			1,392			1,392
Amounts applied	(219		)	(710		)	(929		)
Balance at December 31, 2012	$	792		$	682		$	1,474



	Other Restructuring Costs
(in thousands)	2010 and Prior Plans			2012 Plans			Total

Balance at December 31, 2011	$	34		$	—		$	34
Provisions and adjustments	—			1,222			1,222
Amounts applied	(34		)	(1,136		)	(1,170		)
Balance at December 31, 2012	$	—		$	86		$	86

The following table provides the cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment:



(in thousands)	December 31, 2011		Provisions and Adjustments		Amounts Applied			Change in Estimates			December 31, 2012

Dental Consumable and Laboratory Businesses	$	3,601	$	8,302	$	(2,410	)	$	(360	)	$	9,133
Orthodontics/Canada/Mexico/Japan	240		1,394		(1,260		)	(14		)	360
Select Distribution Businesses	—		264		(42		)	—			222
Implants/Endodontics/Healthcare/Pacific Rim	1,865		8,750		(5,396		)	(482		)	4,737

Total	$	5,706	$	18,710	$	(9,108	)	$	(856	)	$	14,452

Other Costs

For the year ended December 31, 2012, the Company recorded other costs of $7.9 million, other costs including $5.2 million impairments of certain previously acquired technologies and the impact of the U.S. presidential executive order updating trade sanctions. On October 9, 2012, President Obama issued an executive order making it illegal for non-U.S. subsidiaries of U.S. companies to engage in certain transactions involving Iran without a license. The Company reserved appropriate allowances against accounts receivable in its controlled foreign subsidiaries and has discontinued such sales activities. There can be no assurance as to when such sales may be resumed to this region. For the year ended December 31, 2011, the Company recorded other costs of $32.7 million, which were related to the Astra Tech acquisition, legal settlement costs and impairments of certain previously acquired technology.

FINANCIAL INSTRUMENTS AND DERIVATIVES

12 Months Ended

Dec. 31, 2012

FINANCIAL INSTRUMENTS AND DERIVATIVES

Derivative Instruments and Hedging Activities

The Company's activities expose it to a variety of market risks, which primarily include the risks related to the effects of changes in foreign currency exchange rates, interest rates and commodity prices. These financial exposures are monitored and managed by the Company as part of its overall risk management program. The objective of this risk management program is to reduce the volatility that these market risks may have on the Company's operating results and equity. The Company employs derivative financial instruments to hedge certain anticipated transactions, firm commitments, or assets and liabilities denominated in foreign currencies. Additionally, the Company utilizes interest rate swaps to convert variable rate debt to fixed rate and to convert fixed rate debt to variable rate debt, cross currency basis swaps to convert debt denominated in one currency to another currency and commodity swaps to fix certain variable raw material costs.

Derivative Instruments Not Designated as Hedging

The Company enters into derivative financial instruments to hedge the foreign exchange revaluation risk associated with recorded assets and liabilities that are denominated in a non-functional currency. The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances and are recorded in “Other expense (income), net” on the Consolidated Statements of Operations. The Company primarily uses forward foreign exchange contracts and cross currency basis swaps to hedge these risks. The Company's significant contracts outstanding at December 31, 2012 are summarized in the tables that follow.

On December 20, 2012, the Company dedesignated 160.0 million Swiss francs of its net investment hedges and entered into 81.4 million Swiss francs of new cross currency basis swaps maturing December 27, 2013. The combination of these trades total 241.4 million Swiss francs and offset an inter-company Swiss franc note receivable at a U.S. dollar functional entity that was created by a net dividend of 241.4 million Swiss francs. The new 81.4 million Swiss franc swap has an original exchange rate of approximately .91 Swiss franc per U.S. dollar. The Company will pay three-month Swiss franc LIBOR minus 34.0 basis points and receive three-month U.S. dollar LIBOR. The dedesignated cross currency swaps mature in April 2013. On January 17, 2013, the Company extended the hedge to June 2015 with two new forward starting swaps totaling 160.0 million Swiss francs. The Company will pay three-month Swiss franc LIBOR minus 22.1 basis points and receive three-month U.S. dollar LIBOR. The hedges amortize and are intended to offset currency revaluation of the Swiss franc note receivable for as long as it is outstanding. The change in the value of the swaps will be recorded in “Other expense (income), net” on the Consolidated Statements of Operations.

On January 10, 2013, the Company entered into 347.8 million euros of cross currency basis swaps maturing at various times between 2015 and 2018 to hedge a balance sheet liability resulting from a legal entity restructuring pursuant to the Company's acquisitions integration plans. The hedges have an original exchange rate of approximately 1.32 U.S. dollar per euro and will offset currency revaluation of a euro denominated note payable by a U.S. dollar functional company for as long as it is outstanding. The Company will receive three-month Euro Inter-Bank Offered Rate ("EURIBOR") minus 33.2 basis points and pay three-month U.S. dollar LIBOR. The change in the value of the swaps will be recorded in “Other expense (income), net” on the Consolidated Statements of Operations.

The Company wrote put options (“DIO equity option contracts”) to the original sellers of the DIO investment for the remaining DIO common shares held by the seller. The equity options provide the seller the ability to require the Company to purchase their remaining shares on hand at a price based on an agreed-upon formula at specific time frames in the future. The sellers are also allowed to sell their remaining shares on the open market. Changes in the fair value of the DIO equity option contracts are reported in “Other expense (income), net” on the Consolidated Statements of Operations. This derivative is further discussed in Note 16, Fair Value Measurement.

Cash Flow Hedges

Foreign Exchange Risk Management

The Company uses a layered hedging program to hedge select anticipated foreign currency cash flows to reduce volatility in both cash flows and reported earnings of the consolidated Company. The Company accounts for the foreign exchange forward contracts as cash flow hedges. As a result, the Company records the fair value of the contracts primarily through AOCI based on the tested effectiveness of the foreign exchange forward contracts. The Company measures the effectiveness of cash flow hedges of anticipated transactions on a spot-to-spot basis rather than on a forward-to-forward basis. Accordingly, the spot-to-spot change in the derivative fair value will be deferred in AOCI and released and recorded on the consolidated statements of operations in the same period that the hedged transaction is recorded. The time value component of the fair value of the derivative is deemed ineffective and is reported currently in “Other expense (income), net” on the Consolidated Statements of Operations in the period which it is applicable. Any cash flows associated with these instruments are included in cash from operations in accordance with the Company's policy of classifying the cash flows from these instruments in the same category as the cash flows from the items being hedged.

These foreign exchange contracts generally have maturities up to eighteen months and the counterparties to the transactions are typically large international financial institutions. The Company's significant contracts outstanding as of December 31, 2012 are summarized in the table that follows.

Interest Rate Risk Management

The Company uses interest rate swaps to convert a portion of its variable interest rate debt to fixed interest rate debt. As of December 31, 2012, the Company has two groups of significant interest rate swaps. One of the groups of swaps has notional amounts totaling 12.6 billion Japanese yen, and effectively converts the underlying variable interest rates to an average fixed interest rate of 0.2% for a term of three years, ending in September 2014. Another swap has a notional amount of 65.0 million Swiss francs, and effectively converts the underlying variable interest rates to a fixed interest rate of 0.7% for a term of five years, ending in September 2016.

The Company enters into interest rate swap contracts infrequently as they are only used to manage interest rate risk on long-term debt instruments and not for speculative purposes. The Company's significant contracts outstanding as of December 31, 2012 are summarized in the table that follow.

Commodity Risk Management

The Company selectively enters into commodity swaps to effectively fix certain variable raw material costs. These swaps are used purely to stabilize the cost of components used in the production of certain of the Company's products. The Company generally accounts for the commodity swaps as cash flow hedges. As a result, the Company records the fair value of the contracts primarily through AOCI based on the tested effectiveness of the commodity swaps. The Company measures the effectiveness of cash flow hedges of anticipated transactions on a spot-to-spot basis rather than on a forward-to-forward basis. Accordingly, the spot-to-spot change in the derivative fair value will be deferred in AOCI and released and recorded on the Consolidated Statements of Operations in the same period that the hedged transaction is recorded. The time value component of the fair value of the derivative is deemed ineffective and is reported currently in “Interest expense” on the Consolidated Statements of Operations in the period which it is applicable. Any cash flows associated with these instruments are included in cash from operations in accordance with the Company's policy of classifying the cash flows from these instruments in the same category as the cash flows from the items being hedged.

At December 31, 2012, the Company had swaps in place to purchase 758 troy ounces of platinum bullion for use in production at an average fixed rate of $1,571 per troy ounce. In addition, the Company had swaps in place to purchase 56,712 troy ounces of silver bullion for use in production at an average fixed rate of $31 per troy ounce.

The following tables summarize the notional amounts and fair value of the Company's cash flow hedges and non-designated derivatives at December 31, 2012:



Foreign Exchange Forward Contracts	Notional Amounts Maturing in the Year						Fair Value Net Asset (Liability)
(in thousands)	2013			2014			December 31, 2012

Forward sale, 20.9 million Australian dollars	$	20,006		$	1,593		$	19
Forward purchase, 4.8 million British pounds	(7,846		)	—			(52		)
Forward sale, 47.2 million Canadian dollars	38,597			8,573			(385		)
Forward purchase, 17.7 million Danish kroner	(3,129		)	—			(24		)
Forward sale, 45.3 million euros	13,231			45,939			1,585
Forward purchase, 310.4 million Japanese yen	(391		)	(3,222		)	(374		)
Forward sale, 167.4 million Mexican pesos	13,018			—			49
Forward purchase, 2.3 million Norwegian kroner	(412		)	—			—
Forward sale, 17.2 million Polish zlotys	5,560			—			(77		)
Forward sale, 2.9 million Singapore dollars	2,413			—			33
Forward sale, 5.3 billion South Korean won	4,940			—			(30		)
Forward purchase, 1.5 billion Swedish kronor	(197,549		)	(27,544		)	4,296
Forward purchase, 61.1 million Swiss francs	(74,467		)	7,265			(411		)
Forward sale, 50.4 million Taiwanese dollars	1,734			—			1

Total foreign exchange forward contracts	$	(184,295	)	$	32,604		$	4,630



Interest Rate Swaps	Notional Amounts Maturing in the Year										Fair Value Net Asset (Liability)
(in thousands)	2013		2014		2015		2016		2017 and Beyond		December 31, 2012

Euro	$	1,246	$	953	$	953	$	953	$	1,191	$	(530	)
Japanese yen	—		144,681		—		—		—		133
Swiss francs	—		—		—		71,027		—		(1,392		)
Total interest rate swaps	$	1,246	$	145,634	$	953	$	71,980	$	1,191	$	(1,789	)



Commodity Swap Contracts	Notional Amounts Maturing in the Year		Fair Value Net Asset (Liability)
(in thousands)	2013		December 31, 2012

Silver swap - U.S. dollar	$	1,708	$	(68	)
Platinum swap - U.S. dollar	1,164		(27		)
Total commodity contracts	$	2,872	$	(95	)



							Fair Value Net
Cross Currency Basis Swaps	Notional Amounts Maturing in the Year						Asset (Liability)
(in thousands)	2013		2014		2015		December 31, 2012

449.8 million euro at $1.45 pay U.S. dollar three-month LIBOR receive three-month EURIBOR	$	—	$	593,555	$	—	$	(55,858	)
241.4 million Swiss franc at 1.08 pay Swiss franc three-month LIBOR receive U.S. dollar three-month LIBOR	307,474		—		—		(39,489		)
Total cross currency basis swaps	$	307,474	$	593,555	—		$	(95,347	)

At December 31, 2012, deferred net losses on derivative instruments of $1.7 million, which were recorded in AOCI, are expected to be reclassified to current earnings during the next twelve months. This reclassification is primarily due to the sale of inventory that includes previously hedged purchases and interest rate swaps. The maximum term over which the Company is hedging exposures to variability of cash flows (for all forecasted transactions, excluding interest payments on variable interest rate debt) is eighteen months. Overall, the derivatives designated as cash flow hedges are highly effective. Any cash flows associated with these instruments are included in cash from operations in accordance with the Company's policy of classifying the cash flows from these instruments in the same category as the cash flows from the items being hedged.

Hedges of Net Investments in Foreign Operations

The Company has numerous investments in foreign subsidiaries. The net assets of these subsidiaries are exposed to volatility in currency exchange rates. Currently, the Company uses both non-derivative financial instruments, including foreign currency denominated debt held at the parent company level and derivative financial instruments to hedge some of this exposure. Translation gains and losses related to the net assets of the foreign subsidiaries are offset by the spot-to-spot changes in the non-derivative and derivative financial instruments designated as hedges of net investments, which are included in AOCI.

At December 31, 2012 and 2011, the Company had Swiss franc-denominated and Japanese yen-denominated debt and cross currency basis swaps denominated in euro and Swiss franc to hedge the currency exposure related to a designated portion of the net assets of its European, Swiss and Japanese subsidiaries. The fair value of the cross currency interest rate swap agreements is the estimated amount the Company would (pay) receive at the reporting date, taking into account the effective interest rates and foreign exchange rates. As of December 31, 2012 and 2011, the estimated net fair values of the cross currency interest rate swap agreements were liabilities of $90.7 million and $111.9 million, respectively, which were recorded in accumulated other comprehensive income, net of tax effects. At December 31, 2012 and 2011, the accumulated translation loss on investments in foreign subsidiaries, primarily denominated in euros, Swiss francs, Japanese yen and Swedish kronor, net of these net investment hedges, were losses of $71.4 million and $143.7 million, respectively, which were included in AOCI, net of tax effects.

On January 17, 2013, the Company extended 295.5 million Swiss francs of cross currency basis swaps maturing in February, March and April 2013 with five new forward starting swaps totaling 295.5 million Swiss francs maturing in February 2016, March 2017 and April 2018. These net investment hedges were traded at an exchange rate of approximately .93 Swiss franc per U.S. dollar which results in additional investment totaling $55.2 million into the hedge value in February, March, and April 2013. The Company will receive three-month U.S. dollar LIBOR and pay three-month Swiss franc LIBOR minus 31.6 basis points.

The following tables summarize the notional amounts and fair value of the Company's cross currency basis swaps that are designated as hedges of net investments in foreign operations at December 31, 2012:



Cross Currency Basis Swaps	Notional Amounts Maturing in the Year						Fair Value Net Asset (Liability)
(in thousands)	2013		2014		2015		December 31, 2012

432.5 million Swiss franc at 1.06 pay Swiss franc three-month LIBOR receive U.S. dollar three-month LIBOR	$	322,898	$	87,854	$	61,848	$	(62,366	)
618.0 million euro at $1.27 pay three-month EURIBOR receive U.S. dollar three-month LIBOR	815,575		—		—		(28,312		)
Total cross currency basis swaps	$	1,138,473	$	87,854	$	61,848	$	(90,678	)

Fair Value Hedges

Effective April 4, 2011, the Company entered into a group of U.S. dollar denominated interest rate swaps with an initial total notional value of $150.0 million to effectively convert the underlying fixed interest rate of 4.1% on the Company's $250.0 million PPN to variable rate for a term of five years, ending February 2016. The notional value of the swaps will decline proportionately as portions of the PPN mature. These interest rate swaps are designated as fair value hedges of the interest rate risk associated with the hedged portion of the fixed rate PPN. Accordingly, the Company will carry the portion of the hedged debt at fair value, with the change in debt and swap offsetting each other in the income statement. At December 31, 2012, the estimated net fair value of these interest rate swaps was $4.5 million.

The following tables summarize the notional amounts and fair value of the Company's fair value hedges at December 31, 2012:



							Fair Value Net
Interest Rate Swaps	Notional Amounts Maturing in the Year						Asset (Liability)
(in thousands)	2014		2015		2016		December 31, 2012

U.S. dollar	$	45,000	$	60,000	$	45,000	$	4,513
Total interest rate contracts	$	45,000	$	60,000	$	45,000	$	4,513

The following tables summarize the fair value and consolidated balance sheet location of the Company's derivatives at December 31, 2012 and 2011:



	December 31, 2012
	Prepaid Expenses and Other Current Assets		Other Noncurrent Assets, Net		Accrued Liabilities		Other Noncurrent Liabilities
(in thousands)

Designated as Hedges

Foreign exchange forward contracts	$	2,353	$	65	$	2,243	$	844
Commodity contracts	—		—		95		—
Interest rate swaps	2,192		2,535		525		948
Cross currency basis swaps	8,191		—		97,281		1,588
Total	$	12,736	$	2,600	$	100,144	$	3,380
Not Designated as Hedges
Not Designated as Hedges
Foreign exchange forward contracts	$	6,652	$	—	$	1,353	$	—
DIO equity option contracts	—		—		—		153
Interest rate swaps	—		—		114		416
Cross currency basis swaps	537		—		$	40,026	$	55,858
Total	$	7,189	$	—	$	41,493	$	56,427



	December 31, 2011
	Prepaid Expenses and Other Current Assets		Other Noncurrent Assets, Net		Accrued Liabilities		Other Noncurrent Liabilities
(in thousands)

Designated as Hedges

Foreign exchange forward contracts	$	5,464	$	896	$	641	$	107
Commodity contracts	—		15		257		2
Interest rate swaps	2,539		3,160		—		1,050
Cross currency basis swaps	—		19,838		13,790		117,974
Total	$	8,003	$	23,909	$	14,688	$	119,133
Not Designated as Hedges
Not Designated as Hedges
Foreign exchange forward contracts	$	1,943	$	—	$	3,150	$	—
DIO equity option contracts	—		—		—		419
Interest rate swaps	—		—		105		476
Cross currency basis swaps	—		—		—		67,690
Total	$	1,943	$	—	$	3,255	$	68,585

The following tables summarize the statements of operations impact of the Company’s cash flow hedges for the years ended December 31, 2012 and 2011:



December 31, 2012
Derivatives in Cash Flow Hedging	Gain (Loss) in AOCI			Classification of Gains (Losses)	Effective Portion Reclassified from AOCI into Income

(in thousands)
Interest rate swaps	$	(1,987	)	Interest expense	$	(3,611	)
Foreign exchange forward contracts	1,027			Cost of products sold	8,029
Foreign exchange forward contracts	80			SG&A expenses	779
Commodity contracts	472			Cost of products sold	136
Total	$	(408	)		$	5,333



Derivatives in Cash Flow Hedging	Classification of Gains (Losses)	Ineffective portion Recognized in Income

(in thousands)
Foreign exchange forward contracts	Other expense (income), net	915
Commodity contracts	Interest expense	(25		)
Total		$	890



December 31, 2011

Derivatives in Cash Flow Hedging	Gain (Loss) in AOCI			Classification of Gains (Losses)	Effective Portion Reclassified from AOCI into Income

(in thousands)
Interest rate swaps	$	(30,008	)	Interest expense	$	(4,903	)
Foreign exchange forward contracts	6,858			Cost of products sold	1,503
Foreign exchange forward contracts	377			SG&A expenses	39
Commodity contracts	(191		)	Cost of products sold	273
Total	$	(22,964	)		$	(3,088	)



Derivatives in Cash Flow Hedging	Classification of Gains (Losses)	Ineffective portion Recognized in Income

(in thousands)
Interest rate swaps	Other expense (income), net	$	(6,151	)
Foreign exchange forward contracts	Interest expense	(403		)
Foreign exchange forward contracts	Other expense (income), net	(1,307		)
Commodity contracts	Interest expense	2
Total		$	(7,859	)

The following tables summarize the statements of operations impact of the Company’s hedges of net investments for the years ended December 31, 2012 and 2011:



December 31, 2012

Derivatives in Net Investment Hedging	Gain (Loss) in AOCI			Classification of Gains (Losses)	Gain (Loss) Recognized in Income

(in thousands)
Cross currency basis swaps	$	(34,216	)	Interest income	$	4,264
				Interest expense	(1,885		)
Total	$	(34,216	)		$	2,379



December 31, 2011

Derivatives in Net Investment Hedging	Gain (Loss) in AOCI			Classification of Gains (Losses)	Gain (Loss) Recognized in Income

(in thousands)
Cross currency basis swaps	$	3,308		Interest income	$	1,085
				Interest expense	(108		)
Cross currency basis swaps	30,125			Interest expense	(5,675		)
Foreign exchange forward contracts	(2,462		)	Interest expense	—
Total	$	30,971			$	(4,698	)

The following tables summarize the statements of operations impact of the Company’s hedges of fair value for the years ended December 31, 2012 and 2011:



Derivatives in Fair Value Hedging
	Classification of Gains (Losses)	December 31,
(in thousands)	Classification of Gains (Losses)	2012		2011
Interest rate swaps	Interest expense	$	2,284	$	6,328
Total		$	2,284	$	6,328

The following table summarizes the statements of operations impact of the Company’s hedges not designated as hedging for the years ended December 31, 2012 and 2011:



Derivatives Not Designated as Hedging
	Classification of Gains (Losses)	December 31,
(in thousands)	Classification of Gains (Losses)	2012			2011
Foreign exchange forward contracts (a)	Other expense (income), net	$	(1,224	)	$	(2,921	)
DIO equity option contracts	Other expense (income), net	272			383
Interest rate swaps	Interest expense	(155		)	(186		)
Cross currency basis swaps (a)	Other expense (income), net	12,323			(67,213		)
Total		$	11,216		$	(69,937	)

(a) The gains and losses on these derivative transactions offset the gains and losses generated by the revaluation of the underlying non-functional currency balances and are recorded in “Other expense (income), net” on the Consolidated Statements of Operations.

Amounts recorded in AOCI related to cash flow hedging instruments at:



	December 31,
(in thousands, net of tax)	2012			2011

Beginning balance	$	(12,737	)	$	(1,468	)

Changes in fair value of derivatives	105			(13,713		)
Reclassifications to earnings from equity	(4,849		)	2,444
Total activity	(4,744		)	(11,269		)
Ending balance	$	(17,481	)	$	(12,737	)

Amounts recorded in AOCI related to hedges of net investments in foreign operations at:



	December 31,
(in thousands, net of tax)	2012			2011

Beginning balance	$	(143,730	)	$	45,417

Foreign currency translation adjustment	83,283			(200,121		)
Changes in fair value of:
Foreign currency debt	10,097			(9,553		)
Derivative hedge instruments	(21,008		)	20,527
Total activity	72,372			(189,147		)
Ending balance	$	(71,358	)	$	(143,730	)

- Definition

The entire disclosure for the entity's entire derivative instruments and hedging activities. Describes an entity's risk management strategies, derivatives in hedging activities and non-hedging derivative instruments, the assets, obligations, liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41620-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624177-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579240-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7668309&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5708775-113959

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7668309&loc=d3e80748-113994

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41635-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5708773-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5618551-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5580258-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41638-113959

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624181-113959

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 45
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 22: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

FAIR VALUE MEASUREMENT

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

FAIR VALUE MEASUREMENT

The Company records financial instruments at fair value with unrealized gains and losses related to certain financial instruments reflected in AOCI on the Consolidated Balance Sheets. In addition, the Company recognizes certain liabilities at fair value. The Company applies the market approach for recurring fair value measurements. Accordingly, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs.

The fair value of financial instruments is determined by reference to various market data and other valuation techniques as appropriate. The Company believes the carrying amounts of cash and cash equivalents, accounts receivable (net of allowance for doubtful accounts), prepaid expenses and other current assets, accounts payable, accrued liabilities, income taxes payable and notes payable approximate fair value due to the short-term nature of these instruments. The Company estimated the fair value and carrying value of its total long-term debt, including current portion, was $1,515.2 million and $1,472.9 million, respectively, at December 31, 2012. At December 31, 2011, the Company estimated the fair value and carrying value was $1,512.5 million and $1,491.4 million, respectively. The interest rate on the $450.0 million Senior Notes, the $300.0 million Senior Notes, and the $250.0 million Private Placement Notes are fixed rates of 4.1%, 2.8% and 4.1%, respectively, and their fair value is based on the interest rates as of December 31, 2012. The interest rates on variable rate term loan debt and commercial paper are consistent with current market conditions, therefore the fair value of these instruments approximates their carrying values.

The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis at December 31, 2012 and 2011, which are classified as “Cash and cash equivalents,” “Prepaid expenses and other current assets,” “Long-Term investments,” “Other noncurrent assets, net,” “Accrued liabilities,” and “Other noncurrent liabilities” on the Consolidated Balance Sheets. Financial assets and liabilities that are recorded at fair value as of the balance sheet date are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.



	December 31, 2012
(in thousands)	Total		Level 1		Level 2		Level 3

Assets
Interest rate swaps	$	4,727	$	—	$	4,727	$	—
Cross currency basis swaps	8,728		—		8,728		—
Foreign exchange forward contracts	9,070		—		9,070		—
Corporate convertible bonds	75,143		—		—		75,143
Total assets	$	97,668	$	—	$	22,525	$	75,143

Liabilities
Interest rate swaps	$	2,003	$	—	$	2,003	$	—
Commodity forward purchase contracts	95		—		95		—
Cross currency basis swaps	194,753		—		194,753		—
Foreign exchange forward contracts	4,440		—		4,440		—
Long-term debt	154,560		—		154,560		—
DIO equity option contracts	153		—		—		153
Total liabilities	$	356,004	$	—	$	355,851	$	153



	December 31, 2011
(in thousands)	Total		Level 1		Level 2		Level 3

Assets
Money market funds	$	10,516	$	10,516	$	—	$	—
Interest rate swaps	5,699		—		5,699		—
Commodity forward purchase contracts	15		—		15		—
Cross currency basis swaps	19,838		—		19,838		—
Foreign exchange forward contracts	8,303		—		8,303		—
Corporate convertible bonds	47,850		—		—		47,850
Total assets	$	92,221	$	10,516	$	33,855	$	47,850

Liabilities
Interest rate swaps	$	1,631	$	—	$	1,631	$	—
Commodity forward purchase contracts	259		—		259		—
Cross currency basis swaps	199,454		—		199,454		—
Foreign exchange forward contracts	3,898		—		3,898		—
Long-term debt	154,512		—		154,512		—
Contingent considerations on acquisitions	2,917		—		—		2,917
DIO equity option contracts	$	419	$	—	$	—	$	419
Total liabilities	$	363,090	$	—	$	359,754	$	3,336

Derivative valuations are based on observable inputs to the valuation model including interest rates, foreign currency exchange rates, future commodities prices and credit risks. The commodity contracts, certain interest rate swaps and foreign exchange forward contracts are considered cash flow hedges and cross currency interest rate swaps are considered balance sheet or hedges of net investments in foreign operations as discussed in Note 15, Financial Instruments and Derivatives.

The Company uses the income method valuation technique to estimate the fair value of the corporate bonds. The significant unobservable inputs for valuing the corporate bonds are DIO Corporation's stock volatility factor of approximately 40% and corporate bond rating which implies an approximately 15% discount rate on the valuation model. Significant observable inputs used to value the corporate bonds include foreign exchange rates and DIO Corporation's period-ending market stock price.

The Company has valued the DIO equity option contracts using a Monte Carlo simulation which uses several estimates and probability assumptions by management including the future stock price, the stock price as a multiple of DIO earnings and the probability of the sellers to reduce their shares held by selling into the open market. Changes in the fair value of the DIO equity option contracts are reported in “Other expense (income), net” on the Consolidated Statements of Operations.

Certain purchase agreements for acquisitions completed after January 1, 2009 contain provisions where the seller could receive additional consideration based on the future operating performance of the acquired business. In accordance with US GAAP, the Company has recorded the fair value of these additional payments on the acquisition date. The fair value was based on a probability-weighted average payout discounted using a market rate of approximately 5%. The fair value is subject to management's estimates at the time of the acquisition and is based upon Level 3 inputs. The fair values of these additional payments are reported in “Other noncurrent liabilities,” on the Consolidated Balance Sheets.

The following table presents a reconciliation of the Company's Level 3 holdings measured at fair value on a recurring basis using unobservable inputs:



	Corporate		DIO Equity
(in thousands)	Convertible		Options			Contingent
	Bonds		Contracts			Considerations

Balance at December 31, 2011	$	47,850	$	(419	)	$	2,917
Payments, gross	—		—			(2,493		)
Adjustments:
Reported in selling, general and administrative expense	—		—			(412		)
Unrealized gain:
Reported in AOCI	25,775		—			—
Unrealized gain:
Reported in other expense (income), net	—		272			—
Effect of exchange rate changes	1,518		(6		)	(12		)
Balance at December 31, 2012	$	75,143	$	(153	)	$	—

For the year ended December 31, 2012, there were no purchases, issuances or transfers of Level 3 financial instruments. The Company paid $2.5 million of contingent considerations during the year ended December 31, 2012.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13537-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7491637&loc=d3e13433-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15B
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44A, 44B
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 17-22, 27, 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15A
-Subparagraph a-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15C, 15D
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32, 33, 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 3, 10, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

COMMITMENTS AND CONTINGENCIES

12 Months Ended

Dec. 31, 2012

COMMITMENTS AND CONTINGENCIES

Leases

The Company leases automobiles and machinery and equipment and certain office, warehouse and manufacturing facilities under non-cancellable leases. The leases generally require the Company to pay insurance, taxes and other expenses related to the leased property. Total rental expense for all operating leases was $42.3 million, $39.0 million and $34.9 million for 2012, 2011 and 2010, respectively.

Rental commitments, principally for real estate (exclusive of taxes, insurance and maintenance), automobiles and office equipment are as follows:



(in thousands)

2013	$	37,778
2014	28,386
2015	23,424
2016	19,393
2017	17,160
2018 and thereafter	24,772
	$	150,913

Litigation

On June 18, 2004, Marvin Weinstat, DDS and Richard Nathan, DDS filed a class action suit in San Francisco County, California alleging that the Company misrepresented that its Cavitron® ultrasonic scalers are suitable for use in oral surgical procedures. The Complaint seeks a recall of the product and refund of its purchase price to dentists who have purchased it for use in oral surgery. The Court certified the case as a class action in June 2006 with respect to the breach of warranty and unfair business practices claims. The class that was certified is defined as California dental professionals who, at any time during the period beginning June 18, 2000 through September 14, 2012, purchased and used one or more Cavitron® ultrasonic scalers for the performance of oral surgical procedures on their patients, which Cavitrons® were accompanied at sale by Directions for Use that “Indicated” Cavitron® use for “periodontal debridement for all types of periodontal disease.” The case is pending in the San Francisco County Court. A Class Notice was mailed beginning September 14, 2012.

On December 12, 2006, a Complaint was filed by Carole Hildebrand, DDS and Robert Jaffin, DDS in the Eastern District of Pennsylvania (the Plaintiffs subsequently added Dr. Mitchell Goldman as a named class representative). The case was filed by the same law firm that filed the Weinstat case in California. The Complaint asserts putative class action claims on behalf of dentists located in New Jersey and Pennsylvania. The Complaint asserts putative class action claims on behalf of dentists located in New Jersey and Pennsylvania. The Complaint seeks damages and asserts that the Company's Cavitron® ultrasonic scaler was negligently designed and sold in breach of contract and warranty arising from misrepresentations about the potential uses of the product because it cannot assure the delivery of potable or sterile water. Following dismissal of the case for lack of jurisdiction, the plaintiffs filed a second complaint under the name of Dr. Hildebrand's corporate practice. The Company's motion to dismiss this new complaint was denied and the case will now proceed under the name “Center City Periodontists.”

The Company does not believe a loss is probable related to the above litigation. Further a reasonable estimate of a possible range of loss cannot be made. In the event that one or more of these matters is unfavorably resolved, it is possible the Company's results from operations could be materially impacted.

In 2012, the Company has received subpoenas from the United States Attorney's Office for the Southern District of Indiana (the “USAO”) and from the Office of Foreign Assets Control of the United States Department of the Treasury (“OFAC”) requesting documents and information related to compliance with export controls and economic sanctions regulations by certain of its subsidiaries. The Company has voluntarily contacted OFAC and the Bureau of Industry and Security of the United States Department of Commerce (“BIS”), in connection with these matters as well as regarding compliance with export controls and economic sanctions regulations by certain other business units of the Company identified in connection with an ongoing internal review by the Company. The Company is cooperating with the USAO, OFAC and BIS with respect to these matters.

At this stage of the inquiries, the Company is unable to predict the ultimate outcome of these matters or what impact, if any, the outcome of these matters might have on the Company's consolidated financial position, results of operations or cash flows. Violations of export control or economic sanctions laws or regulations could result in a range of governmental enforcement actions, including fines or penalties, injunctions and/or criminal or other civil proceedings, which actions could have a material adverse effect on the Company's reputation, business, financial condition and results of operations. At this time, no claims have been made against the Company.

In addition to the matters disclosed above, the Company is, from time to time, subject to a variety of litigation and similar proceedings incidental to its business. These legal matters primarily involve claims for damages arising out of the use of the Company's products and services and claims relating to intellectual property matters, employment matters, tax matters, commercial disputes, competition and sales and trading practices, personal injury and insurance coverage. The Company may also become subject to lawsuits as a result of past or future acquisitions or as a result of liabilities retained from, or representations, warranties or indemnities provided in connection with, divested businesses. Some of these lawsuits may include claims for punitive and consequential, as well as compensatory damages. Based upon the Company's experience, current information and applicable law, it does not believe that these proceedings and claims will have a material adverse effect on its consolidated results of operations, financial position or liquidity. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to the Company's business, financial condition, results of operations or liquidity.

While the Company maintains general, products, property, workers' compensation, automobile, cargo, aviation, crime, fiduciary and directors' and officers' liability insurance up to certain limits that cover certain of these claims, this insurance may be insufficient or unavailable to cover such losses. In addition, while the Company believes it is entitled to indemnification from third parties for some of these claims, these rights may also be insufficient or unavailable to cover such losses.

Purchase and Other Commitments

The Company has no material non-cancelable purchase commitments.

The Company has employment agreements with its executive officers. These agreements generally provide for salary continuation for a specified number of months under certain circumstances. If all of the employees under contract were to be terminated by the Company without cause, as defined in the agreements, the Company's liability would be approximately $16.4 million at December 31, 2012.

The Company is required to complete the purchase of the remaining shares of one VIE, acquired in 2008, during the first quarter of 2014. The final purchase price is subject to adjustments but is currently expected to be approximately 62.6 million euros.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Disclosure - Schedule II Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2012

Valuation and Qualifying Accounts [Abstract]

Schedule of Valuation and Qualifying Accounts Disclosure

SCHEDULE II

VALUATION AND QUALIFYING ACCOUNTS

FOR THE YEARS ENDED DECEMBER 31, 2012, 2011 and 2010



			Additions
(in thousands)	Balance at Beginning of Period		Charged (Credited) To Costs And Expenses			Charged to Other Accounts				Write-offs Net of Recoveries			Translation Adjustment			Balance at End of Period

Description

Allowance for doubtful accounts:

For Year Ended December 31,
2010	$	12,235	$	(233	)	$	111			$	(2,611	)	$	(682	)	$	8,820
2011	8,820		469			7,930			(a)	(1,373		)	(941		)	14,905
2012	14,905		2,409			115				(3,798		)	16			13,647

Inventory valuation reserves:

For Year Ended December 31,
2010	$	31,932	$	6,590		$	760			$	(3,652	)	$	(161	)	$	35,469
2011	35,469		3,325			697			(b)	(3,924		)	(463		)	35,104
2012	35,104		2,500			(78		)		(4,673		)	(292		)	32,561

Deferred tax asset valuation allowance:

For Year Ended December 31,
2010	$	51,809	$	47,304		$	—			$	—		$	(6,059	)	$	93,054
2011	93,054		(22,400		)	2,174			(c)	—			(1,070		)	71,758
2012	71,758		107,995			—				—			(54		)	179,699

(a) Amount includes $7.8 million allowance for Astra Tech opening balance at August 31, 2011.

(b) Amount includes $1.1 million reserve for Astra Tech opening balance at August 31, 2011.

SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Use Of Estimates

Use of Estimates

Principles of Consolidation

Cash and Cash Equivalents

Cash and cash equivalents include deposits with banks as well as highly liquid time deposits with maturities at the date of purchase of ninety days or less.

Short-term Investments

Short-term investments are highly liquid time deposits with original maturities at the date of purchase greater than ninety days and with remaining maturities of one year or less.

Accounts and Notes Receivable-Trade

Inventories

Valuation of Goodwill and Other Long-Lived Assets

Goodwill

Indefinite-Lived Intangible Assets

Identifiable Definite-Lived Intangible Assets

Property, Plant and Equipment

Marketable Security

Marketable Securities

Derivative Financial Instruments

Pension and Other Postretirement Benefits

Accruals for Self-Insured Losses

Litigation

Accumulated Other Comprehensive Income

The balances included in AOCI in the consolidated balance sheets are as follows:



	December 31,
(in thousands)	2012			2011

Foreign currency translation adjustments	$	54,302		$	(39,078	)
Net loss on derivative financial instruments	(143,142		)	(117,390		)
Net unrealized holding (loss) gain on available for-sale securities	17,822			(516		)
Pension liability adjustments	(73,182		)	(33,986		)
	$	(144,200	)	$	(190,970	)

Accumulated Other Comprehensive Income

Foreign Currency Translation

The functional currency for foreign operations, except for those in highly inflationary economies, generally has been determined to be the local currency.

Revenue Recognition

Cost of Products Sold

Warranties

Selling, General and Administrative Expenses

Research and Development Costs

Stock Compensation

Income Taxes

Earnings Per Share

Business Acquisitions

Equity Method Investments

Investments in partnerships, joint ventures and less-than-majority-owned subsidiaries in which the Company has significant influence are accounted for under the equity method.

Noncontrolling Interests

Variable Interest Entities

Segment Reporting

Fair Value Measurement

Recurring Basis

Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reported date.

Non-Recurring Basis

Reclassification of Prior Year Amounts

Certain reclassifications have been made to prior years' data in order to conform to current year presentation.

SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The balances included in AOCI in the consolidated balance sheets are as follows:



	December 31,
(in thousands)	2012			2011

Foreign currency translation adjustments	$	54,302		$	(39,078	)
Net loss on derivative financial instruments	(143,142		)	(117,390		)
Net unrealized holding (loss) gain on available for-sale securities	17,822			(516		)
Pension liability adjustments	(73,182		)	(33,986		)
	$	(144,200	)	$	(190,970	)

Accumulated Other Comprehensive Income

Prepaid Expense and other current assets

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:



	December 31,
(in thousands)	2012	2011

Deferred taxes	80,903	67,159
Prepaid expenses	54,881	32,899
Other current assets	49,828	46,246
	185,612	146,304

EARNINGS PER COMMON SHARE (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Computation of Basic and Diluted Earnings Per Common Share

The following table sets forth the computation of basic and diluted earnings per common share:



(in thousands, except for per share amounts)	Net income attributable to DENTSPLY International		Shares	Earnings per common share

Year Ended December 31, 2012
Basic	$	314,213	141,850	$	2.22
Incremental shares from assumed exercise of dilutive options	—		2,095

Diluted	$	314,213	143,945	$	2.18

Year Ended December 31, 2011
Basic	$	244,520	141,386	$	1.73
Incremental shares from assumed exercise of dilutive options	—		2,167

Diluted	$	244,520	143,553	$	1.70

Year Ended December 31, 2010
Basic	$	265,708	143,980	$	1.85
Incremental shares from assumed exercise of dilutive options	—		2,005

Diluted	$	265,708	145,985	$	1.82

BUSINESS ACQUISITIONS AND INVESTMENTS IN AFFILIATES (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Preliminary Fair Values Of Assets Acquired And Liabilities Assumed Related To Acquisition



(in thousands)

Inventory	$	84,659
Other current assets	140,546
Property, plant, and equipment	178,495
Identifiable intangible assets	844,100
Goodwill	952,108
Other long-term assets	15,969
Total assets	2,215,877
Current liabilities	107,243
Long-term liabilities	313,594
Total liabilities	420,837
Net assets	$	1,795,040

Intangible Assets Acquired

Intangible assets acquired consist of the following:



(in thousands, except for useful life)			Useful Life
	Amount		(in years)

Customer relationships	$	494,700	15 - 18
Developed technology and patents	116,500		10
Trade names and Trademarks	229,100		Indefinite
In-process R&D	3,800		—
Total	$	844,100

Pro forma Unaudited Financial Information



(in thousands, except per share data)	Year Ended December 31,
	2011		2010

Net Sales	$	2,918,347	$	2,755,300
Net income attributable to DENTSPLY	250,363		274,962
Diluted earnings per common share	$	1.74	$	1.88

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References + Details

SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Net Sales

The following table sets forth information about the Company’s segments for the years ended December 31, 2012, 2011 and 2010.



Third Party Net Sales
(in thousands)	2012			2011			2010

Dental Consumable and Laboratory Businesses	$	958,266		$	946,464		$	890,499
Orthodontics/Canada/Mexico/Japan	331,811			322,444			359,780
Select Distribution Businesses	294,643			300,544			272,622
Implants/Endodontics/Healthcare/Pacific Rim	1,347,380			973,296			701,417
All Other (a)	(3,671		)	(5,030		)	(3,304		)
Total net sales	$	2,928,429		$	2,537,718		$	2,221,014


(a)	Includes amounts recorded at Corporate headquarters

Net Sales, Excluding Precious Metal Content



Third Party Net Sales, Excluding Precious Metal Content
(in thousands)	2012			2011			2010

Dental Consumable and Laboratory Businesses	$	792,035		$	794,736		$	750,924
Orthodontics/Canada/Mexico/Japan	297,877			289,529			331,971
Select Distribution Businesses	288,348			292,087			264,743
Implants/Endodontics/Healthcare/Pacific Rim	1,340,109			961,267			687,422
All Other (b)	(3,671		)	(5,030		)	(3,304		)
Total net sales, excluding precious metal content	$	2,714,698		$	2,332,589		$	2,031,756
Precious metal content of sales	213,731			205,129			189,258
Total net sales, including precious metal content	$	2,928,429		$	2,537,718		$	2,221,014


(b)	Includes amounts recorded at Corporate headquarters

Intersegment Net Sales



Intersegment Net Sales
(in thousands)	2012			2011			2010

Dental Consumable and Laboratory Businesses	$	220,229		$	220,671		$	223,504
Orthodontics/Canada/Mexico/Japan	4,000			4,065			4,105
Select Distribution Businesses	12,231			16,036			13,515
Implants/Endodontics/Healthcare/Pacific Rim	154,127			148,241			126,597
All Other (c)	221,867			211,658			179,780
Eliminations	(612,454		)	(600,671		)	(547,501		)
Total	$	—		$	—		$	—


(c)	Includes amounts recorded at Corporate headquarters and one distribution warehouse not managed by named segments.

Depreciation and Amortization



Depreciation and Amortization
(in thousands)	2012		2011		2010

Dental Consumable and Laboratory Businesses	$	33,022	$	34,874	$	30,960
Orthodontics/Canada/Mexico/Japan	5,076		4,473		4,447
Select Distribution Businesses	1,311		1,203		1,476
Implants/Endodontics/Healthcare/Pacific Rim	87,324		41,886		22,297
All Other (d)	2,466		2,599		6,732
Total	$	129,199	$	85,035	$	65,912


(d)	Includes amounts recorded at Corporate headquarters

Segment Operating Income



Segment Operating Income (Loss)
(in thousands)	2012			2011			2010

Dental Consumable and Laboratory Businesses	$	227,912		$	210,239		$	208,873
Orthodontics/Canada/Mexico/Japan	16,596			15,753			42,106
Select Distribution Businesses	(339		)	2,496			12,197
Implants/Endodontics/Healthcare/Pacific Rim	282,436			210,900			209,384
All Other (e)	(118,949		)	(102,795		)	(81,303		)
Segment Operating Income	$	407,656		$	336,593		$	391,257

Reconciling Items:
Restructuring and other costs	25,717			35,865			10,984
Interest expense	56,851			43,814			25,089
Interest income	(8,760		)	(8,237		)	(4,254		)
Other expense (income), net	3,169			9,040			1,782
Income before income taxes	$	330,679		$	256,111		$	357,656


(e)	Includes results of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments. Amount recorded in 2011 includes $31.9 million of Astra Tech acquisition costs

Capital Expenditures



Capital Expenditures
(in thousands)	2012		2011		2010

Dental Consumable and Laboratory Businesses	$	18,912	$	20,391	$	15,639
Orthodontics/Canada/Mexico/Japan	9,071		7,494		2,432
Select Distribution Businesses	724		1,439		1,352
Implants/Endodontics/Healthcare/Pacific Rim	58,367		32,949		21,297
All Other (f)	4,998		8,913		3,516
Total	$	92,072	$	71,186	$	44,236


(f)	Includes capital expenditures of Corporate headquarters.

Assets



Assets
(in thousands)	2012		2011

Dental Consumable and Laboratory Businesses	$	1,007,307	$	1,180,001
Orthodontics/Canada/Mexico/Japan	294,348		328,376
Select Distribution Businesses	192,684		168,500
Implants/Endodontics/Healthcare/Pacific Rim	3,195,382		2,881,591
All Other (g)	282,576		196,930
Total	$	4,972,297	$	4,755,398


(g)	Includes assets of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segmen

Company's Operations in Different Geographic Areas



(in thousands)	United States		Germany		Sweden		Other Foreign		Consolidated

2012
Net sales	$	993,980	$	546,092	$	54,507	$	1,333,850	$	2,928,429
Property, plant and equipment, net	148,950		122,310		133,502		209,943		614,705

2011
Net sales	$	875,471	$	515,819	$	20,383	$	1,126,045	$	2,537,718
Property, plant and equipment, net	137,871		118,229		150,167		185,178		591,445

2010
Net sales	$	846,834	$	470,953	$	—	$	903,227	$	2,221,014
Property, plant and equipment, net	119,599		116,951		—		186,555		423,105

Schedule of Sales by Product Category

The following table presents net sales information by product category:



	December 31,
(in thousands)	2012		2011		2010

Dental consumables products	$	768,098	$	766,385	$	717,718
Dental laboratory products	518,668		525,008		511,061
Dental specialty products	1,306,217		1,078,034		925,317
Consumable medical device products	335,446		168,291		66,918
Total net sales	$	2,928,429	$	2,537,718	$	2,221,014

OTHER EXPENSE (INCOME), NET (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Other expense (income), net

Other expense (income), net, consists of the following:



	December 31,
(in thousands)	2012		2011		2010

Foreign exchange transaction losses	$	2,679	$	1,713	$	3,331
Other expense (income), net	490		7,327		(1,549		)
Total other expense (income), net	$	3,169	$	9,040	$	1,782

INVENTORIES, NET (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Inventories, net

Inventories, net, consist of the following:



	December 31,
(in thousands)	2012		2011

Finished goods	$	248,870	$	218,814
Work-in-process	72,533		66,952
Raw materials and supplies	81,537		75,996
Inventories, net	$	402,940	$	361,762

PROPERTY, PLANT AND EQUIPMENT, NET (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Property, plant and equipment, net

Property, plant and equipment, net, consist of the following:



	December 31,
(in thousands)	2012		2011

Assets, at cost:
Land	$	45,561	$	45,840
Buildings and improvements	409,451		372,156
Machinery and equipment	848,331		680,240
Construction in progress	50,647		42,648
	1,353,990		1,140,884
Less: Accumulated depreciation	739,285		549,439
Property, plant and equipment, net	$	614,705	$	591,445

GOODWILL AND INTANGIBLE ASSETS (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Reconciliation of Changes in the Company's Goodwill

Goodwill by reportable segment is as follows:



	December 31,
(in thousands)	2012		2011

Dental Consumable and Laboratory Businesses	$	488,206	$	484,779
Orthodontics/Canada/Mexico/Japan	102,065		102,950
Select Distribution Businesses	92,473		108,566
Implants/Endodontics/Healthcare/Pacific Rim	1,528,209		1,493,768
Total	$	2,210,953	$	2,190,063

A reconciliation of changes in the Company’s goodwill is as follows:



	December 31,
(in thousands)	2012			2011

Balance, beginning of the year	$	2,190,063		$	1,303,055
Acquisition activity	867			978,191
Additional consideration for post closing adjustments	6,574			2,833
Adjustment of provisional amounts on prior acquisition	(22,516		)	—
Effect of exchange rate changes	35,965			(94,016		)
Balance, end of the year	$	2,210,953		$	2,190,063

Identifiable Definite-Lived Intangible Assets

Identifiable definite-lived and indefinite-lived intangible assets consist of the following:



	December 31, 2012							December 31, 2011
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount

Patents	$	179,512	$	(81,390	)	$	98,122	$	131,252	$	(17,393	)	$	113,859
Trademarks	83,073		(33,129		)	49,944		73,413		(23,885		)	49,528
Licensing agreements	30,695		(18,966		)	11,729		30,444		(17,277		)	13,167
Customer relationships	491,859		(50,632		)	441,227		411,626		(19,066		)	392,560
Total definite-lived	$	785,139	$	(184,117	)	$	601,022	$	646,735	$	(77,621	)	$	569,114

Trademarks and In-process R&D	$	229,620	$	—		$	229,620	$	221,986	$	—		$	221,986

Total identifiable intangible assets	$	1,014,759	$	(184,117	)	$	830,642	$	868,721	$	(77,621	)	$	791,100

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References + Details

ACCRUED LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Accrued Liabilities

Accrued liabilities consist of the following:



	December 31,
(in thousands)	2012		2011

Payroll, commissions, bonuses, other cash compensation and employee benefits	$	96,206	$	85,855
General insurance	12,204		12,164
Sales and marketing programs	32,742		34,528
Professional and legal costs	12,202		10,269
Restructuring costs	14,452		4,787
Warranty liabilities	3,693		3,765
Deferred income	5,514		6,304
Accrued vacation and holidays	29,804		28,169
Third party royalties	11,288		10,174
Current portion of derivatives	144,195		18,143
Other	62,036		75,043
	$	424,336	$	289,201

FINANCING ARRANGEMENTS (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Short-Term Borrowings

Short-Term Debt

Short-term debt consisted of the following:



	December 31,
	2012					2011
	Principal			Interest		Principal			Interest
(in thousands)	Balance			Rate		Balance			Rate

Bank overdrafts	$	123				$	192
Corporate commercial paper facility	45,000			0.5	%	266,828			0.5	%
European short-term loan	1,962			3.9	%	2,438			3.4	%
Brazil short-term loan	1,000			2.0	%	5,834			12.9	%
Add: Current portion of long-term debt	250,878					1,409
Total short-term debt	$	298,963				$	276,701

	2012					2011
Maximum month-end outstanding during the year	$	399,931				$	355,304
Average amount outstanding during the year	$	248,318				$	225,498
Weighted-average interest rate at year-end	0.6		%			0.8		%

Long-Term Borrowings

Long-Term Debt

Long-term debt consisted of the following:



	December 31,
	2012				2011
	Principal		Interest		Principal		Interest
(in thousands)	Balance		Rate		Balance		Rate

Floating rate senior notes $250 million due August 2013	$	250,000	1.8	%	$	250,000	2.0	%
Term loan Japanese yen denominated expiring September 2014	144,681		1.1	%	162,956		1.1	%
Private placement notes $250 million expiring March 2016	254,560		4.1	%	254,512		4.1	%
Fixed rate senior notes $300 million due August 2016	299,689		2.8	%	299,603		2.8	%
Term loan Swiss francs denominated expiring September 2016	71,027		1.2	%	69,197		1.2	%
Fixed rate senior notes $450 million due August 2021	448,653		4.1	%	448,497		4.1	%
Other borrowings, various currencies and rates	4,303				6,654
	$	1,472,913			$	1,491,419
Less: Current portion
(included in notes payable and current portion of long-term debt)	250,878				1,409
Long-term portion	$	1,222,035			$	1,490,010

Contractual Maturity Dates of Various Borrowings

The table below reflects the contractual maturity dates of the various borrowings at December 31, 2012:



(in thousands)

2013	$	250,878
2014	221,865
2015	102,230
2016	448,440
2017	442
2018 and Beyond	449,058
	$	1,472,913

EQUITY (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Total Outstanding Shares

The following table represents total outstanding shares for the years ended December 31:



(in thousands)	Common Shares	Treasury Shares		Outstanding Shares

Balance at December 31, 2009	162,776	(15,815	)	146,961
Shares issued	—	1,489		1,489
Repurchase of common stock at cost	—	(6,715	)	(6,715	)

Balance at December 31, 2010	162,776	(21,041	)	141,735
Shares issued	—	2,084		2,084
Repurchase of common stock at cost	—	(2,187	)	(2,187	)

Balance at December 31, 2011	162,776	(21,144	)	141,632
Shares issued	—	1,688		1,688
Repurchase of common stock at cost	—	(998	)	(998	)

Balance at December 31, 2012	162,776	(20,454	)	142,322

Total Stock Based Compensation Expense and the Tax Related Benefit

The following table represents total stock based compensation expense and the tax related benefit for the years ended:



	December 31,
(in thousands)	2012		2011		2010

Stock option expense	$	11,126	$	10,369	$	10,420
RSU expense	9,644		9,243		7,227
Total stock based compensation expense	$	20,770	$	19,612	$	17,647

Related deferred income tax benefit	$	5,775	$	5,021	$	4,886

Assumptions Used to Determine Compensation Cost for the Company's Non-qualified Stock Options Issued



	December 31,
	2012			2011			2010 (a)

Weighted average fair value per share	$	8.91		$	8.86		$	9.06
Expected dividend yield	0.57		%	0.55		%	0.58		%
Risk-free interest rate	0.93		%	2.35		%	2.55		%
Expected volatility	26		%	24		%	22		%
Expected life (years)	5.10			5.07			6.42

(a)

Summary of the Non-qualified Stock Option Transactions

The following table summarizes the NQSO transactions for the year ended December 31, 2012:



	Outstanding						Exercisable
(in thousands, except per share amounts)	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Shares	Weighted Average Exercise Price		Aggregate Intrinsic Value

December 31, 2011	10,148		$	31.23	$	51,402	8,049	$	30.06	$	50,365
Granted	1,346		38.62
Exercised	(1,409	)	24.26
Cancelled	(85	)	33.26
Forfeited	(94	)	33.97
December 31, 2012	9,906		$	33.18	$	69,079	7,599	$	31.79	$	64,819

Summary of Information about Non-qualified Stock Options Outstanding

The following table summarizes information about NQSO outstanding for the year ended December 31, 2012:



			Outstanding				Exercisable
(in thousands, except per share amounts and life)			Number Outstanding at December 31,	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number Exercisable at December 31,	Weighted Average Exercise Price
Range of			Number Outstanding at December 31,				Number Exercisable at December 31,
Exercise Prices			2012				2012

10.01	-	20.00	6	0.4	$	18.02	6	$	18.02
20.01	-	30.00	3,525	3.7	26.45		3,522	26.45
30.01	-	40.00	5,366	7.2	35.40		3,065	35.40
40.01	-	50.00	1,009	4.9	44.99		1,006	44.90
			9,906	5.7	$	33.18	7,599	$	31.79

Summary of the Unvested RSU Transactions

The following table summarizes the unvested RSU transactions for the year ended December 31, 2012:



	Unvested Restricted Stock Units
	Shares		Weighted Average Grant Date Fair Value
(in thousands, except per share amounts)


Unvested at December 31, 2011	897		$	32.50
Granted	422		38.65
Vested	(247	)	26.38
Forfeited	(38	)	35.97
Unvested at December 31, 2012	1,034		$	36.34

INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Components of Income Before Income Taxes from Operations

The components of income before income taxes from operations are as follows:



	December 31,
(in thousands)	2012		2011		2010

United States	$	67,668	$	7,041	$	104,424
Foreign	263,011		249,070		253,232
	$	330,679	$	256,111	$	357,656

Components of the Provision for Income Taxes from Operations

The components of the provision for income taxes from operations are as follows:



	December 31,
(in thousands)	2012			2011			2010

Current:
U.S. federal	$	23,412		$	34,870		$	21,848
U.S. state	2,788			5,151			3,795
Foreign	69,954			59,397			62,196
Total	$	96,154		$	99,418		$	87,839

Deferred:
U.S. federal	$	(128,832	)	$	(29,664	)	$	3,067
U.S. state	11,730			(4,089		)	1,062
Foreign	29,868			(54,649		)	(2,743		)
Total	$	(87,234	)	$	(88,402	)	$	1,386

	$	8,920		$	11,016		$	89,225

Reconciliation of the U.S. Federal Statutory Tax Rate to the Effective Rate

The reconciliation of the U.S. federal statutory tax rate to the effective rate for the years ended is as follows:



	December 31,
	2012		2011		2010

Statutory U. S. federal income tax rate	35.0	%	35.0	%	35.0	%
Effect of:
State income taxes, net of federal benefit	0.7		0.3		0.9
Federal benefit of R&D and foreign tax credits	(7.2	)	(8.6	)	(6.9	)
Tax effect of international operations	(7.4	)	(7.9	)	(3.7	)
Net effect of tax audit activity	(0.6	)	2.1		1.0
Tax effect of enacted statutory rate changes	(3.7	)	0.2		—
Federal tax on unremitted earnings of certain foreign subsidiaries	0.1		0.1		0.2
Valuation allowance adjustments	12.0		(18.1	)	(1.0	)
Foreign outside basis differences	(26.5	)	—		—
Other	0.3		1.2		(0.5	)

Effective income tax rate on operations	2.7	%	4.3	%	25.0	%

Tax Effect of Significant Temporary Differences Giving Rise to Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities are included in the following consolidated balance sheet line items:



	December 31,
(in thousands)	2012		2011

Prepaid expenses and other current assets	$	80,903	$	67,159
Income taxes payable	2,856		2,678
Other noncurrent assets	86,029		51,250
Deferred income taxes	232,641		249,822

The tax effect of significant temporary differences giving rise to deferred tax assets and liabilities are as follows:



	December 31, 2012					December 31, 2011
(in thousands)	Deferred Tax Asset			Deferred Tax Liability		Deferred Tax Asset			Deferred Tax Liability

Commission and bonus accrual	$	2,529		$	—	$	2,812		$	—
Employee benefit accruals	44,266			—		38,061			—
Foreign outside basis difference	189,125			—		—			—
Inventory	21,173			—		19,972			—
Identifiable intangible assets	—			359,303		—			336,822
Insurance premium accruals	4,381			—		4,533			—
Miscellaneous accruals	12,685			—		12,273			—
Other	15,844			—		13,166			—
Unrealized losses included in other
comprehensive income	39,879			—		28,424			—
Property, plant and equipment	—			51,020		—			52,251
Product warranty accruals	1,154			—		907			—
R&D and foreign tax credit carryforward	—			—		49,552			—
Restructuring and other cost accruals	1,048			—		1,439			—
Sales and marketing accrual	4,480			—		4,874			—
Taxes on unremitted earnings of foreign subsidiaries	—			2,556		—			2,273
Tax loss carryforwards and other tax attributes	187,449			—		152,999			—
Valuation allowance	(179,699		)	—		(71,758		)	—
	$	344,314		$	412,879	$	257,254		$	391,346

Unrecognized Tax Benefits

The Company had the following activity recorded for unrecognized tax benefits:



	December 31,
(in thousands)	2012			2011			2010

Unrecognized tax benefits at beginning of period	$	14,956		$	13,143		$	12,864
Gross change for prior period positions	(3,029		)	1,425			47
Gross change for current year positions	268			640			1,036
Decrease due to settlements and payments	—			—			—
Decrease due to statute expirations	—			(123		)	(424		)
Increase due to effect of foreign currency translation	—			—			—
Decrease due to effect from foreign currency translation	69			(129		)	(380		)

Unrecognized tax benefits at end of period	$	12,264		$	14,956		$	13,143

BENEFIT PLANS (Tables)

12 Months Ended

Dec. 31, 2012

Notes to Financial Statements [Abstract]

Reconciliations of Changes in the Defined Benefit and Postretirement Healthcare Plans' Benefit Obligations, Fair Value of Assets and Statement of Funded Status

Reconciliations of changes in the defined benefit and postretirement healthcare plans’ benefit obligations, fair value of assets and statement of funded status are as follows:



							Other Postretirement
	Pension Benefits						Benefits
	December 31,						December 31,
(in thousands)	2012			2011			2012			2011

Change in Benefit Obligation
Benefit obligation at beginning of year	$	270,607		$	211,504		$	12,217		$	11,607
Service cost	12,178			10,950			195			61
Interest cost	10,600			9,633			490			553
Participant contributions	3,638			3,562			535			583
Actuarial losses	59,461			2,991			1,601			537
Plan amendments	(93		)	(3,034		)	—			—
Acquisitions/Divestitures	3,745			52,282			—			—
Effect of exchange rate changes	8,100			(8,355		)	—			—
Foreign plan additions	540			—			—			—
Plan curtailments	(310		)	—			—			—
Benefits paid	(12,700		)	(8,926		)	(820		)	(1,124		)
Benefit obligation at end of year	$	355,766		$	270,607		$	14,218		$	12,217

Change in Plan Assets
Fair value of plan assets at beginning of year	$	108,708		$	99,546		$	—		$	—
Actual return on assets	10,732			(889		)	—			—
Acquisitions/Divestitures	—			7,006			—			—
Effect of exchange rate changes	2,362			(1,238		)	—			—
Employer contributions	12,144			9,647			285			541
Participant contributions	3,638			3,562			535			583
Benefits paid	(12,700		)	(8,926		)	(820		)	(1,124		)
Fair value of plan assets at end of year	$	124,884		$	108,708		$	—		$	—

Funded status at end of year	$	(230,882	)	$	(161,899	)	$	(14,218	)	$	(12,217	)

Amounts Recognized in the Accompanying Consolidated Balance Sheets, Net of Tax Effects

The amounts recognized in the accompanying Consolidated Balance Sheets, net of tax effects, are as follows:



	Pension Benefits						Other Postretirement Benefits
	December 31,						December 31,
(in thousands)	2012			2011			2012			2011

Other noncurrent assets, net	$	263		$	355		$	—		$	—
Deferred tax asset	26,421			10,972			1,764			1,247
Total assets	$	26,684		$	11,327		$	1,764		$	1,247

Current liabilities	(4,561		)	(4,411		)	(654		)	(977		)
Other noncurrent liabilities	(226,584		)	(157,843		)	(13,564		)	(11,240		)
Deferred tax liability	(449		)	(269		)	—			—
Total liabilities	$	(231,594	)	$	(162,523	)	$	(14,218	)	$	(12,217	)

Accumulated other comprehensive income	70,377			32,002			2,805			1,984
Net amount recognized	$	(134,533	)	$	(119,194	)	$	(9,649	)	$	(8,986	)

Amounts Recognized in Accumulated Other Comprehensive Income

Amounts recognized in AOCI consist of:



							Other Postretirement
	Pension Benefits						Benefits
	December 31,						December 31,
(in thousands)	2012			2011			2012		2011

Net actuarial loss	$	99,129		$	45,462		$	4,569	$	3,232
Net prior service cost	(2,780		)	(2,757		)	—		—
Before tax AOCI	$	96,349		$	42,705		$	4,569	$	3,232
Less: Deferred taxes	25,972			10,703			1,764		1,248
Net of tax AOCI	$	70,377		$	32,002		$	2,805	$	1,984

Information for Pension Plans with an Accumulated Benefit Obligation in Excess of Plan Assets

Information for pension plans with an accumulated benefit obligation in excess of plan assets:



	December 31,
(in thousands)	2012		2011

Projected benefit obligation	$	344,653	$	268,391
Accumulated benefit obligation	315,963		246,515
Fair value of plan assets	117,413		106,137

Components of Net Periodic Benefit Cost

Components of net periodic benefit cost:



	Pension Benefits									Other Postretirement Benefits
(in thousands)	2012			2011			2010			2012		2011		2010

Service cost	$	12,178		$	10,950		$	8,108		$	195	$	61	$	58
Interest cost	10,600			9,633			8,415			490		553		605
Expected return on assets	(4,727		)	(5,184		)	(4,662		)	—		—		—
Amortization of transition obligation	—			—			124			—		—		—
Amortization of prior service cost (credit)	(138		)	80			86			—		—		—
Amortization of net actuarial loss	1,995			1,584			1,002			264		189		265
Curtailment and settlement gains	(303		)	4			—			—		—		—
Net periodic benefit cost	$	19,605		$	17,067		$	13,073		$	949	$	803	$	928

Other Changes in Plan Assets and Benefit Obligations Recognized in AOCI

Other changes in plan assets and benefit obligations recognized in AOCI:



	Pension Benefits									Other Postretirement Benefits
(in thousands)	2012			2011			2010			2012			2011			2010

Net actuarial (gain) loss	$	55,662		$	8,352		$	12,640		$	1,601		$	537		$	(548	)
Net prior service (credit)	(161		)	(2,845		)	(8		)	—			—			—
Net transition obligation	—			—			(1		)	—			—			—
Amortization	(1,857		)	(1,664		)	(1,212		)	(264		)	(189		)	(265		)
Total recognized in AOCI	$	53,644		$	3,843		$	11,419		$	1,337		$	348		$	(813	)
Total recognized in net periodic benefit cost and AOCI	$	73,249		$	20,910		$	24,492		$	2,286		$	1,151		$	115

Amounts in AOCI that are Expected to be Amortized as Net Expense (Income) During Next Fiscal Year

The amounts in AOCI that are expected to be amortized as net expense (income) during fiscal year 2013 are as follows:



(in thousands)	Pension Benefits			Other Postretirement Benefits

Amount of net prior service cost	$	(139	)	$	—
Amount of net loss	5,144			352

Weighted Average Assumptions Used to Determine Benefit Obligations, Principally in Foreign Locations

The weighted average assumptions used to determine benefit obligations for the Company's plans, principally in foreign locations, at December 31, 2012, 2011 and 2010 are as follows:



	Pension Benefits						Other Postretirement Benefits
	2012		2011		2010		2012		2011		2010

Discount rate	2.8	%	4.0	%	4.1	%	3.5	%	4.0	%	5.0	%
Rate of compensation increase	2.7	%	2.8	%	2.6	%	n/a		n/a		n/a
Health care cost trend	n/a		n/a		n/a		8.0	%	7.5	%	8.0	%
Ultimate health care cost trend	n/a		n/a		n/a		5.0	%	5.0	%	5.0	%
Years until ultimate trend is reached	n/a		n/a		n/a		7.0		6.0		7.0

Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost



	Pension Benefits						Other Postretirement Benefits
	2012		2011		2010		2012		2011		2010

Discount rate	4.0	%	4.1	%	4.7	%	4.0	%	5.0	%	5.5	%
Expected return on plan assets	4.1	%	4.8	%	5.2	%	n/a		n/a		n/a
Rate of compensation increase	2.8	%	2.6	%	2.7	%	n/a		n/a		n/a
Health care cost trend	n/a		n/a		n/a		8.0	%	7.5	%	8.0	%
Ultimate health care cost trend	n/a		n/a		n/a		5.0	%	5.0	%	5.0	%
Years until ultimate trend is reached	n/a		n/a		n/a		7.0		6.0		7.0

Measurement Date	12/31/2012		12/31/2011		12/31/2010		12/31/2012		12/31/2011		12/31/2010

Effect of One Percentage Point in Assumed Healthcare Cost Trend Rates



	Other Postretirement Benefits
(in thousands)	1% Increase		1% Decrease

Effect on total of service and interest cost components	$	140	$	(108	)
Effect on postretirement benefit obligation	2,503		(1,976		)

Fair Value Measurements of Plan Assets



	December 31, 2012
(in thousands)	Total		Level 1		Level 2		Level 3

Assets Category
Cash and cash equivalents	$	5,930	$	5,930	$	—	$	—
Equity securities:
U. S.	1,015		1,015		—		—
International	34,197		34,197		—		—
Fixed income securities:
Fixed rate bonds (a)	48,450		48,450		—		—
Other types of investments:
Mutual funds (b)	8,994		—		8,994		—
Real estate mutual funds	9,713		9,713		—		—
Common trusts (c)	2,708		—		—		2,708
Insurance contracts	12,199		—		3,865		8,334
Hedge funds	1,311		—		—		1,311
Real estate	367		—		—		367
Total	$	124,884	$	99,305	$	12,859	$	12,720



	December 31, 2011
(in thousands)	Total		Level 1		Level 2		Level 3

Assets Category
Cash and cash equivalents	$	5,165	$	5,001	$	164	$	—
Equity securities:
U. S.	2,036		2,036		—		—
International	27,982		27,982		—		—
Fixed income securities:
Fixed rate bonds (a)	44,499		44,499		—		—
Other types of investments:
Mutual funds (b)	8,065		—		8,065		—
Real estate mutual funds	8,307		8,307		—		—
Common trusts (c)	2,083		—		—		2,083
Insurance contracts	9,323		—		3,503		5,820
Hedge funds	891		—		—		891
Real estate	357		—		—		357
Total	$	108,708	$	87,825	$	11,732	$	9,151


(a)	This category includes fixed income securities invested primarily in Swiss bonds, foreign bonds denominated in Swiss francs, foreign currency bonds, mortgage notes and pledged letters.


(b)	This category includes mutual funds balanced between moderate-income generation and moderate capital appreciation with investment allocations of approximately 50% equities and 50% fixed income investments.


(c)	This category includes common/collective funds with investments in approximately 65% equities and 35% in fixed income investments.

Reconciliation for the Plans Assets Categorized as Level 3



	Changes within Level 3 Category for
	Year Ended December 31, 2012
(in thousands)	Common Trust		Insurance Contracts		Hedge Funds		Real Estate		Total

Balance at December 31, 2011	$	2,083	$	5,820	$	890	$	358	$	9,151
Actual return on plan assets:
Relating to assets still held at the reporting date	284		1,700		52		—		2,036
Relating to assets sold during the period	8		—		6		—		14
Purchases, sales and settlements, net	333		533		331		—		1,197
Effect of exchange rate changes	—		281		32		9		322
Balance at December 31, 2012	$	2,708	$	8,334	$	1,311	$	367	$	12,720



	Changes within Level 3 Category for
	Year Ended December 31, 2011
(in thousands)	Common Trust		Insurance Contracts			Hedge Funds			Real Estate			Total

Balance at December 31, 2010	$	2,066	$	1,824		$	1,334		$	360		$	5,584
Actual return on plan assets:
Relating to assets still held at the reporting date	5		(1,355		)	(80		)	—			(1,430		)
Relating to assets sold during the period	5		—			—			—			5
Acquisitions/Divestitures	—		6,738			—			—			6,738
Purchases, sales and settlements, net	7		(1,144		)	(384		)	—			(1,521		)
Effect of exchange rate changes	—		(243		)	20			(2		)	(225		)
Balance at December 31, 2011	$	2,083	$	5,820		$	890		$	358		$	9,151

Estimated Future Benefit Payments



(in thousands)	Pension Benefits		Other Postretirement Benefits

2013	$	9,229	$	665
2014	10,619		634
2015	10,899		612
2016	10,999		633
2017	12,512		614
2018-2022	70,668		3,058

RESTRUCTURING AND OTHER COSTS (Tables)

12 Months Ended

Dec. 31, 2012

Restructuring Accruals

At December 31, 2012, the Company’s restructuring accruals were as follows:



	Severances
(in thousands)	2010 and Prior Plans			2011 Plans			2012 Plans			Total

Balance at December 31, 2011	$	3,380		$	1,281		$	—		$	4,661
Provisions and adjustments	—			556			15,540			16,096
Amounts applied	(1,511		)	(1,392		)	(4,143		)	(7,046		)
Change in estimates	(720		)	(99		)	—			(819		)
Balance at December 31, 2012	$	1,149		$	346		$	11,397		$	12,892



	Lease/Contract Terminations
(in thousands)	2010 and Prior Plans			2012 Plans			Total

Balance at December 31, 2011	$	1,011		$	—		$	1,011
Provisions and adjustments	—			1,392			1,392
Amounts applied	(219		)	(710		)	(929		)
Balance at December 31, 2012	$	792		$	682		$	1,474



	Other Restructuring Costs
(in thousands)	2010 and Prior Plans			2012 Plans			Total

Balance at December 31, 2011	$	34		$	—		$	34
Provisions and adjustments	—			1,222			1,222
Amounts applied	(34		)	(1,136		)	(1,170		)
Balance at December 31, 2012	$	—		$	86		$	86

Cumulative Amounts for the Provisions and Adjustments and Amounts Applied for All the Plans by Segment

The following table provides the cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment:



(in thousands)	December 31, 2011		Provisions and Adjustments		Amounts Applied			Change in Estimates			December 31, 2012

Dental Consumable and Laboratory Businesses	$	3,601	$	8,302	$	(2,410	)	$	(360	)	$	9,133
Orthodontics/Canada/Mexico/Japan	240		1,394		(1,260		)	(14		)	360
Select Distribution Businesses	—		264		(42		)	—			222
Implants/Endodontics/Healthcare/Pacific Rim	1,865		8,750		(5,396		)	(482		)	4,737

Total	$	5,706	$	18,710	$	(9,108	)	$	(856	)	$	14,452

FINANCIAL INSTRUMENTS AND DERIVATIVES (Tables)

12 Months Ended

Dec. 31, 2012

Fair Value and Consolidated Balance Sheet Location of the Company's Derivatives

The following tables summarize the fair value and consolidated balance sheet location of the Company's derivatives at December 31, 2012 and 2011:



	December 31, 2012
	Prepaid Expenses and Other Current Assets		Other Noncurrent Assets, Net		Accrued Liabilities		Other Noncurrent Liabilities
(in thousands)

Designated as Hedges

Foreign exchange forward contracts	$	2,353	$	65	$	2,243	$	844
Commodity contracts	—		—		95		—
Interest rate swaps	2,192		2,535		525		948
Cross currency basis swaps	8,191		—		97,281		1,588
Total	$	12,736	$	2,600	$	100,144	$	3,380
Not Designated as Hedges
Not Designated as Hedges
Foreign exchange forward contracts	$	6,652	$	—	$	1,353	$	—
DIO equity option contracts	—		—		—		153
Interest rate swaps	—		—		114		416
Cross currency basis swaps	537		—		$	40,026	$	55,858
Total	$	7,189	$	—	$	41,493	$	56,427



	December 31, 2011
	Prepaid Expenses and Other Current Assets		Other Noncurrent Assets, Net		Accrued Liabilities		Other Noncurrent Liabilities
(in thousands)

Designated as Hedges

Foreign exchange forward contracts	$	5,464	$	896	$	641	$	107
Commodity contracts	—		15		257		2
Interest rate swaps	2,539		3,160		—		1,050
Cross currency basis swaps	—		19,838		13,790		117,974
Total	$	8,003	$	23,909	$	14,688	$	119,133
Not Designated as Hedges
Not Designated as Hedges
Foreign exchange forward contracts	$	1,943	$	—	$	3,150	$	—
DIO equity option contracts	—		—		—		419
Interest rate swaps	—		—		105		476
Cross currency basis swaps	—		—		—		67,690
Total	$	1,943	$	—	$	3,255	$	68,585

Amounts Recorded in AOCI, Net of Tax, Related to Cash Flow Hedging Instruments

Amounts recorded in AOCI related to cash flow hedging instruments at:



	December 31,
(in thousands, net of tax)	2012			2011

Beginning balance	$	(12,737	)	$	(1,468	)

Changes in fair value of derivatives	105			(13,713		)
Reclassifications to earnings from equity	(4,849		)	2,444
Total activity	(4,744		)	(11,269		)
Ending balance	$	(17,481	)	$	(12,737	)

Amounts Recorded in AOCI, Net of Tax, Related to Hedges of Net Investments in Foreign Operations

Amounts recorded in AOCI related to hedges of net investments in foreign operations at:



	December 31,
(in thousands, net of tax)	2012			2011

Beginning balance	$	(143,730	)	$	45,417

Foreign currency translation adjustment	83,283			(200,121		)
Changes in fair value of:
Foreign currency debt	10,097			(9,553		)
Derivative hedge instruments	(21,008		)	20,527
Total activity	72,372			(189,147		)
Ending balance	$	(71,358	)	$	(143,730	)

Cash Flow Hedging

Summary of Notional Amounts and Fair Value of the Company's Hedges

The following tables summarize the notional amounts and fair value of the Company's cash flow hedges and non-designated derivatives at December 31, 2012:



Foreign Exchange Forward Contracts	Notional Amounts Maturing in the Year						Fair Value Net Asset (Liability)
(in thousands)	2013			2014			December 31, 2012

Forward sale, 20.9 million Australian dollars	$	20,006		$	1,593		$	19
Forward purchase, 4.8 million British pounds	(7,846		)	—			(52		)
Forward sale, 47.2 million Canadian dollars	38,597			8,573			(385		)
Forward purchase, 17.7 million Danish kroner	(3,129		)	—			(24		)
Forward sale, 45.3 million euros	13,231			45,939			1,585
Forward purchase, 310.4 million Japanese yen	(391		)	(3,222		)	(374		)
Forward sale, 167.4 million Mexican pesos	13,018			—			49
Forward purchase, 2.3 million Norwegian kroner	(412		)	—			—
Forward sale, 17.2 million Polish zlotys	5,560			—			(77		)
Forward sale, 2.9 million Singapore dollars	2,413			—			33
Forward sale, 5.3 billion South Korean won	4,940			—			(30		)
Forward purchase, 1.5 billion Swedish kronor	(197,549		)	(27,544		)	4,296
Forward purchase, 61.1 million Swiss francs	(74,467		)	7,265			(411		)
Forward sale, 50.4 million Taiwanese dollars	1,734			—			1

Total foreign exchange forward contracts	$	(184,295	)	$	32,604		$	4,630



Interest Rate Swaps	Notional Amounts Maturing in the Year										Fair Value Net Asset (Liability)
(in thousands)	2013		2014		2015		2016		2017 and Beyond		December 31, 2012

Euro	$	1,246	$	953	$	953	$	953	$	1,191	$	(530	)
Japanese yen	—		144,681		—		—		—		133
Swiss francs	—		—		—		71,027		—		(1,392		)
Total interest rate swaps	$	1,246	$	145,634	$	953	$	71,980	$	1,191	$	(1,789	)



Commodity Swap Contracts	Notional Amounts Maturing in the Year		Fair Value Net Asset (Liability)
(in thousands)	2013		December 31, 2012

Silver swap - U.S. dollar	$	1,708	$	(68	)
Platinum swap - U.S. dollar	1,164		(27		)
Total commodity contracts	$	2,872	$	(95	)



							Fair Value Net
Cross Currency Basis Swaps	Notional Amounts Maturing in the Year						Asset (Liability)
(in thousands)	2013		2014		2015		December 31, 2012

449.8 million euro at $1.45 pay U.S. dollar three-month LIBOR receive three-month EURIBOR	$	—	$	593,555	$	—	$	(55,858	)
241.4 million Swiss franc at 1.08 pay Swiss franc three-month LIBOR receive U.S. dollar three-month LIBOR	307,474		—		—		(39,489		)
Total cross currency basis swaps	$	307,474	$	593,555	—		$	(95,347	)

Fair Value and Consolidated Balance Sheet Location of the Company's Derivatives

The following tables summarize the statements of operations impact of the Company’s cash flow hedges for the years ended December 31, 2012 and 2011:



December 31, 2012
Derivatives in Cash Flow Hedging	Gain (Loss) in AOCI			Classification of Gains (Losses)	Effective Portion Reclassified from AOCI into Income

(in thousands)
Interest rate swaps	$	(1,987	)	Interest expense	$	(3,611	)
Foreign exchange forward contracts	1,027			Cost of products sold	8,029
Foreign exchange forward contracts	80			SG&A expenses	779
Commodity contracts	472			Cost of products sold	136
Total	$	(408	)		$	5,333



Derivatives in Cash Flow Hedging	Classification of Gains (Losses)	Ineffective portion Recognized in Income

(in thousands)
Foreign exchange forward contracts	Other expense (income), net	915
Commodity contracts	Interest expense	(25		)
Total		$	890



December 31, 2011

Derivatives in Cash Flow Hedging	Gain (Loss) in AOCI			Classification of Gains (Losses)	Effective Portion Reclassified from AOCI into Income

(in thousands)
Interest rate swaps	$	(30,008	)	Interest expense	$	(4,903	)
Foreign exchange forward contracts	6,858			Cost of products sold	1,503
Foreign exchange forward contracts	377			SG&A expenses	39
Commodity contracts	(191		)	Cost of products sold	273
Total	$	(22,964	)		$	(3,088	)



Derivatives in Cash Flow Hedging	Classification of Gains (Losses)	Ineffective portion Recognized in Income

(in thousands)
Interest rate swaps	Other expense (income), net	$	(6,151	)
Foreign exchange forward contracts	Interest expense	(403		)
Foreign exchange forward contracts	Other expense (income), net	(1,307		)
Commodity contracts	Interest expense	2
Total		$	(7,859	)

Net Investment Hedging

Summary of Notional Amounts and Fair Value of the Company's Hedges



Cross Currency Basis Swaps	Notional Amounts Maturing in the Year						Fair Value Net Asset (Liability)
(in thousands)	2013		2014		2015		December 31, 2012

432.5 million Swiss franc at 1.06 pay Swiss franc three-month LIBOR receive U.S. dollar three-month LIBOR	$	322,898	$	87,854	$	61,848	$	(62,366	)
618.0 million euro at $1.27 pay three-month EURIBOR receive U.S. dollar three-month LIBOR	815,575		—		—		(28,312		)
Total cross currency basis swaps	$	1,138,473	$	87,854	$	61,848	$	(90,678	)

Gain (Loss) on Derivatives in the Consolidated Statement of Operatoins

The following tables summarize the statements of operations impact of the Company’s hedges of net investments for the years ended December 31, 2012 and 2011:



December 31, 2012

Derivatives in Net Investment Hedging	Gain (Loss) in AOCI			Classification of Gains (Losses)	Gain (Loss) Recognized in Income

(in thousands)
Cross currency basis swaps	$	(34,216	)	Interest income	$	4,264
				Interest expense	(1,885		)
Total	$	(34,216	)		$	2,379



December 31, 2011

Derivatives in Net Investment Hedging	Gain (Loss) in AOCI			Classification of Gains (Losses)	Gain (Loss) Recognized in Income

(in thousands)
Cross currency basis swaps	$	3,308		Interest income	$	1,085
				Interest expense	(108		)
Cross currency basis swaps	30,125			Interest expense	(5,675		)
Foreign exchange forward contracts	(2,462		)	Interest expense	—
Total	$	30,971			$	(4,698	)

Fair Value Hedging

Summary of Notional Amounts and Fair Value of the Company's Hedges

The following tables summarize the notional amounts and fair value of the Company's fair value hedges at December 31, 2012:



							Fair Value Net
Interest Rate Swaps	Notional Amounts Maturing in the Year						Asset (Liability)
(in thousands)	2014		2015		2016		December 31, 2012

U.S. dollar	$	45,000	$	60,000	$	45,000	$	4,513
Total interest rate contracts	$	45,000	$	60,000	$	45,000	$	4,513

Gain (Loss) on Derivatives in the Consolidated Statement of Operatoins

The following tables summarize the statements of operations impact of the Company’s hedges of fair value for the years ended December 31, 2012 and 2011:



Derivatives in Fair Value Hedging
	Classification of Gains (Losses)	December 31,
(in thousands)	Classification of Gains (Losses)	2012		2011
Interest rate swaps	Interest expense	$	2,284	$	6,328
Total		$	2,284	$	6,328

Not Designated as Hedging Instrument [Member]

Gain (Loss) on Derivatives in the Consolidated Statement of Operatoins

The following table summarizes the statements of operations impact of the Company’s hedges not designated as hedging for the years ended December 31, 2012 and 2011:



Derivatives Not Designated as Hedging
	Classification of Gains (Losses)	December 31,
(in thousands)	Classification of Gains (Losses)	2012			2011
Foreign exchange forward contracts (a)	Other expense (income), net	$	(1,224	)	$	(2,921	)
DIO equity option contracts	Other expense (income), net	272			383
Interest rate swaps	Interest expense	(155		)	(186		)
Cross currency basis swaps (a)	Other expense (income), net	12,323			(67,213		)
Total		$	11,216		$	(69,937	)

- Definition

Tabular disclosure of the location and amount of gains and losses reported in the statement of financial performance, or when applicable, the statement of financial position. For example, (a) gains and losses recognized in the income statement on derivative instruments designated and qualifying as hedging instruments in fair value hedges and related hedged items designated and qualifying in fair value hedges and (b) gains and losses initially recognized in other comprehensive income on derivative instruments designated and qualifying as cash flow hedges.

+ References + Details

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624163-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41641-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41638-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41678-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5580258-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5624171-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579245-113959

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7476318&loc=SL5579240-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n)(2))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7476318&loc=d3e41620-113959

+ Details

FAIR VALUE MEASUREMENT (Tables)

12 Months Ended

Dec. 31, 2012

Financial Assets and Liabilities that are Recorded at Fair Value and Classified Based on the Lowest Level of Input



	December 31, 2012
(in thousands)	Total		Level 1		Level 2		Level 3

Assets
Interest rate swaps	$	4,727	$	—	$	4,727	$	—
Cross currency basis swaps	8,728		—		8,728		—
Foreign exchange forward contracts	9,070		—		9,070		—
Corporate convertible bonds	75,143		—		—		75,143
Total assets	$	97,668	$	—	$	22,525	$	75,143

Liabilities
Interest rate swaps	$	2,003	$	—	$	2,003	$	—
Commodity forward purchase contracts	95		—		95		—
Cross currency basis swaps	194,753		—		194,753		—
Foreign exchange forward contracts	4,440		—		4,440		—
Long-term debt	154,560		—		154,560		—
DIO equity option contracts	153		—		—		153
Total liabilities	$	356,004	$	—	$	355,851	$	153



	December 31, 2011
(in thousands)	Total		Level 1		Level 2		Level 3

Assets
Money market funds	$	10,516	$	10,516	$	—	$	—
Interest rate swaps	5,699		—		5,699		—
Commodity forward purchase contracts	15		—		15		—
Cross currency basis swaps	19,838		—		19,838		—
Foreign exchange forward contracts	8,303		—		8,303		—
Corporate convertible bonds	47,850		—		—		47,850
Total assets	$	92,221	$	10,516	$	33,855	$	47,850

Liabilities
Interest rate swaps	$	1,631	$	—	$	1,631	$	—
Commodity forward purchase contracts	259		—		259		—
Cross currency basis swaps	199,454		—		199,454		—
Foreign exchange forward contracts	3,898		—		3,898		—
Long-term debt	154,512		—		154,512		—
Contingent considerations on acquisitions	2,917		—		—		2,917
DIO equity option contracts	$	419	$	—	$	—	$	419
Total liabilities	$	363,090	$	—	$	359,754	$	3,336

Reconciliation of the Company's Assets Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3):

The following table presents a reconciliation of the Company's Level 3 holdings measured at fair value on a recurring basis using unobservable inputs:



	Corporate		DIO Equity
(in thousands)	Convertible		Options			Contingent
	Bonds		Contracts			Considerations

Balance at December 31, 2011	$	47,850	$	(419	)	$	2,917
Payments, gross	—		—			(2,493		)
Adjustments:
Reported in selling, general and administrative expense	—		—			(412		)
Unrealized gain:
Reported in AOCI	25,775		—			—
Unrealized gain:
Reported in other expense (income), net	—		272			—
Effect of exchange rate changes	1,518		(6		)	(12		)
Balance at December 31, 2012	$	75,143	$	(153	)	$	—

- Definition

Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.

+ References + Details

COMMITMENTS AND CONTINGENCIES (Tables)

12 Months Ended

Dec. 31, 2012

Rental commitments

Rental commitments, principally for real estate (exclusive of taxes, insurance and maintenance), automobiles and office equipment are as follows:



(in thousands)

2013	$	37,778
2014	28,386
2015	23,424
2016	19,393
2017	17,160
2018 and thereafter	24,772
	$	150,913

Significant Accounting Policies - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2012 USD ($) Country	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)
Significant Accounting Policies [Line Items]
Deferred Tax Assets, Net, Current	$ 80,903	$ 67,159
Number of Countries in which Entity Operates \| Country	120
Cost of inventories determined by LIFO method	$ 6,300	7,100
Cost of inventories determined by LIFO method, amount of increase if FIFO method was used	5,900	5,600
Foreign currency translation adjustments, gains	177,700	94,400
Foreign currency translation adjustments, losses	123,400	133,500
Net exchange gains(losses)	2,700	1,700	$ 3,300
Precious metal content of sales	213,731	205,129	189,258
R&D costs included in selling, general and administrative expenses	85,400	66,700	49,400
Prepaid Expense, Current	54,881	32,899
Other Assets, Current	49,828	46,246
Prepaid expenses and other current assets	185,612	146,304
Accumulated Translation Adjustment
Significant Accounting Policies [Line Items]
Foreign currency translation adjustments recorded in AOCI net of tax effects	185,600	167,500	158,700
Foreign currency translation adjustments recorded in AOCI net of tax effects	(10,100)	(9,600)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges
Significant Accounting Policies [Line Items]
Foreign currency translation adjustments recorded in AOCI net of tax effects	83,300	(200,100)
Precious Metal Content
Significant Accounting Policies [Line Items]
Precious metal content of sales	$ 213,700	$ 205,100	$ 189,200
Dental Products
Significant Accounting Policies [Line Items]
Percentage of sales, professional dental products	89.00%	93.00%	97.00%
Building
Significant Accounting Policies [Line Items]
Estimated useful life (in years)	P40Y
Trade Accounts Receivable
Significant Accounting Policies [Line Items]
Allowance for doubtful accounts	$ 13,600	$ 14,900
Allowance for Doubtful Accounts Receivable, Charge-offs	3,800	1,400
Provision for doubtful accounts	2,400	500
Notes Receivable
Significant Accounting Policies [Line Items]
Write-off of Provision for doubtful accounts	200	900
Allowance for Notes, Loans and Financing Receivable, Current	900	900
Provision for doubtful accounts	$ 100	$ 1,000
Astra Tech [Member] \| Building
Significant Accounting Policies [Line Items]
Estimated useful life, minimum (in years)	40 years
Minimum [Member] \| Machinery and equipment
Significant Accounting Policies [Line Items]
Estimated useful life, minimum (in years)	4 years
Minimum [Member] \| Astra Tech [Member] \| Machinery and equipment
Significant Accounting Policies [Line Items]
Estimated useful life, minimum (in years)	5 years
Maximum [Member] \| Machinery and equipment
Significant Accounting Policies [Line Items]
Estimated useful life, minimum (in years)	15 years
Maximum [Member] \| Astra Tech [Member] \| Machinery and equipment
Significant Accounting Policies [Line Items]
Estimated useful life, minimum (in years)	15 years

Balances included in AOCI in the Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency translation adjustments	$ 54,302	$ (39,078)
Net loss on derivative financial instruments	(143,142)	(117,390)
Net unrealized holding (loss) gain on available for-sale securities	17,822	(516)
Pension liability adjustments	(73,182)	(33,986)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total	$ (144,200)	$ (190,970)

- Definition

Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.

+ References + Details

- Definition

The total of net gain (loss), prior service cost (credit), and transition assets (obligations), as well as minimum pension liability if still remaining, included in accumulated other comprehensive income associated with a defined benefit pension or other postretirement plan(s) because they have yet to be recognized as components of net periodic benefit cost.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (j-k)
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e681-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669686-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 158
-Paragraph 7
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph i
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e681-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669646-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669686-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32022-110900

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 52
-Paragraph 12, 13
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 45
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 52
-Paragraph 31
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 17, 18, 19, 22, 23, 24, 25, 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS115-1/124-1
-Paragraph 15D
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 14, 17, 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Computation of Basic and Diluted Earnings Per Common Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Net Income attributable to Dentsply International
Basic	$ 314,213	$ 244,520	$ 265,708
Diluted	$ 314,213	$ 244,520	$ 265,708
Shares
Basic	141,850	141,386	143,980
Incremental shares from assumed exercise of dilutive options	2,095	2,167	2,005
Diluted	143,945	143,553	145,985
Earnings per common share
Basic	$ 2.22	$ 1.73	$ 1.85
Diluted	$ 2.18	$ 1.70	$ 1.82

Earnings per Common Share - Additional Information (Detail) - shares shares in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common stock options not included in the computation of diluted earnings per common share	4.1	3.2	3.1

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Antidilution
-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Diluted Earnings Per Share
-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Contingent Stock Agreement
-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 40
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 13, 14
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 07-4
-Paragraph 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 171
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Business Acquisitions - Additional Information (Detail) $ in Thousands	1 Months Ended		4 Months Ended	12 Months Ended
	Aug. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2011 USD ($)	Dec. 31, 2012 USD ($)	Dec. 31, 2011 USD ($) Entity	Dec. 31, 2010 USD ($)	Dec. 09, 2010
Business Acquisition [Line Items]
Business Acquisitions and Contingent Consideration Payments				$ 7,400
Acquisition related activity, net of cash acquired				$ (4,861)	$ (1,787,516)	$ (35,556)
Cash acquired from acquisitions completed during 2011					$ 23,400
Number of acquisitions in period				1	6
Number of earn-out payments in period				1	2
Trade accounts receivable				$ 101,200
Accrued and other current liabilities				80,100
Trade accounts payable				27,100
Noncurrent deferred tax liabilities				260,300
Pension obligaitons				53,300
Goodwill acquired during period				867	$ 978,191
Net sales				2,928,429	2,537,718	2,221,014
Operating loss				381,939	300,728	380,273
Business acquisitions related costs					44,200
Purchase of convertible debt issued by affiliate		$ 49,700		0	0	49,654
Net unrealized holding gains on available-for-sale investments				(17,800)	11,545	(11,029)
Dental Consumable and Laboratory Businesses Segment [Member]
Business Acquisition [Line Items]
Net sales				958,266	946,464	890,499
Implants/Endodontics/Healthcare/Pacific Rim Segments
Business Acquisition [Line Items]
Goodwill, Purchase Accounting Adjustments				5,000
Goodwill acquired during period				952,100
Net sales				1,347,380	973,296	701,417
Goodwill increase					9,700
Select Distribution Businesses Segments
Business Acquisition [Line Items]
Net sales				294,643	300,544	$ 272,622
Astra Tech [Member]
Business Acquisition [Line Items]
Acquisition related activity, net of cash acquired				(4,300)
Percentage of interests acquired, common shares	100.00%
Inventory fair value adjustment	$ 32,800
Property, plant and equipment fair value adjustment				28,700
Business acquisitions related costs					31,900
Astra Tech [Member] \| Implants/Endodontics/Healthcare/Pacific Rim Segments
Business Acquisition [Line Items]
Net sales			$ 207,100
Operating loss			18,500
DIO Corporation
Business Acquisition [Line Items]
Initial ownership interest							17.00%
Noncurrent Assets
Business Acquisition [Line Items]
Available-for-sale securities, fair value of DIO bond			$ 47,800	$ 75,100	$ 47,800
Building \| Astra Tech [Member]
Business Acquisition [Line Items]
Estimated useful life, minimum (in years)				40 years
Depreciable lives range, minimum				40 years
Machinery and equipment \| Minimum [Member]
Business Acquisition [Line Items]
Estimated useful life, minimum (in years)				4 years
Depreciable lives range, minimum				4 years
Machinery and equipment \| Minimum [Member] \| Astra Tech [Member]
Business Acquisition [Line Items]
Estimated useful life, minimum (in years)				5 years
Depreciable lives range, minimum				5 years
Machinery and equipment \| Maximum [Member]
Business Acquisition [Line Items]
Estimated useful life, minimum (in years)				15 years
Depreciable lives range, minimum				15 years
Machinery and equipment \| Maximum [Member] \| Astra Tech [Member]
Business Acquisition [Line Items]
Estimated useful life, minimum (in years)				15 years
Depreciable lives range, minimum				15 years

Aggregate Purchase Price Allocation for Acquisitions Based on Final Estimates of Fair Value (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Aug. 31, 2011
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	$ 4,861	$ 1,787,516	$ 35,556
Inventory				$ 84,659
Other current assets				140,546
Property, plant and equipment				178,495
Identifiable intangible assets				844,100
Goodwill				952,108
Other long-term assets				15,969
Total assets				2,215,877
Current liabilities				107,243
Long-term liabilities				313,594
Total liabilities				420,837
Net assets				$ 1,795,040
Astra Tech [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	$ 4,300

Intangible Asset Acquired (Details) $ in Thousands	12 Months Ended
Intangible Asset Acquired (Details) $ in Thousands	Dec. 31, 2012 USD ($)
Acquired Finite and Infinite Lived Intangible Assets [Line Items]
Finite lived Intangible Asset Useful Life Minimum	15 years
Finite-Lived Intangible Asset, Useful Life	10 years
Acquired finite and infinite-lived intangible assets	$ 844,100
Finite lived Intangible Asset Useful Life Maximum	18 years
Tradenames and Trademarks [Member]
Acquired Finite and Infinite Lived Intangible Assets [Line Items]
Infinite-lived intangible asset acquired	$ 229,100
In-process research and development
Acquired Finite and Infinite Lived Intangible Assets [Line Items]
Infinite-lived intangible asset acquired	3,800
Customer Relationships
Acquired Finite and Infinite Lived Intangible Assets [Line Items]
Finite-lived intangible asset acquired	494,700
Patents and developed technology
Acquired Finite and Infinite Lived Intangible Assets [Line Items]
Finite-lived intangible asset acquired	$ 116,500

BUSINESS ACQUISITIONS AND INVESTMENTS IN AFFILIATES Unaudited Financial Information had the Astra Tech Acquisition Occurred (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Business Acquisition, Pro Forma Information [Line Items]
Net sales	$ 2,918,347	$ 2,755,300
Net income attributable to DENTSPLY	$ 250,363	$ 274,962
Diluted earnings per common share	$ 1.74	$ 1.88

Net Sales (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Net sales

$ 2,928,429

$ 2,537,718

$ 2,221,014

Dental Consumable and Laboratory Businesses Segment [Member]

Net sales

958,266

946,464

890,499

OrthodonticsCanadaMexicoJapan Segment [Member]

Net sales

331,811

322,444

359,780

Select Distribution Businesses Segments

Net sales

294,643

300,544

272,622

Implants/Endodontics/Healthcare/Pacific Rim Segments

Net sales

1,347,380

973,296

701,417

All Other

Net sales

^[1]

$ (3,671)

$ (5,030)

$ (3,304)

[1]	Includes amounts recorded at Corporate headquarters.

Net Sales, Excluding Precious Metal Content (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Statement [Line Items]

Net Sales, excluding precious metal content

$ 2,714,698

$ 2,332,589

$ 2,031,756

Precious metal content of sales

213,731

205,129

189,258

Net Sales, including precious metal content

2,928,429

2,537,718

2,221,014

Dental Consumable and Laboratory Businesses Segment [Member]

Statement [Line Items]

Net Sales, excluding precious metal content

792,035

794,736

750,924

Net Sales, including precious metal content

958,266

946,464

890,499

OrthodonticsCanadaMexicoJapan Segment [Member]

Statement [Line Items]

Net Sales, excluding precious metal content

297,877

289,529

331,971

Net Sales, including precious metal content

331,811

322,444

359,780

Select Distribution Businesses Segments

Statement [Line Items]

Net Sales, excluding precious metal content

288,348

292,087

264,743

Net Sales, including precious metal content

294,643

300,544

272,622

Implants/Endodontics/Healthcare/Pacific Rim Segments

Statement [Line Items]

Net Sales, excluding precious metal content

1,340,109

961,267

687,422

Net Sales, including precious metal content

1,347,380

973,296

701,417

All Other

Statement [Line Items]

Net Sales, excluding precious metal content

^[1]

(3,671)

(5,030)

(3,304)

Net Sales, including precious metal content

^[2]

$ (3,671)

$ (5,030)

$ (3,304)

[1]	Includes amounts recorded at Corporate headquarters
[2]	Includes amounts recorded at Corporate headquarters.

Intersegment Net Sales (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Segment Reporting, Revenue Reconciling Item [Line Items]

Eliminations

$ (612,454)

$ (600,671)

$ (547,501)

Total

Dental Consumable and Laboratory Businesses Segment [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

Intersegment net sales

220,229

220,671

223,504

OrthodonticsCanadaMexicoJapan Segment [Member]

Segment Reporting, Revenue Reconciling Item [Line Items]

Intersegment net sales

4,000

4,065

4,105

Select Distribution Businesses Segments

Segment Reporting, Revenue Reconciling Item [Line Items]

Intersegment net sales

12,231

16,036

13,515

Implants/Endodontics/Healthcare/Pacific Rim Segments

Segment Reporting, Revenue Reconciling Item [Line Items]

Intersegment net sales

154,127

148,241

126,597

All Other

Segment Reporting, Revenue Reconciling Item [Line Items]

Intersegment net sales

^[1]

$ 221,867

$ 211,658

$ 179,780

[1]	Includes amounts recorded at Corporate headquarters and one distribution warehouse not managed by named segments.

Depreciation and Amortization (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Reconciliation of Depreciation by Segment [Line Items]

Depreciation and amortization

$ 129,199

$ 85,035

$ 65,912

Dental Consumable and Laboratory Businesses Segment [Member]

Reconciliation of Depreciation by Segment [Line Items]

Depreciation and amortization

33,022

34,874

30,960

OrthodonticsCanadaMexicoJapan Segment [Member]

Reconciliation of Depreciation by Segment [Line Items]

Depreciation and amortization

5,076

4,473

4,447

Select Distribution Businesses Segments

Reconciliation of Depreciation by Segment [Line Items]

Depreciation and amortization

1,311

1,203

1,476

Implants/Endodontics/Healthcare/Pacific Rim Segments

Reconciliation of Depreciation by Segment [Line Items]

Depreciation and amortization

87,324

41,886

22,297

All Other

Reconciliation of Depreciation by Segment [Line Items]

Depreciation and amortization

^[1]

$ 2,466

$ 2,599

$ 6,732

[1]	Includes amounts recorded at Corporate headquarters.

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References + Details

Segment Operating Income (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Segment operating income

$ 381,939

$ 300,728

$ 380,273

Restructuring and other costs

25,717

35,865

10,984

Interest expense

56,851

43,814

25,089

Interest income

(8,760)

(8,237)

(4,254)

Other expense (income), net

3,169

9,040

1,782

Income before income taxes

330,679

256,111

357,656

Business acquisitions related costs

44,200

Operating Segments [Member] | Dental Consumable and Laboratory Businesses Segment [Member]

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Segment operating income

227,912

210,239

208,873

Operating Segments [Member] | OrthodonticsCanadaMexicoJapan Segment [Member]

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Segment operating income

16,596

15,753

42,106

Operating Segments [Member] | Select Distribution Businesses Segments

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Segment operating income

(339)

2,496

12,197

Operating Segments [Member] | Implants/Endodontics/Healthcare/Pacific Rim Segments

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Segment operating income

282,436

210,900

209,384

Operating Segments [Member] | All Other

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Segment operating income

^[1]

(118,949)

(102,795)

(81,303)

Operating Segments, Corporate and Eliminations [Member]

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Segment operating income

$ 407,656

336,593

$ 391,257

Astra Tech [Member]

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Business acquisitions related costs

$ 31,900

[1]	Includes results of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments. Amount recorded in 2011 includes $31.9 million of Astra Tech acquisition cost

Capital Expenditures (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Capital expenditures

$ 92,072

$ 71,186

$ 44,236

Dental Consumable and Laboratory Businesses Segment [Member]

Capital expenditures

18,912

20,391

15,639

OrthodonticsCanadaMexicoJapan Segment [Member]

Capital expenditures

9,071

7,494

2,432

Select Distribution Businesses Segments

Capital expenditures

724

1,439

1,352

Implants/Endodontics/Healthcare/Pacific Rim Segments

Capital expenditures

58,367

32,949

21,297

All Other

Capital expenditures

^[1]

$ 4,998

$ 8,913

$ 3,516

[1]	(f)Includes capital expenditures of Corporate headquarters.

Assets (Details) - USD ($)
$ in Thousands

Dec. 31, 2012

Dec. 31, 2011

Segment Reporting, Asset Reconciling Item [Line Items]

Assets

$ 4,972,297

$ 4,755,398

Dental Consumable and Laboratory Businesses Segment [Member]

Segment Reporting, Asset Reconciling Item [Line Items]

Assets

1,007,307

1,180,001

OrthodonticsCanadaMexicoJapan Segment [Member]

Segment Reporting, Asset Reconciling Item [Line Items]

Assets

294,348

328,376

Select Distribution Businesses Segments

Segment Reporting, Asset Reconciling Item [Line Items]

Assets

192,684

168,500

Implants/Endodontics/Healthcare/Pacific Rim Segments

Segment Reporting, Asset Reconciling Item [Line Items]

Assets

3,195,382

2,881,591

All Other

Segment Reporting, Asset Reconciling Item [Line Items]

Assets

^[1]

$ 282,576

$ 196,930

[1]	(g)Includes assets of Corporate headquarters, inter-segment eliminations and one distribution warehouse not managed by named segments.

Information about the Company's Operations in different Geographic Areas (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Net sales	$ 2,928,429	$ 2,537,718	$ 2,221,014
Long-lived assets	614,705	591,445	423,105
United States [Member]
Net sales	993,980	875,471	846,834
Long-lived assets	148,950	137,871	119,599
Germany [Member]
Net sales	546,092	515,819	470,953
Long-lived assets	122,310	118,229	116,951
Sweden [Member]
Net sales	54,507	20,383	0
Long-lived assets	133,502	150,167	0
Other Foreign [Member]
Net sales	1,333,850	1,126,045	903,227
Long-lived assets	$ 209,943	$ 185,178	$ 186,555

Schedule of Sales by Product Category (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Segment Reporting Information [Line Items]
Net sales	$ 2,928,429	$ 2,537,718	$ 2,221,014
Dental consumables products [Member]
Segment Reporting Information [Line Items]
Net sales	768,098	766,385	717,718
Dental laboratory products [Member]
Segment Reporting Information [Line Items]
Net sales	518,668	525,008	511,061
Dental speciality products [Member]
Segment Reporting Information [Line Items]
Net sales	1,306,217	1,078,034	925,317
Consumable medical device products [Member]
Segment Reporting Information [Line Items]
Net sales	$ 335,446	$ 168,291	$ 66,918

Segment and Geographic Information - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Segment Reporting Information [Line Items]
Percentage of sales accounting for more than ten percent of consolidated net sales	11.00%	11.00%

Other Expense (Income), Net (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Component of Operating Other Cost and Expense [Line Items]
Foreign exchange transaction losses	$ 2,679	$ 1,713	$ 3,331
Other (income) expense, net	490	7,327	(1,549)
Total other expense (income), net	$ 3,169	9,040	$ 1,782
Nonoperating Income (Expense)		600
Interest Rate Swap [Member]
Component of Operating Other Cost and Expense [Line Items]
Derivative, notional amount		2,900
Treasury Rate Lock
Component of Operating Other Cost and Expense [Line Items]
Derivative, notional amount		$ 3,800

- Definition

The aggregate foreign currency transaction gain (loss) (both realized and unrealized) included in determining net income for the reporting period. Excludes foreign currency transactions designated as hedges of net investment in a foreign entity and intercompany foreign currency transactions that are of a long-term nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements. For certain enterprises, primarily banks, that are dealers in foreign exchange, foreign currency transaction gains (losses) may be disclosed as dealer gains (losses).

+ References + Details

Inventories, Net (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Schedule of Inventory [Line Items]
Inventory, Finished Goods, Net of Reserves	$ 248,870	$ 218,814
Inventory, Work in Process, Net of Reserves	72,533	66,952
Inventory, Raw Materials and Supplies, Net of Reserves	81,537	75,996
Inventory, Net	$ 402,940	$ 361,762

Inventories, Net - Additional Information (Detail) - USD ($) $ in Millions	Dec. 31, 2012	Dec. 31, 2011
Disclosure - Inventories, Net - Additional Information [Abstract]
Inventory valuation reserve	$ 32.6	$ 35.1

- Definition

The amount of the valuation account as of the balance sheet date which reduces the carrying amount of inventory to net realizable value; takes into consideration such factors as market value, excessive quantities based on expected sales, technological obsolescence, and shrinkage. May also provide for estimated product returns or price concessions pertaining to product cost.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.BB)
-URI http://asc.fasb.org/extlink&oid=6386940&loc=d3e100047-122729

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09)
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e24092-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Paragraph 14
-Chapter 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Paragraph 8, 9, 14
-Chapter 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Section A
-Paragraph 9
-Chapter 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 09
-Article 12

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 6
-Subparagraph a
-Article 5

+ Details

Property, Plant and Equipment, Net (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	$ 1,353,990	$ 1,140,884
Less: Accumulated depreciation	739,285	549,439
Property, plant and equipment, net	614,705	591,445	$ 423,105
Land
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	45,561	45,840
Building and building improvements
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	409,451	372,156
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	848,331	680,240
Construction in progress
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross, Total	$ 50,647	$ 42,648

- Definition

The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.

+ References + Details

Goodwill and Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Goodwill and Intangible Assets Disclosure [Line Items]
Number of reporting units	13
Cash flows discounted range lower limit	8.50%
Cash flows discounted range upper limit	10.50%
Impairments of finite-lived identifiable intangible assets	$ 5.2	$ 1.5	$ 0.4
Amortization of intangible assets	49.7	$ 21.0	$ 9.0
Estimated future amortizatiof expense of intangible assets for 2012	46.4
Estimated future amortizatiof expense of intangible assets for 2013	45.6
Estimated future amortizatiof expense of intangible assets for 2014	45.5
Estimated future amortizatiof expense of intangible assets for 2015	45.1
Estimated future amortizatiof expense of intangible assets for 2016	$ 44.4

Reconciliation of Changes in Goodwill (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Goodwill [Roll Forward]
Balance, beginning of the year	$ 2,190,063	$ 1,303,055
Acquisition activity	867	978,191
Changes to purchase price allocations	6,574	2,833
Goodwill, Translation and Purchase Accounting Adjustments	(22,516)	0
Effects of exchange rate changes	35,965	(94,016)
Balance, end of the year	$ 2,210,953	$ 2,190,063

- Definition

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 72
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-Subparagraph l
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The increase (decrease) in the recorded value of goodwill for foreign currency translation adjustments and purchase accounting adjustments needed to revise the carrying amount of goodwill to fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 72
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e
-Clause 7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Goodwill by Reportable Segment (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Goodwill and Intangible Assets Disclosure [Line Items]
Goodwill, Other Changes	$ 13,200
Goodwill	2,210,953	$ 2,190,063	$ 1,303,055
Dental Consumable and Laboratory Businesses Segment [Member]
Goodwill and Intangible Assets Disclosure [Line Items]
Goodwill	488,206	484,779
OrthodonticsCanadaMexicoJapan Segment [Member]
Goodwill and Intangible Assets Disclosure [Line Items]
Goodwill	102,065	102,950
Dental Laboratory Business/ Implants/ Non Dental
Goodwill and Intangible Assets Disclosure [Line Items]
Goodwill	92,473	108,566
Implants/Endodontics/Healthcare/Pacific Rim Segments
Goodwill and Intangible Assets Disclosure [Line Items]
Goodwill	$ 1,528,209	$ 1,493,768

- Definition

+ References

+ Details

Identifiable Definite-Lived Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 785,139	$ 646,735
Accumulated Amortization	(184,117)	(77,621)
Net Carrying Amount	601,022	569,114
Indefinite-Lived Intangible Assets (Excluding Goodwill)	229,620	221,986
Identifiable Intangible Assets Gross	1,014,759	868,721
Identifiable Intangible Assets Accumulated Amortization Total	(184,117)	(77,621)
Intangible Assets, Net (Excluding Goodwill)	830,642	791,100
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	179,512	131,252
Accumulated Amortization	(81,390)	(17,393)
Net Carrying Amount	98,122	113,859
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	491,859	411,626
Accumulated Amortization	(50,632)	(19,066)
Net Carrying Amount	441,227	392,560
Licensing Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	30,695	30,444
Accumulated Amortization	(18,966)	(17,277)
Net Carrying Amount	11,729	13,167
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	83,073	73,413
Accumulated Amortization	(33,129)	(23,885)
Net Carrying Amount	$ 49,944	$ 49,528

Accrued Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Other Liabilities [Line Items]
Payroll, commissions, bonuses, other cash compensation and employee benefits	$ 96,206	$ 85,855
General insurance	12,204	12,164
Sales and marketing programs	32,742	34,528
Professional and legal costs	12,202	10,269
Restructuring costs	14,452	4,787
Warranty liabilities	3,693	3,765
Deferred income	5,514	6,304
Accrued vacation and holidays	29,804	28,169
Third party royalties	11,288	10,174
Current portion of derivatives	144,195	18,143
Other	62,036	75,043
Accrued Liabilities, Current, Total	$ 424,336	$ 289,201

Reconciliation of Changes in Warranty Liability (Detail) $ in Thousands	Dec. 31, 2012 USD ($)
Product Warranty [Roll Forward]
Balance, beginning of the year	$ 3,765
Balance, end of the year	$ 3,693

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References + Details

Financing Arrangements- Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Feb. 28, 2010
Debt Instrument [Line Items]
Short-term debt, average outstanding amount	$ 248,318	$ 225,498
Short term debt, weighted average interest rates	0.60%	0.80%
Total unused lines of credit	$ 527,400
Floating rate senior term loan	1,472,913	$ 1,491,419
Private Placement Notes
Debt Instrument [Line Items]
Debt instrument issued			$ 250,000
Tranche A \| Unsecured Senior Notes
Debt Instrument [Line Items]
Debt instrument issued	250,000
Tranche B \| Unsecured Senior Notes
Debt Instrument [Line Items]
Debt instrument issued	300,000
Tranche C \| Unsecured Senior Notes
Debt Instrument [Line Items]
Debt instrument issued	450,000
Commercial Paper [Member]
Debt Instrument [Line Items]
Credit facilities, maximum borrowing capacity	500,000
Short-term debt	45,000	$ 266,800
Short-term debt, average outstanding amount	$ 267,100

Long-Term Borrowings (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Debt Instrument [Line Items]
Long-term debt	$ 1,472,913	$ 1,491,419
Less: Current portion (included in notes payable and current portion of long-term debt)	250,878	1,409
Long-term portion	1,222,035	1,490,010
Fixed rate senior notes $450 million due August 2021
Debt Instrument [Line Items]
Long-term debt	$ 448,653	$ 448,497
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	4.10%	4.10%
Floating Rate Senior Notes \| U.S. Dollar Denominated Due August 2013
Debt Instrument [Line Items]
Long-term debt	$ 250,000	$ 250,000
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	1.80%	2.00%
Term Loan Agreement \| Japanese Yen Denominated Expiring September 2014
Debt Instrument [Line Items]
Long-term debt	$ 144,681	$ 162,956
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	1.10%	1.10%
Term Loan Agreement \| Swiss francs denominated expiring September 2016
Debt Instrument [Line Items]
Long-term debt	$ 71,027	$ 69,197
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	1.20%	1.20%
Private Placement Notes \| U.S. Dollar Denominated Expiring March 2016
Debt Instrument [Line Items]
Long-term debt	$ 254,560	$ 254,512
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	4.10%	4.10%
Fixed Rate Senior Notes \| U.S. Dollar Denominated Due August 2016
Debt Instrument [Line Items]
Long-term debt	$ 299,689	$ 299,603
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	2.80%	2.80%
Other Borrowings Various Currencies And Rates
Debt Instrument [Line Items]
Long-term debt	$ 4,303	$ 6,654

Contractual Maturity Dates of the Various Borrowings (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Debt Instrument [Line Items]
2012	$ 250,878
2013	221,865
2014	102,230
2015	448,440
2016	442
2016 and beyond	449,058
Floating rate senior term loan	1,472,913	$ 1,491,419
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 500,000

FINANCING ARRANGEMENTS Short-Term Borrowings (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Short-term Debt [Line Items]
Debt, Current	$ 298,963	$ 276,701
Long-term Debt, Current Maturities	250,878	1,409
Short-term Debt, Maximum Month-end Outstanding Amount	399,931	355,304
Short-term debt, average outstanding amount	$ 248,318	$ 225,498
Short term debt, weighted average interest rates	0.60%	0.80%
Line Of Credit Facility Borrowing Capacity Terminated	$ 250,000
Bank Overdrafts [Member]
Short-term Debt [Line Items]
Debt, Current	123	$ 192
Commercial Paper [Member]
Short-term Debt [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	500,000
Short-term debt	45,000	266,800
Debt, Current	$ 45,000	$ 266,828
Short-term Debt, Percentage Bearing Fixed Interest Rate	0.50%	0.50%
Short-term debt, average outstanding amount	$ 267,100
Revolving Credit Facility [Member]
Short-term Debt [Line Items]
Short-term debt	500,000
European Short Term Loan [Member]
Short-term Debt [Line Items]
Debt, Current	$ 1,962	$ 2,438
Short-term Debt, Percentage Bearing Fixed Interest Rate	3.90%	3.40%
Brazil Short Term Loan [Member]
Short-term Debt [Line Items]
Debt, Current	$ 1,000	$ 5,834
Short-term Debt, Percentage Bearing Fixed Interest Rate	2.00%	12.90%

Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Authorized For Repurchase	34,000,000
Stock repurchased under the repurchase program	998,356	2,187,382	6,715,000
Stock repurchased under the repurchase program, average price	$ 38.90	$ 36.34
Treasury stock, shares held	20,500,000	21,100,000
Treasury stock repurchased	$ 38,837	$ 79,500	$ 223,993
Proceeds from exercise of stock option	$ 34,183	$ 42,275	30,189
Number of stock option exercised	1,800,000	2,100,000
Tax benefit realized for the options exercised	$ 6,800	$ 9,200
Intrinsic value of options exercised	$ 21,100	$ 27,000	$ 16,500
Weighted average remaining contractual term of all outstanding options (in years)	5 years 8 months
Weighted average remaining contractual term of exercisable options (in years)	4 years 9 months
Equity Incentive Plan 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized grants under the plan	13,000,000
Percentage threshold of outstanding stock for determining availability of grants under Company Plan	7.00%
Number of shares available for grant	10,500,000
Equity Incentive Plan 2010 \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cap on restricted stock or RSU	2,500,000
Equity Incentive Plan 2010 \| Key Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cap on restricted stock or RSU	200,000
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	100.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Restricted Stock Units Member
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unamortized compensation costs	$ 15,000
Weighted average remaining contractual term of all outstanding options (in years)	1 year 3 months
Nonqualified Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock option exercised	1,409,000
Number of unvested stock options	2,300,000
Unamortized compensation costs	$ 13,500
Weighted average remaining contractual term of all outstanding options (in years)	1 year 7 months
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration term (in years)	10 years

Total Outstanding Shares (Detail) - shares	12 Months Ended
Total Outstanding Shares (Detail) - shares	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Class of Stock [Line Items]
Beginning Balance	141,632,000	141,735,000	146,961,000
Shares Issued	1,688,000	2,084,000	1,489,000
Repurchase of common stock at cost	(998,356)	(2,187,382)	(6,715,000)
Ending Balance	142,322,000	141,632,000	141,735,000
Common Stock
Class of Stock [Line Items]
Beginning Balance	162,776,000	162,776,000	162,776,000
Shares Issued	0	0	0
Repurchase of common stock at cost	0	0	0
Ending Balance	162,776,000	162,776,000	162,776,000
Treasury Stock
Class of Stock [Line Items]
Beginning Balance	(21,144,000)	(21,041,000)	(15,815,000)
Shares Issued	1,688,000	2,084,000	1,489,000
Repurchase of common stock at cost	(998,000)	(2,187,000)	(6,715,000)
Ending Balance	(20,454,000)	(21,144,000)	(21,041,000)

Total Stock Based Compensation Expense and the Tax Related Benefit (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option expense	$ 11,126	$ 10,369	$ 10,420
RSU expense	9,644	9,243	7,227
Total stock based compensation expense	20,770	19,612	17,647
Related deferred income tax benefit	$ 5,775	$ 5,021	$ 4,886

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References + Details

Assumptions Used to Determine Compensation Cost for the Company's Non-Qualified Stock Options Issued (Detail) - Nonqualified Stock Options - $ / shares

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

^[1]

Dec. 31, 2010

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Weighted average fair value per share

$ 8.91

$ 8.86

$ 9.06

Expected dividend yield

0.57%

0.55%

0.58%

Risk-free interest rate

0.93%

2.35%

2.55%

Expected volatility

26.00%

24.00%

22.00%

Expected life (years)

5 years 1 month 6 days

5 years 26 days

6 years 5 months 1 day

[1]

Non-Qualified Stock Option Transactions (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Shares, Exercised	(1,800)	(2,100)
Exercisable Shares at Year End	7,599	8,049
Exercisable Weighted Average Exercise Price at Year-End	$ 31.79	$ 30.06
Exercisable Aggregate Intrinsic Value at Year End	$ 64,819	$ 50,365
Nonqualified Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding Shares, Beginning Balance	10,148
Outstanding Shares, Granted	1,346
Outstanding Shares, Exercised	(1,409)
Outstanding Shares, Cancelled	(85)
Outstanding Shares, Forfeited	(94)
Outstanding Shares, Ending Balance	9,906	10,148
Outstanding Weighted Average Exercise Price, Beginning Balance	$ 31.23
Outstanding Weighted Average Exercise Price, Granted	38.62
Outstanding Weighted Average Exercise Price, Exercised	24.26
Outstanding Weighted Average Exercise Price, Cancelled	33.26
Outstanding Weighted Average Exercise Price, Forfeited	33.97
Outstanding Weighted Average Exercise Price, Ending Balance	$ 33.18	$ 31.23
Outstanding Aggregate Intrinsic Value, Balance at Year End	$ 69,079	$ 51,402
Exercisable Shares at Year End	7,599
Exercisable Weighted Average Exercise Price at Year-End	$ 31.79

Information About Non-Qualified Stock Options Outstanding (Detail) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Exercisable at Year-End	7,599	8,049
Exercisable Weighted Average Exercise Price at Year-End	$ 31.79	$ 30.06
Nonqualified Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Outstanding at Year-End	9,906	10,148
Outstanding Weighted Average Remaining Contractual Life (in years)	5 years 8 months 12 days
Outstanding Weighted Price Average Exercise at Year-End	$ 33.18	$ 31.23
Number Exercisable at Year-End	7,599
Exercisable Weighted Average Exercise Price at Year-End	$ 31.79
Nonqualified Stock Options \| Range 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incremental Changes in Stock Price Lower Range Limit	10.01
Incremental Changes in Stock Price Upper Range Limit	$ 20.00
Number Outstanding at Year-End	6
Outstanding Weighted Average Remaining Contractual Life (in years)	4 months 24 days
Outstanding Weighted Price Average Exercise at Year-End	$ 18.02
Number Exercisable at Year-End	6
Exercisable Weighted Average Exercise Price at Year-End	$ 18.02
Nonqualified Stock Options \| Range 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incremental Changes in Stock Price Lower Range Limit	20.01
Incremental Changes in Stock Price Upper Range Limit	$ 30.00
Number Outstanding at Year-End	3,525
Outstanding Weighted Average Remaining Contractual Life (in years)	3 years 8 months 12 days
Outstanding Weighted Price Average Exercise at Year-End	$ 26.45
Number Exercisable at Year-End	3,522
Exercisable Weighted Average Exercise Price at Year-End	$ 26.45
Nonqualified Stock Options \| Range 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incremental Changes in Stock Price Lower Range Limit	30.01
Incremental Changes in Stock Price Upper Range Limit	$ 40.00
Number Outstanding at Year-End	5,366
Outstanding Weighted Average Remaining Contractual Life (in years)	7 years 2 months 12 days
Outstanding Weighted Price Average Exercise at Year-End	$ 35.40
Number Exercisable at Year-End	3,065
Exercisable Weighted Average Exercise Price at Year-End	$ 35.40
Nonqualified Stock Options \| Range 4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incremental Changes in Stock Price Lower Range Limit	40.01
Incremental Changes in Stock Price Upper Range Limit	$ 50.00
Number Outstanding at Year-End	1,009
Outstanding Weighted Average Remaining Contractual Life (in years)	4 years 10 months 24 days
Outstanding Weighted Price Average Exercise at Year-End	$ 44.99
Number Exercisable at Year-End	1,006
Exercisable Weighted Average Exercise Price at Year-End	$ 44.90

Unvested RSU Transactions (Detail) shares in Thousands	12 Months Ended
Unvested RSU Transactions (Detail) shares in Thousands	Dec. 31, 2012 $ / shares shares
Weighted Average Grant Date Fair Value
Unvested Beginning Balance \| $ / shares	$ 32.50
Granted \| $ / shares	38.65
Vested \| $ / shares	26.38
Forfeited \| $ / shares	35.97
Unvested Ending Balance \| $ / shares	$ 36.34
Number of Shares
Unvested at December 31, 2010 \| shares	897
Granted \| shares	422
Vested \| shares	(247)
Forfeited \| shares	(38)
Unvested at December 31, 2011 \| shares	1,034

Components of Income Before Income Taxes From Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Income Taxes [Line Items]
United States	$ 67,668	$ 7,041	$ 104,424
Foreign	263,011	249,070	253,232
Income before income taxes	$ 330,679	$ 256,111	$ 357,656

Components of the Provision for Income Taxes from Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Current:
U.S. federal	$ 23,412	$ 34,870	$ 21,848
U.S. state	2,788	5,151	3,795
Foreign	69,954	59,397	62,196
Total	96,154	99,418	87,839
Deferred:
U.S. federal	(128,832)	(29,664)	3,067
U.S. state	11,730	(4,089)	1,062
Foreign	29,868	(54,649)	(2,743)
Total	(87,234)	(88,402)	1,386
Provision for income taxes	$ 8,920	$ 11,016	$ 89,225

The Reconciliation of the U.S. Federal Statutory Tax Rate to the Effective Rate (Detail)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Reconciliation of Statutory Federal Tax Rate [Line Items]
Statutory U.S. federal income tax rate	35.00%	35.00%	35.00%
State income taxes, net of federal benefit	0.70%	0.30%	0.90%
Federal benefit of R&D and foreign tax credits	(7.20%)	(8.60%)	(6.90%)
Tax effect of international operations	(7.40%)	(7.90%)	(3.70%)
Net effect of tax audit activity	(0.60%)	2.10%	1.00%
Tax effect of enacted statutory rate changes	(3.70%)	0.20%	0.00%
Federal tax on unremitted earnings of certain foreign subsidiaries	0.10%	0.10%	0.20%
Valuation allowance adjustments	12.00%	(18.10%)	(1.00%)
Foreign outside basis difference	(26.50%)
Other	0.30%	1.20%	(0.50%)
Effective income tax rate on operations	2.70%	4.30%	25.00%

The Tax Effect of Significant Temporary Differences Giving Rise to Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Deferred Tax Liability Not Recognized [Line Items]
Commission and bonus accrual	$ 0	$ 0
Deferred Tax Asset, Foreign outside tax basis	189,125
Employee benefit accruals	0	0
Inventory	0	0
Identifiable intangible assets	359,303	336,822
Insurance premium accruals	0	0
Miscellaneous accruals	0	0
Other	0	0
Unrealized losses included in other comprehensive income	0	0
Property, plant and equipment	51,020	52,251
Product warranty accruals	0	0
R&D and foreign tax credit carryforward	0	0
Restructuring and other cost accruals	0	0
Sales and marketing accrual	0	0
Taxes on unremitted earnings of foreign subsidiaries	2,556	2,273
Tax loss carryforwards and other tax attributes	0	0
Valuation allowance	0	0
Deferred Tax Liabilities, Total	412,879	391,346
Commission and bonus accrual	2,529	2,812
Employee benefit accruals	44,266	38,061
Inventory	21,173	19,972
Identifiable intangible assets	0	0
Insurance premium accruals	4,381	4,533
Miscellaneous accruals	12,685	12,273
Other	15,844	13,166
Unrealized losses included in other comprehensive income	39,879	28,424
Property, plant and equipment	0	0
Product warranty accruals	1,154	907
R&D and foreign tax credit carryforward	0	49,552
Restructuring and other cost accruals	1,048	1,439
Sales and marketing accrual	4,480	4,874
Taxes on unremitted earnings of foreign subsidiaries	0	0
Tax loss carryforwards and other tax attributes	187,449	152,999
Valuation allowance	(179,699)	(71,758)
Deferred Tax Assets, Net, Total	$ 344,314	$ 257,254

The Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Schedule of Deferred Income Tax Assets and Liabilities [Line Items]
Prepaid expenses and other current assets	$ 80,903	$ 67,159
Income taxes payable	2,856	2,678
Other noncurrent assets	86,029	51,250
Deferred income taxes	$ 232,641	$ 249,822

- Definition

Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.

+ References + Details

- Definition

Amount after allocation of valuation allowances of noncurrent deferred tax asset attributable to deductible temporary differences and carryforwards. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References + Details

- Definition

Amount of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards net of valuation allowances expected to be realized or consumed within one year or operating cycle, if longer.

+ References + Details

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Income Taxes [Line Items]
Deferred Tax Assets, Operating Loss Carryforwards	$ 136.5
Valuation Allowance, Amount	118.0
Valuation allowance other deferred tax assets	61.7
Tax loss carryforward	853.3
Operating Loss Carryforwards, Valuation Allowance	179.7
Cumulative earnings of foreign subsidiaries	1,065.8
The total gross unrecognized tax benefits	18.4
Unrecognized tax benefits, if recognized, would affect the effective income tax rate	16.9
Unrecognized tax benefits, final settlement and resolution of outstanding tax	1.4
The total amount of accrued interest and penalties	6.1	$ 6.9
Recognized income tax expense (benefits), interest and penalties	0.9	$ 0.9	$ 0.6
Expire Through 2031
Income Taxes [Line Items]
Tax credit carryforwards	497.1
Without Expiry Date
Income Taxes [Line Items]
Tax credit carryforwards	$ 356.2

Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Income Tax Contingency [Line Items]
Unrecognized tax benefits at beginning of period	$ 14,956	$ 13,143	$ 12,864
Gross change for prior period positions	(3,029)	1,425	47
Gross change for current year positions	268	640	1,036
Decrease due to settlements and payments	0	0	0
Decrease due to statute expirations	0	(123)	(424)
Increase due to effect of foreign currency translation	0	0	0
Decrease due to effect from foreign currency translation	69	(129)	(380)
Unrecognized tax benefits at end of period	$ 12,264	$ 14,956	$ 13,143

Benefits Plan - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Defined Benefit Plan Disclosure [Line Items]
Total defined benefit, defined contribution and employee stock ownership costs			$ 45,700	$ 34,600	$ 27,400
Targeted future ESOP allocations for Covered Compensation			3.00%
Employee Stock Ownership Plan (ESOP), Plan
Defined Benefit Plan Disclosure [Line Items]
Amendment to the DENTSPLY to redesign future distribution of allocations of Covered Compensation			3.00%
Contributions to defined contribution benefit plans			$ 4,600	3,600	3,000
Defined Contribution Pension Plan 401k
Defined Benefit Plan Disclosure [Line Items]
Amendment to the DENTSPLY to redesign future distribution of allocations of Covered Compensation			3.00%
Contributions to defined contribution benefit plans	$ 5,300	$ 4,900	$ 7,600	5,800	4,600
Other Defined Contribution Plans			13,900	8,100	$ 6,700
Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Contributions to defined contribution benefit plans			$ 12,144	9,647
Minimum target allocation for plan asset of Fixed Income Securities			30.00%
Defined Benefit Plan Target Allocation Percentage Of Assets Fixed Income Securities Range Maximum			65.00%
Defined Benefit Plan Target Allocation Percentage Of Assets Real Estate Funds Range Minimum			0.00%
Defined Benefit Plan Target Allocation Percentage Of Assets Real Estate Funds Range Maximum			15.00%
Defined Benefit Plan Target Allocation Percentage Of Assets all other investment types Range Minimum			0.00%
Defined Benefit Plan Target Allocation Percentage Of Assets all other investment types Range Maximum			25.00%
Maximum target allocation for plan asset of Fixed Income Securities			30.00%
Defined Benefit Plan Target Allocation Percentage Of Assets Equity Range Maximum			65.00%
Defined benefit plan narrative description			The objective is to achieve a long-term rate of return in excess of 5% while at the same time mitigating the impact of investment risk associated with investment categories that are expected to yield greater than average returns.
Defined benefit plans that will be amortized from AOCI into net periodic benefit cost			$ 5,000
Percentage of Total Plan Assets Categorized As Level One			80.00%
Expected contributions to defined benefit pension plans in 2012			$ 7,700
Other Postretirement Benefit Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Contributions to defined contribution benefit plans			285	$ 541
Defined benefit plans that will be amortized from AOCI into net periodic benefit cost			400
Postretirement Medical Benefits
Defined Benefit Plan Disclosure [Line Items]
Expected contributions to defined benefit pension plans in 2012			$ 700

Reconciliations of Changes in the Defined Benefit and Postretirement Healthcare Plans' Benefit Obligations, Fair Value of Assets and Funded Status (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Change in Plan Assets [Roll Forward]
Beginning balance	$ 108,708
Ending balance	124,884	$ 108,708
Pension Plans, Defined Benefit
Change in Benefit Obligation [Roll Forward]
Benefit obligation at beginning of year	270,607	211,504
Service cost	12,178	10,950	$ 8,108
Interest cost	10,600	9,633	8,415
Participant contributions	3,638	3,562
Actuarial losses (gains)	59,461	2,991
Amendments	(93)	(3,034)
Acquisitions/Divestitures	3,745	52,282
Effects of exchange rate changes	8,100	(8,355)
Defined Benefit Plan, Other Costs	540
Defined Benefit Plan, Curtailments	(310)	0
Benefits paid	(12,700)	(8,926)
Benefit obligation at end of year	355,766	270,607	211,504
Change in Plan Assets [Roll Forward]
Beginning balance	108,708	99,546
Actual return on assets	10,732	(889)
Acquisitions/Divestitures	0	7,006
Effects of exchange rate changes	2,362	(1,238)
Employer contributions	12,144	9,647
Participant contributions	3,638	3,562
Benefits paid	(12,700)	(8,926)
Ending balance	124,884	108,708	99,546
Funded status at end of year	(230,882)	(161,899)
Other Postretirement Benefit Plans, Defined Benefit
Change in Benefit Obligation [Roll Forward]
Benefit obligation at beginning of year	12,217	11,607
Service cost	195	61	58
Interest cost	490	553	605
Participant contributions	535	583
Actuarial losses (gains)	1,601	537
Amendments	0	0
Acquisitions/Divestitures	0	0
Effects of exchange rate changes	0	0
Defined Benefit Plan, Curtailments	0	0
Benefits paid	(820)	(1,124)
Benefit obligation at end of year	14,218	12,217	11,607
Change in Plan Assets [Roll Forward]
Beginning balance	0	0
Actual return on assets	0	0
Acquisitions/Divestitures	0	0
Effects of exchange rate changes	0	0
Employer contributions	285	541
Participant contributions	535	583
Benefits paid	(820)	(1,124)
Ending balance	0	0	$ 0
Funded status at end of year	$ (14,218)	$ (12,217)

Pension Benefits And Other Postretirement Benefits Recognized In the Accompanying Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Other noncurrent assets	$ 263	$ 355
Deferred tax asset	26,421	10,972
Total assets	26,684	11,327
Current liabilities	(4,561)	(4,411)
Long-term liabilities	(226,584)	(157,843)
Deferred tax liability	(449)	(269)
Total liabilities	(231,594)	(162,523)
Accumulated other comprehensive income	70,377	32,002
Net amount recognized	(134,533)	(119,194)
Other Postretirement Benefit Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Other noncurrent assets	0	0
Deferred tax asset	1,764	1,247
Total assets	1,764	1,247
Current liabilities	(654)	(977)
Long-term liabilities	(13,564)	(11,240)
Deferred tax liability	0	0
Total liabilities	(14,218)	(12,217)
Accumulated other comprehensive income	2,805	1,984
Net amount recognized	$ (9,649)	$ (8,986)

Amounts Recognized in Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Pension Plans, Defined Benefit
Schedule of Pension and Other Postretirment Benefits Recgonized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial loss	$ 99,129	$ 45,462
Net prior service cost	(2,780)	(2,757)
Pretax AOCI	96,349	42,705
Less deferred taxes	25,972	10,703
Post tax AOCI	70,377	32,002
Other Postretirement Benefit Plans, Defined Benefit
Schedule of Pension and Other Postretirment Benefits Recgonized in Accumulated Other Comprehensive Income (Loss) [Line Items]
Net actuarial loss	4,569	3,232
Net prior service cost	0	0
Pretax AOCI	4,569	3,232
Less deferred taxes	1,764	1,248
Post tax AOCI	$ 2,805	$ 1,984

- Definition

The pretax net amount of gains and losses that are not yet recognized as a component of net periodic benefit cost, and that are recognized as increases or decreases in other comprehensive income as they arise. Gains and losses are due to changes in the value of either the benefit obligation or the plan assets resulting from experience different from that assumed or from a change in an actuarial assumption, or the consequence of a decision to temporarily deviate from the substantive plan.

+ References + Details

- Definition

Amount related to the pretax cost of benefit changes attributable to plan participants' prior service pursuant to a plan amendment or a plan initiation, which has not yet been recognized as components of net periodic benefit cost.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Glossary Prior Service Cost
-URI http://asc.fasb.org/extlink&oid=6521920

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=21915506&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=20435746&loc=SL7669646-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 30
-Glossary Prior Service Cost
-URI http://asc.fasb.org/extlink&oid=6521884

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 158
-Paragraph 7
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph i
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Pension Plans with an Accumulated Benefit Obligation in Excess of Plan Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Schedule of Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets [Line Items]
Projected benefit obligation	$ 344,653	$ 268,391
Accumulated benefit obligation	315,963	246,515
Fair value of plan assets	$ 117,413	$ 106,137

Components of Net Periodic Benefit Cost (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Pension Plans, Defined Benefit
Service cost	$ 12,178	$ 10,950	$ 8,108
Interest cost	10,600	9,633	8,415
Expected return on assets	(4,727)	(5,184)	(4,662)
Amortization of actuarial losses	0	0	124
Amortization of prior service	(138)	80	86
Amortization of net loss	1,995	1,584	1,002
Settlement gains	(303)	4	0
Net periodic benefit cost	19,605	17,067	13,073
Other Postretirement Benefit Plans, Defined Benefit
Service cost	195	61	58
Interest cost	490	553	605
Expected return on assets	0	0	0
Amortization of actuarial losses	0	0	0
Amortization of prior service	0	0	0
Amortization of net loss	264	189	265
Settlement gains	0	0	0
Net periodic benefit cost	$ 949	$ 803	$ 928

Other Changes in Plan Assets and Benefit Obligations Recognized in AOCI (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Net actuarial (gain) loss	$ 55,662	$ 8,352	$ 12,640
Net prior service (credit)	(161)	(2,845)	(8)
Net transition obligation	0	0	(1)
Amortization	(1,857)	(1,664)	(1,212)
Total recognized in AOCI	53,644	3,843	11,419
Total recognized in net periodic benefit cost and AOCI	73,249	20,910	24,492
Other Postretirement Benefit Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Net actuarial (gain) loss	1,601	537	(548)
Net prior service (credit)	0	0	0
Net transition obligation	0	0	0
Amortization	(264)	(189)	(265)
Total recognized in AOCI	1,337	348	(813)
Total recognized in net periodic benefit cost and AOCI	$ 2,286	$ 1,151	$ 115

The Amounts in AOCI That are Expected to be Amortized as Net Expense (Income) During Next Fiscal Year (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2012 USD ($)
Pension Plans, Defined Benefit
Schedule of Pension and Other Postretirment Benefits Expected Benefit Payments [Line Items]
Amount of net prior service cost	$ (139)
Amount of net loss	5,144
Other Postretirement Benefit Plans, Defined Benefit
Schedule of Pension and Other Postretirment Benefits Expected Benefit Payments [Line Items]
Amount of net prior service cost	0
Amount of net loss	$ 352

Weighted Average Assumptions Used to Determine Benfit Obligations (Detail)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Pension Plans, Defined Benefit
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]
Discount rate	2.80%	4.00%	4.10%
Rate of compensation increase	2.70%	2.80%	2.60%
Other Postretirement Benefit Plans, Defined Benefit
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items]
Discount rate	3.50%	4.00%	5.00%
Health care cost trend	8.00%	7.50%	8.00%
Ultimate health care cost trend	5.00%	5.00%	5.00%
Years until ultimate trend is reached	7.0	6.0	7.0

Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost (Detail)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Pension Plans, Defined Benefit
Schedule of Net Periodic Benefit Costs Weighted Average Assumptions [Line Items]
Discount rate	4.00%	4.10%	4.70%
Expected return on plan assets	4.10%	4.80%	5.20%
Rate of compensation increase	2.80%	2.60%	2.70%
Measurement Date	12/31/2012	December 31, 2011	December 31, 2010
Other Postretirement Benefit Plans, Defined Benefit
Schedule of Net Periodic Benefit Costs Weighted Average Assumptions [Line Items]
Discount rate	4.00%	5.00%	5.50%
Health care cost trend	8.00%	7.50%	8.00%
Ultimate health care cost trend	5.00%	5.00%	5.00%
Years until ultimate trend is reached	7.0	6.0	7.0
Measurement Date	12/31/2012	December 31, 2011	December 31, 2010

Effect of One Percentage Point in Assumed Healthcare Cost Trend Rates (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2012 USD ($)
Effect on total of service and interest cost components	$ 140
Effect on postretirement benefit obligation	2,503
Effect on total of service and interest cost components	(108)
Effect on postretirement benefit obligation	$ (1,976)

Fair Values of Pension Plan Assets (Parenthetical) (Detail)	Dec. 31, 2012
Mutual Funds \| Equity
Schedule of Pension and Other Postretirment Benefits Changes in Benefit Obligation and Fair Value of Plan Assets [Line Items]
Percentage of investments	50.00%
Mutual Funds \| Fixed Income Investments
Schedule of Pension and Other Postretirment Benefits Changes in Benefit Obligation and Fair Value of Plan Assets [Line Items]
Percentage of investments	50.00%
Common Collective Trusts \| Equity
Schedule of Pension and Other Postretirment Benefits Changes in Benefit Obligation and Fair Value of Plan Assets [Line Items]
Percentage of investments	65.00%
Common Collective Trusts \| Fixed Income Investments
Schedule of Pension and Other Postretirment Benefits Changes in Benefit Obligation and Fair Value of Plan Assets [Line Items]
Percentage of investments	35.00%

BENEFIT PLANS Reconciliation for the Plans Assets Categorized as Level 3 (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Change in Plan Assets. Level 3 [Roll Forward]
Beginning balance	$ 108,708
Ending balance	124,884	$ 108,708
Fair Value, Inputs, Level 3 [Member]
Change in Plan Assets. Level 3 [Roll Forward]
Beginning balance	9,151	5,584
Relating to assets still held at the reporting date	2,036	(1,430)
Relating to assets sold during the period	14	5
Defined Benefit Plan, Business Combinations and Acquisitions, Benefit Obligation		6,738
Purchases, sales and settlements, net	1,197	(1,521)
Effects of exchange rate changes	322	(225)
Ending balance	12,720	9,151
Common Collective Trusts Member \| Fair Value, Inputs, Level 3 [Member]
Change in Plan Assets. Level 3 [Roll Forward]
Beginning balance	2,083	2,066
Relating to assets still held at the reporting date	284	5
Relating to assets sold during the period	8	5
Defined Benefit Plan, Business Combinations and Acquisitions, Benefit Obligation		0
Purchases, sales and settlements, net	333	7
Effects of exchange rate changes	0	0
Ending balance	2,708	2,083
Insurance Contracts Member \| Fair Value, Inputs, Level 3 [Member]
Change in Plan Assets. Level 3 [Roll Forward]
Beginning balance	5,820	1,824
Relating to assets still held at the reporting date	1,700	(1,355)
Relating to assets sold during the period	0	0
Defined Benefit Plan, Business Combinations and Acquisitions, Benefit Obligation		6,738
Purchases, sales and settlements, net	533	(1,144)
Effects of exchange rate changes	281	(243)
Ending balance	8,334	5,820
Hedge Funds [Member] \| Fair Value, Inputs, Level 3 [Member]
Change in Plan Assets. Level 3 [Roll Forward]
Beginning balance	890	1,334
Relating to assets still held at the reporting date	52	(80)
Relating to assets sold during the period	6	0
Defined Benefit Plan, Business Combinations and Acquisitions, Benefit Obligation		0
Purchases, sales and settlements, net	331	(384)
Effects of exchange rate changes	32	20
Ending balance	1,311	890
Real Estate [Member] \| Fair Value, Inputs, Level 3 [Member]
Change in Plan Assets. Level 3 [Roll Forward]
Beginning balance	358	360
Relating to assets still held at the reporting date	0	0
Relating to assets sold during the period	0	0
Defined Benefit Plan, Business Combinations and Acquisitions, Benefit Obligation		0
Purchases, sales and settlements, net	0	0
Effects of exchange rate changes	9	(2)
Ending balance	$ 367	$ 358

Estimated Future Benefit Payments on Defined Benefit Plan (Detail) $ in Thousands	Dec. 31, 2012 USD ($)
Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
2013	$ 9,229
2014	10,619
2015	10,899
2016	10,999
2017	12,512
2018-2022	70,668
Other Postretirement Benefit Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
2013	665
2014	634
2015	612
2016	633
2017	614
2018-2022	$ 3,058

Restructuring Impairments and Other Costs - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Restructuring Cost and Reserve [Line Items]
Settlement of legal matters and impairments of intangible assets	$ 7,900
Impairment Of Intangible Assets	5,200
Restructuring Reserve Previous And Current Accrual Adjustments	18,710	$ 500
Effect on Future Earnings, Minimum Amount	10,000
Restructuring costs	17,800	3,100
Selling, general and administrative expenses	1,148,731	936,847	$ 738,901
Restructuring Reserve, Accrual Adjustment	(856)
Restructuring Reserve, Settled with Cash	9,108
Restructuring Reserve	14,452	5,706
Expenses Related To Acquisiton Costs Litigation Settlement And Impairment Of Long Lived Assets To Be Disposed Of		32,700
Effect on Future Earnings, Amount	15,000
Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve Previous And Current Accrual Adjustments	1,392
Restructuring Reserve, Settled with Cash	929
Restructuring Reserve	1,474	1,011
Restructuring Orthodontic Plan
Restructuring Cost and Reserve [Line Items]
Restructuring costs		1,700
Selling, general and administrative expenses		3,300
Other Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve Previous And Current Accrual Adjustments	1,222
Restructuring costs		1,900
Restructuring Reserve, Settled with Cash	1,170
Restructuring Reserve	86	34
Restructuring Prior Year Plans - 2010 and 2009
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Accrual Adjustment	800
Restructuring Fiscal 2012 Plan [Member] \| Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve Previous And Current Accrual Adjustments	1,392
Restructuring Reserve, Settled with Cash	710
Restructuring Reserve	682
Restructuring Fiscal 2012 Plan [Member] \| Other Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve Previous And Current Accrual Adjustments	1,222
Restructuring Reserve, Settled with Cash	1,136
Restructuring Reserve	$ 86	$ 0

Restructuring Accruals (Detail) - USD ($) $ in Thousands	12 Months Ended
Restructuring Accruals (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 5,706
Restructuring Reserve Previous And Current Accrual Adjustments	18,710	$ 500
Amounts applied	(9,108)
Restructuring Reserve, Accrual Adjustment	(856)
Ending Balance	14,452	5,706
Employee Severance
Restructuring Reserve [Roll Forward]
Beginning Balance	4,661
Restructuring Reserve Previous And Current Accrual Adjustments	16,096
Amounts applied	(7,046)
Restructuring Reserve, Accrual Adjustment	(819)
Ending Balance	12,892	4,661
Employee Severance \| Restructuring Fiscal 2009 and Prior Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	3,380
Restructuring Reserve Previous And Current Accrual Adjustments	0
Amounts applied	(1,511)
Restructuring Reserve, Accrual Adjustment	(720)
Ending Balance	1,149	3,380
Employee Severance \| Restructuring Fiscal 2011 Plan Member
Restructuring Reserve [Roll Forward]
Beginning Balance	1,281
Restructuring Reserve Previous And Current Accrual Adjustments	556
Amounts applied	(1,392)
Restructuring Reserve, Accrual Adjustment	(99)
Ending Balance	346	1,281
Employee Severance \| Restructuring Fiscal 2012 Plan [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	0
Restructuring Reserve Previous And Current Accrual Adjustments	15,540
Amounts applied	(4,143)
Restructuring Reserve, Accrual Adjustment	0
Ending Balance	11,397	0
Contract Termination
Restructuring Reserve [Roll Forward]
Beginning Balance	1,011
Restructuring Reserve Previous And Current Accrual Adjustments	1,392
Amounts applied	(929)
Ending Balance	1,474	1,011
Contract Termination \| Restructuring Fiscal 2009 and Prior Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	1,011
Restructuring Reserve Previous And Current Accrual Adjustments	0
Amounts applied	(219)
Ending Balance	792	1,011
Contract Termination \| Restructuring Fiscal 2012 Plan [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve Previous And Current Accrual Adjustments	1,392
Amounts applied	(710)
Ending Balance	682
Other Restructuring
Restructuring Reserve [Roll Forward]
Beginning Balance	34
Restructuring Reserve Previous And Current Accrual Adjustments	1,222
Amounts applied	(1,170)
Ending Balance	86	34
Other Restructuring \| Restructuring Fiscal 2009 and Prior Plans
Restructuring Reserve [Roll Forward]
Beginning Balance	34
Restructuring Reserve Previous And Current Accrual Adjustments	0
Amounts applied	(34)
Ending Balance	0	34
Other Restructuring \| Restructuring Fiscal 2012 Plan [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	0
Restructuring Reserve Previous And Current Accrual Adjustments	1,222
Amounts applied	(1,136)
Ending Balance	$ 86	$ 0

Provisions and Adjustments and Amounts Applied for All Plans by Segment (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 5,706
Restructuring Reserve Previous And Current Accrual Adjustments	18,710	$ 500
Amounts applied	(9,108)
Restructuring Reserve, Accrual Adjustment	(856)
Ending Balance	14,452	5,706
Dental Consumable and Laboratory Businesses Segment [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	3,601
Restructuring Reserve Previous And Current Accrual Adjustments	8,302
Amounts applied	(2,410)
Restructuring Reserve, Accrual Adjustment	(360)
Ending Balance	9,133	3,601
OrthodonticsCanadaMexicoJapan Segment [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	240
Restructuring Reserve Previous And Current Accrual Adjustments	1,394
Amounts applied	(1,260)
Restructuring Reserve, Accrual Adjustment	(14)
Ending Balance	360	240
Implants/Endodontics/Healthcare/Pacific Rim Segments
Restructuring Reserve [Roll Forward]
Beginning Balance	1,865
Restructuring Reserve Previous And Current Accrual Adjustments	8,750
Amounts applied	(5,396)
Restructuring Reserve, Accrual Adjustment	(482)
Ending Balance	4,737	1,865
Dental Laboratory Business/ Implants/ Non Dental
Restructuring Reserve [Roll Forward]
Beginning Balance	0
Restructuring Reserve Previous And Current Accrual Adjustments	264
Amounts applied	(42)
Restructuring Reserve, Accrual Adjustment	0
Ending Balance	$ 222	$ 0

- Definition

Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for a specified type of restructuring cost, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.

+ References + Details

Financial Instruments and Derivatives - Additional Information (Detail) $ in Thousands, € in Millions, ¥ in Millions, £ in Millions, zł in Millions, kr in Millions, kr in Millions, SFr in Millions, $ in Millions, $ in Millions, $ in Millions, $ in Millions, $ in Millions, ₩ in Billions, kr in Billions	12 Months Ended
	Dec. 31, 2012 USD ($)	Dec. 31, 2011 USD ($)	Jan. 17, 2013 CHF (SFr)	Jan. 17, 2013 USD ($)	Jan. 10, 2013 EUR (€)	Dec. 31, 2012 AUD ($) $ / ozt	Dec. 31, 2012 CAD ($) $ / ozt	Dec. 31, 2012 CHF (SFr) $ / ozt	Dec. 31, 2012 DKK (kr) $ / ozt	Dec. 31, 2012 EUR (€) $ / ozt	Dec. 31, 2012 GBP (£) $ / ozt	Dec. 31, 2012 JPY (¥) $ / ozt	Dec. 31, 2012 KRW (₩) $ / ozt	Dec. 31, 2012 MXN ($) $ / ozt	Dec. 31, 2012 NOK (kr) $ / ozt	Dec. 31, 2012 PLN (zł) $ / ozt	Dec. 31, 2012 SEK (kr) $ / ozt	Dec. 31, 2012 SGD ($) $ / ozt	Dec. 31, 2012 TWD ($) $ / ozt	Dec. 31, 2012 USD ($) $ / ozt	Apr. 04, 2011 USD ($)	Dec. 31, 2010 USD ($)	Feb. 28, 2010 USD ($)
Derivative [Line Items]
Fair Value Net Asset (Liability)																				$ (90,678)
Notional Amount of Foreign Currency Derivative Instruments Not Designated as Hedging Instruments								SFr 81.4												241,400
Advances to Affiliate																				241,000
Notional Amount of Derivative Instruments Designated as Net Investment Hedges \| €					€ 347.8
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax		$ (117,390)																		(143,142)
Accumulated translation gains on investments		(39,078)																		54,302
Deferred net losses on derivative instruments recorded in AOCI that are expected to be reclassified to current earnings during the next twelve months																				1,700
Notional Amount of Foreign Currency Derivatives \| SFr			SFr 295.5
Cash Flow Hedging
Derivative [Line Items]
Ineffective portion Recognized in Income	$ 890	(7,859)
Effective Portion Reclassified from AOCI into Income	$ 5,333	(3,088)
Net Investment Hedging
Derivative [Line Items]
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax		(143,730)																		(71,358)		$ 45,417
Fair Value Hedging
Derivative [Line Items]
Derivative, Notional Amount																					$ 150,000
Derivative, Fixed Interest Rate																					4.10%
Interest Rate Derivatives, at Fair Value, Net																				4,500
Treasury Rate Lock
Derivative [Line Items]
Derivative, Notional Amount		3,800
International Subsidiaries
Derivative [Line Items]
Accumulated translation gains on investments		143,700																		$ 71,400
Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount		2,900
Interest Rate Swap [Member] \| Group 1
Derivative [Line Items]
Derivative, maturity date	Sep. 30, 2014
Interest Rate Swap [Member] \| Group 1 \| Cash Flow Hedging
Derivative [Line Items]
Derivative, Notional Amount \| ¥												¥ 12,600.0
Average fixed interest rate						0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%	0.20%
Interest Rate Swap [Member] \| Group 2
Derivative [Line Items]
Derivative, maturity date	Sep. 30, 2016
Interest Rate Swap [Member] \| Group 2 \| Cash Flow Hedging
Derivative [Line Items]
Derivative, Notional Amount \| SFr								SFr 65.0
Average fixed interest rate						0.70%	0.70%	0.70%	0.70%	0.70%	0.70%	0.70%	0.70%	0.70%	0.70%	0.70%	0.70%	0.70%	0.70%	0.70%
Commodity Contract [Member] \| Cash Flow Hedging \| Platinum Bullion
Derivative [Line Items]
Description of derivative activity	swaps in place to purchase 758 troy ounces
Average fixed rate price \| $ / ozt						1,571	1,571	1,571	1,571	1,571	1,571	1,571	1,571	1,571	1,571	1,571	1,571	1,571	1,571	1,571
Commodity Contract [Member] \| Cash Flow Hedging \| Silver Bullion
Derivative [Line Items]
Description of derivative activity	swaps in place to purchase 56,712 troy ounces
Average fixed rate price \| $ / ozt						31	31	31	31	31	31	31	31	31	31	31	31	31	31	31
Cross Currency Interest Rate Swaps
Derivative [Line Items]
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax		$ 111,900																		$ 90,700
Foreign Exchange Contract \| Cash Flow Hedging
Derivative [Line Items]
Notional Amount of Foreign Currency Derivative Sale Contracts						$ 20.9	$ 47.2			€ 45.3			₩ 5.3	$ 167.4		zł 17.2		$ 2.9	$ 50.4
Notional Amount of Foreign Currency Derivative Purchase Contracts								SFr 61.1	kr 17.7		£ 4.8	¥ 310.4			kr 2.3		kr 1.5
Currency Swap [Member]
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(95,347)
Private Placement Notes
Derivative [Line Items]
Debt Instrument, Face Amount																							$ 250,000
Unsecured Senior Notes \| Tranche C
Derivative [Line Items]
Debt Instrument, Face Amount																				450,000
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional Amount of Foreign Currency Derivative Instruments Not Designated as Hedging Instruments \| SFr								SFr 160.0
Commodity Contract [Member]
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(95)
Foreign Exchange Forward
Derivative [Line Items]
Fair Value Net Asset (Liability)																				4,630
Maturing In Year Two \| Foreign Exchange Forward
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				32,604
Current year \| Foreign Exchange Forward
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				(184,295)
Currency, Australian Dollar \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				19
Currency, Australian Dollar \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				1,593
Currency, Australian Dollar \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				20,006
Currency, British Pound Sterling \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(52)
Currency, British Pound Sterling \| Maturing In Year Two \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				0
Currency, British Pound Sterling \| Current year \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				(7,846)
Canada, Dollars \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(385)
Canada, Dollars \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				8,573
Canada, Dollars \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				38,597
Denmark, Kroner \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(24)
Denmark, Kroner \| Maturing In Year Two \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				0
Denmark, Kroner \| Current year \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				$ (3,129)
Euro Member Countries, Euro \| Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative, Forward Exchange Rate						1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.45	1.45
Euro Member Countries, Euro \| Not Designated as Hedging Instrument [Member] \| Currency Swap [Member]
Derivative [Line Items]
Foreign Currency Cash Flow Hedge Asset at Fair Value																				$ 449,800
Euro Member Countries, Euro \| Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative, Forward Exchange Rate						1.27	1.27	1.27	1.27	1.27	1.27	1.27	1.27	1.27	1.27	1.27	1.27	1.27	1.27	1.27
Euro Member Countries, Euro \| Designated as Hedging Instrument [Member] \| Currency Swap [Member]
Derivative [Line Items]
Foreign Currency Cash Flow Hedge Asset at Fair Value																				$ 618,000
Euro Member Countries, Euro \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				1,585
Euro Member Countries, Euro \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				45,939
Euro Member Countries, Euro \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				13,231
Currency, Japanese Yen \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(374)
Currency, Japanese Yen \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				(3,222)
Currency, Japanese Yen \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				(391)
Currency, Mexican Pesos \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				49
Currency, Mexican Pesos \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				0
Currency, Mexican Pesos \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				13,018
Norway, Krone \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Fair Value Net Asset (Liability)																				0
Norway, Krone \| Maturing In Year Two \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				0
Norway, Krone \| Current year \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				(412)
Currency, Polish Zlotys \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(77)
Currency, Polish Zlotys \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				0
Currency, Polish Zlotys \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				5,560
Currency, Singapore Dollar \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				33
Currency, Singapore Dollar \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				0
Currency, Singapore Dollar \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				2,413
Currency, South Korean Won \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(30)
Currency, South Korean Won \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				0
Currency, South Korean Won \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				4,940
Currency, Swedish Kronor \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Fair Value Net Asset (Liability)																				4,296
Currency, Swedish Kronor \| Maturing In Year Two \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				(27,544)
Currency, Swedish Kronor \| Current year \| Foreign Exchange Forward \| Derivative Purchased
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				$ (197,549)
Switzerland, Francs \| Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative, Forward Exchange Rate						1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08
Switzerland, Francs \| Not Designated as Hedging Instrument [Member] \| Currency Swap [Member]
Derivative [Line Items]
Foreign Currency Cash Flow Hedge Asset at Fair Value																				$ 241,400
Switzerland, Francs \| Designated as Hedging Instrument [Member]
Derivative [Line Items]
Derivative, Forward Exchange Rate						1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06
Switzerland, Francs \| Designated as Hedging Instrument [Member] \| Currency Swap [Member]
Derivative [Line Items]
Foreign Currency Cash Flow Hedge Asset at Fair Value																				$ 432,500
Switzerland, Francs \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(411)
Switzerland, Francs \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				7,265
Switzerland, Francs \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				(74,467)
Currency, Taiwanese Dollars \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Fair Value Net Asset (Liability)																				1
Currency, Taiwanese Dollars \| Maturing In Year Two \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				0
Currency, Taiwanese Dollars \| Current year \| Foreign Exchange Forward \| Derivatives Sold
Derivative [Line Items]
Notional Amount of Cash Flow Hedge Instruments																				1,734
Maturing in the Next Twelve Months
Derivative [Line Items]
Derivative, Notional Amount																				1,138,473
Maturing in the Next Twelve Months \| Interest Rate Swap [Member]
Derivative [Line Items]
Notional Amount of Interest Rate Derivatives																				1,246
Maturing in the Next Twelve Months \| Currency Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount																				307,474
Maturing in the Next Twelve Months \| Commodity Contract [Member]
Derivative [Line Items]
Derivative, Notional Amount																				2,872
Maturing in the Next Twelve Months \| Euro Member Countries, Euro \| Interest Rate Swap [Member]
Derivative [Line Items]
Notional Amount of Interest Rate Derivatives																				1,246
Maturing in the Next Twelve Months \| Currency, Japanese Yen \| Interest Rate Swap [Member]
Derivative [Line Items]
Notional Amount of Interest Rate Derivatives																				0
Maturing in the Next Twelve Months \| Switzerland, Francs \| Interest Rate Swap [Member]
Derivative [Line Items]
Notional Amount of Interest Rate Derivatives																				0
Maturing In Year Two
Derivative [Line Items]
Derivative, Notional Amount																				87,854
Maturing In Year Two \| Interest Rate Swap [Member]
Derivative [Line Items]
Notional Amount of Interest Rate Derivatives																				145,634
Maturing In Year Two \| Euro Member Countries, Euro \| Interest Rate Swap [Member]
Derivative [Line Items]
Notional Amount of Interest Rate Derivatives																				953
Maturing In Year Two \| Currency, Japanese Yen \| Interest Rate Swap [Member]
Derivative [Line Items]
Notional Amount of Interest Rate Derivatives																				144,681
Maturing In Year Two \| Switzerland, Francs \| Interest Rate Swap [Member]
Derivative [Line Items]
Notional Amount of Interest Rate Derivatives																				0
Silver Bullion \| Commodity Contract [Member] \| Swap
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(68)
Silver Bullion \| Maturing in the Next Twelve Months \| Commodity Contract [Member] \| Swap
Derivative [Line Items]
Derivative, Notional Amount																				1,708
Platinum Bullion \| Commodity Contract [Member] \| Swap
Derivative [Line Items]
Fair Value Net Asset (Liability)																				(27)
Platinum Bullion \| Maturing in the Next Twelve Months \| Commodity Contract [Member] \| Swap
Derivative [Line Items]
Derivative, Notional Amount																				1,164
Maturing in Year Four
Derivative [Line Items]
Notional Amount of Interest Rate Derivatives																				$ 71,027
Subsequent Event [Member]
Derivative [Line Items]
Notional Amount of Foreign Currency Derivative Instruments Not Designated as Hedging Instruments				$ 160,000
Subsequent Event [Member] \| Designated as Hedging Instrument [Member]
Derivative [Line Items]
Debt Instrument, Basis Spread on Variable Rate			0.316%	0.316%
Subsequent Event [Member] \| Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Debt Instrument, Basis Spread on Variable Rate			0.34%	0.34%	0.221%
Subsequent Event [Member] \| Designated as Hedging Instrument [Member]
Derivative [Line Items]
Accumulated Other Comprehensive Income (Loss) Cumulative Changes In Net Gain (Loss) From Hedging Activities Effect, Net of Tax				$ 55,200

Summary of Notional Amounts and Fair Value of the Company's Cash Flow Hedges (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Maturing in Year Three
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative, Notional Amount	$ 61,848
Maturing in the Next Twelve Months
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative, Notional Amount	1,138,473
Maturing In Year Two
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative, Notional Amount	87,854
Commodity Contract [Member] \| Maturing in the Next Twelve Months
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative, Notional Amount	2,872
Commodity Contract [Member] \| Maturing in the Next Twelve Months \| Silver Bullion \| Swap
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative, Notional Amount	1,708
Commodity Contract [Member] \| Maturing in the Next Twelve Months \| Platinum Bullion \| Swap
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative, Notional Amount	1,164
Interest Rate Swap [Member]
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative, Notional Amount		$ 2,900
Interest Rate Derivative Liabilities, at Fair Value	(1,789)
Interest Rate Swap [Member] \| Euro Member Countries, Euro
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Interest Rate Derivative Liabilities, at Fair Value	(530)
Interest Rate Swap [Member] \| Currency, Japanese Yen
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Interest Rate Derivative Assets, at Fair Value	133
Interest Rate Swap [Member] \| Switzerland, Francs
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Interest Rate Derivative Liabilities, at Fair Value	(1,392)
Interest Rate Swap [Member] \| Maturing in Year Three
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	953
Interest Rate Swap [Member] \| Maturing in Year Three \| Euro Member Countries, Euro
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	953
Interest Rate Swap [Member] \| Maturing in Year Three \| Currency, Japanese Yen
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	0
Interest Rate Swap [Member] \| Maturing in Year Three \| Switzerland, Francs
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	0
Interest Rate Swap [Member] \| Maturing in Year Four
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	71,980
Interest Rate Swap [Member] \| Maturing in Year Four \| Euro Member Countries, Euro
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	953
Interest Rate Swap [Member] \| Maturing in Year Four \| Currency, Japanese Yen
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	0
Interest Rate Swap [Member] \| Maturing in the Next Twelve Months
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	1,246
Interest Rate Swap [Member] \| Maturing in the Next Twelve Months \| Euro Member Countries, Euro
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	1,246
Interest Rate Swap [Member] \| Maturing in the Next Twelve Months \| Currency, Japanese Yen
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	0
Interest Rate Swap [Member] \| Maturing in the Next Twelve Months \| Switzerland, Francs
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	0
Interest Rate Swap [Member] \| Maturing In Year Two
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	145,634
Interest Rate Swap [Member] \| Maturing In Year Two \| Euro Member Countries, Euro
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	953
Interest Rate Swap [Member] \| Maturing In Year Two \| Currency, Japanese Yen
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	144,681
Interest Rate Swap [Member] \| Maturing In Year Two \| Switzerland, Francs
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	0
Interest Rate Swap [Member] \| Maturing in Year Five and Thereafter
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	1,191
Interest Rate Swap [Member] \| Maturing in Year Five and Thereafter \| Euro Member Countries, Euro
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	1,191
Interest Rate Swap [Member] \| Maturing in Year Five and Thereafter \| Currency, Japanese Yen
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	0
Interest Rate Swap [Member] \| Maturing in Year Five and Thereafter \| Switzerland, Francs
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	$ 0

Summary of Notional Amounts and Fair Value of the Company's Cash Flow Hedges (Parenthetical) (Detail) - Dec. 31, 2012 - Foreign Exchange Contract - Cash Flow Hedging € in Millions, ¥ in Millions, £ in Millions, zł in Millions, kr in Millions, kr in Millions, SFr in Millions, $ in Millions, $ in Millions, $ in Millions, $ in Millions, $ in Millions, ₩ in Billions, kr in Billions	AUD ($)	CAD ($)	CHF (SFr)	DKK (kr)	EUR (€)	GBP (£)	JPY (¥)	KRW (₩)	MXN ($)	NOK (kr)	PLN (zł)	SEK (kr)	SGD ($)	TWD ($)
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Foreign Currency Derivative Sale Contracts	$ 20.9	$ 47.2			€ 45.3			₩ 5.3	$ 167.4		zł 17.2		$ 2.9	$ 50.4
Notional Amount of Foreign Currency Derivative Purchase Contracts			SFr 61.1	kr 17.7		£ 4.8	¥ 310.4			kr 2.3		kr 1.5

Fair Value of Cross Currency Basis Swaps that are Designated as Hedges of Net Investments in Foreign Operations (Detail) $ in Thousands	Dec. 31, 2012 USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Fair Value Net Asset (Liability)	$ (90,678)
Swiss franc 432.5 million 1.06 Pay CHF 3 month LIBOR rec USD 3 month LIBOR [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Fair Value Net Asset (Liability)	(62,366)
Euros 618.0 million 1.27 Pay 3 month EURIBOR rec. USD 3 month LIBOR [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Fair Value Net Asset (Liability)	(28,312)
Currency Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Fair Value Net Asset (Liability)	(95,347)
Currency Swap [Member] \| Euros 358.0 Million 1.22 Pay EUR 3 Month EURIBOR Rec USD 3 Month LIBOR
Derivative Instruments, Gain (Loss) [Line Items]
Foreign Currency Cash Flow Hedge Liability at Fair Value	(55,858)
Maturing in the Next Twelve Months
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,138,473
Maturing in the Next Twelve Months \| Swiss franc 432.5 million 1.06 Pay CHF 3 month LIBOR rec USD 3 month LIBOR [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	322,898
Maturing in the Next Twelve Months \| Euros 618.0 million 1.27 Pay 3 month EURIBOR rec. USD 3 month LIBOR [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	815,575
Maturing in the Next Twelve Months \| Currency Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	307,474
Maturing in the Next Twelve Months \| Currency Swap [Member] \| Euros 358.0 Million 1.22 Pay EUR 3 Month EURIBOR Rec USD 3 Month LIBOR
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount of Foreign Currency Cash Flow Hedge Derivatives	0
Maturing in the Next Twelve Months \| Currency Swap [Member] \| Swiss Franc 241.4 million 1.08 Pay CHF 3 month LIBOR rec USD 3 month LIBOR [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Foreign Currency Cash Flow Hedge Liability at Fair Value	(39,489)
Notional Amount of Foreign Currency Cash Flow Hedge Derivatives	307,474
Maturing In Year Two
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	87,854
Maturing In Year Two \| Swiss franc 432.5 million 1.06 Pay CHF 3 month LIBOR rec USD 3 month LIBOR [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	87,854
Maturing In Year Two \| Euros 618.0 million 1.27 Pay 3 month EURIBOR rec. USD 3 month LIBOR [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	0
Maturing In Year Two \| Currency Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount of Foreign Currency Cash Flow Hedge Derivatives	593,555
Maturing In Year Two \| Currency Swap [Member] \| Euros 358.0 Million 1.22 Pay EUR 3 Month EURIBOR Rec USD 3 Month LIBOR
Derivative Instruments, Gain (Loss) [Line Items]
Notional Amount of Foreign Currency Cash Flow Hedge Derivatives	593,555
Maturing in Year Three
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	61,848
Maturing in Year Three \| Swiss franc 432.5 million 1.06 Pay CHF 3 month LIBOR rec USD 3 month LIBOR [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	61,848
Maturing in Year Three \| Euros 618.0 million 1.27 Pay 3 month EURIBOR rec. USD 3 month LIBOR [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 0

Fair Value and Location on the Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Prepaid Expenses and Other Current Assets
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	$ 12,736	$ 8,003
Derivative Assets Not Designated as Hedges	7,189	1,943
Prepaid Expenses and Other Current Assets \| Foreign Exchange Forward
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	2,353	5,464
Derivative Assets Not Designated as Hedges	6,652	1,943
Prepaid Expenses and Other Current Assets \| DIO Equity Option Contracts
Derivatives, Fair Value [Line Items]
Derivative Assets Not Designated as Hedges	0	0
Prepaid Expenses and Other Current Assets \| Commodity Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	0	0
Prepaid Expenses and Other Current Assets \| Interest Rate Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	2,192	2,539
Derivative Assets Not Designated as Hedges	0	0
Prepaid Expenses and Other Current Assets \| Cross Currency Basis Swaps
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	8,191
Derivative Assets Not Designated as Hedges	537	0
Prepaid Expenses and Other Current Assets \| Currency Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges		0
Other Noncurrent Assets
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	2,600	23,909
Derivative Assets Not Designated as Hedges	0	0
Other Noncurrent Assets \| Foreign Exchange Forward
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	65	896
Derivative Assets Not Designated as Hedges	0	0
Other Noncurrent Assets \| DIO Equity Option Contracts
Derivatives, Fair Value [Line Items]
Derivative Assets Not Designated as Hedges	0	0
Other Noncurrent Assets \| Commodity Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	0	15
Other Noncurrent Assets \| Interest Rate Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	2,535	3,160
Derivative Assets Not Designated as Hedges	0	0
Other Noncurrent Assets \| Cross Currency Basis Swaps
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges	0
Derivative Assets Not Designated as Hedges	0	0
Other Noncurrent Assets \| Currency Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges		19,838
Accrued Liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges	100,144	14,688
Derivative Liabilities Not Designated as Hedges	41,493	3,255
Accrued Liabilities \| Foreign Exchange Forward
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges	2,243	641
Derivative Liabilities Not Designated as Hedges	1,353	3,150
Accrued Liabilities \| DIO Equity Option Contracts
Derivatives, Fair Value [Line Items]
Derivative Liabilities Not Designated as Hedges	0	0
Accrued Liabilities \| Commodity Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges		257
Derivative Liabilities Designated as Hedges	95
Accrued Liabilities \| Interest Rate Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges	525	0
Derivative Liabilities Not Designated as Hedges	114	105
Accrued Liabilities \| Cross Currency Basis Swaps
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges	97,281
Derivative Liabilities Not Designated as Hedges	40,026	0
Accrued Liabilities \| Currency Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges		13,790
Other Noncurrent Liabilities
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges	3,380	119,133
Derivative Liabilities Not Designated as Hedges	56,427	68,585
Other Noncurrent Liabilities \| Foreign Exchange Forward
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges	844	107
Derivative Liabilities Not Designated as Hedges	0	0
Other Noncurrent Liabilities \| DIO Equity Option Contracts
Derivatives, Fair Value [Line Items]
Derivative Liabilities Not Designated as Hedges	153	419
Other Noncurrent Liabilities \| Commodity Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative Assets Designated as Hedges		2
Derivative Liabilities Designated as Hedges	0
Other Noncurrent Liabilities \| Interest Rate Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges	948	1,050
Derivative Liabilities Not Designated as Hedges	416	476
Other Noncurrent Liabilities \| Cross Currency Basis Swaps
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges	1,588
Derivative Liabilities Not Designated as Hedges	$ 55,858	67,690
Other Noncurrent Liabilities \| Currency Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative Liabilities Designated as Hedges		$ 117,974

Impact of the Company's Cash Flow Hedges (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) in AOCI	$ (34,216)	$ 30,971
Cash Flow Hedging
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Effective Portion Reclassified from AOCI into Income	5,333	(3,088)
Gain (Loss) in AOCI	(408)	(22,964)
Ineffective portion Recognized in Income	890	(7,859)
Cash Flow Hedging \| Interest Rate Contract \| Interest Rate Contract
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Effective Portion Reclassified from AOCI into Income	(3,611)	(4,903)
Gain (Loss) in AOCI	(1,987)	(30,008)
Cash Flow Hedging \| Interest Rate Contract \| Other Expense
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Ineffective portion Recognized in Income		(6,151)
Cash Flow Hedging \| Foreign Exchange Forward \| Cost of Sales
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Effective Portion Reclassified from AOCI into Income	8,029	1,503
Gain (Loss) in AOCI	1,027	6,858
Cash Flow Hedging \| Foreign Exchange Forward \| Selling, General And Administrative Expense
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Effective Portion Reclassified from AOCI into Income	779	39
Gain (Loss) in AOCI	80	377
Cash Flow Hedging \| Foreign Exchange Forward \| Group 1 \| Interest Expense
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Ineffective portion Recognized in Income	915	(403)
Cash Flow Hedging \| Foreign Exchange Forward \| Group 1 \| Other Expense
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Ineffective portion Recognized in Income		(1,307)
Cash Flow Hedging \| Commodity Contract [Member] \| Interest Expense
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Ineffective portion Recognized in Income	(25)	2
Cash Flow Hedging \| Commodity Contract [Member] \| Cost of Sales
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Effective Portion Reclassified from AOCI into Income	136	273
Gain (Loss) in AOCI	$ 472	$ (191)

Impact of the Company's Hedges of Net Investments (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) Recognized in Income	$ 2,379,000	$ (4,698,000)
Gain (Loss) in AOCI	(34,216,000)	30,971,000
Net Investment Hedging \| Interest Expense
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) Recognized in Income		(108,000)
Net Investment Hedging \| Group 1 \| Interest Income
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) Recognized in Income	4,264,000	1,085,000
Net Investment Hedging \| Group 1 \| Interest Expense
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) Recognized in Income	(1,885,000)
Net Investment Hedging \| Cross Currency Interest Rate Swaps \| Group 1
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) in AOCI	$ (34,216,000)	3,308,000
Net Investment Hedging \| Cross Currency Interest Rate Swaps \| Group 2
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) in AOCI		30,125,000
Net Investment Hedging \| Cross Currency Interest Rate Swaps \| Group 2 \| Interest Expense
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) Recognized in Income		(5,675,000)
Net Investment Hedging \| Foreign Exchange Contract \| Group 2
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) in AOCI		(2,462,000)
Net Investment Hedging \| Foreign Exchange Contract \| Group 2 \| Interest Expense
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Gain (Loss) Recognized in Income		$ 0

FINANCIAL INSTRUMENTS AND DERIVATIVES Impact of the Company’s Fair Value Hedges (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Income, Net	$ 2,379	$ (4,698)
Cash Flow Hedging \| Interest Expense
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Income, Net	2,284	6,328
Interest Rate Contract \| Cash Flow Hedging \| Interest Expense
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Instruments, Gain (Loss) Recognized in Income, Net	$ 2,284	$ 6,328

- Definition

The amount of net gains and losses recognized in income during the period on derivative instruments designated and qualifying as hedging instruments in fair value hedges and related hedged items designated and qualifying in fair value hedges, on derivative instruments designated and qualifying as hedging instruments in cash flow hedges, and on derivative instruments not designated as hedging instruments.

+ References + Details

Impact of the Company's Hedges Not Designated as Hedging (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Derivative [Line Items]
Derivatives Not Designated as Hedging, Gains (Losses)	$ 11,216	$ (69,937)
Foreign Exchange Forward \| Other Expense
Derivative [Line Items]
Derivatives Not Designated as Hedging, Gains (Losses)	(1,224)	(2,921)
DIO Corporation \| Other Expense
Derivative [Line Items]
Derivatives Not Designated as Hedging, Gains (Losses)	272	383
Interest Rate Contract \| Other Expense
Derivative [Line Items]
Derivatives Not Designated as Hedging, Gains (Losses)	12,323	(67,213)
Interest Rate Contract \| Interest Expense
Derivative [Line Items]
Derivatives Not Designated as Hedging, Gains (Losses)	$ (155)	$ (186)

Amounts recorded in AOCI related to cash flow hedging instruments (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Derivative Instruments, Gain (Loss) [Line Items]
Beginning balance	$ (117,390)
Changes in fair value of derivatives	(25,752)	$ 9,258	$ (12,848)
Ending balance	(143,142)	(117,390)
Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Beginning balance	(143,730)	45,417
Foreign currency translation adjustment	83,283	(200,121)
Changes in fair value of foreign currency debt	10,097	(9,553)
Changes in fair value of derivative hedge instruments	(21,008)	20,527
Total activity	72,372	(189,147)
Ending balance	(71,358)	(143,730)	45,417
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Beginning balance	(12,737)	(1,468)
Changes in fair value of derivatives	105	(13,713)
Reclassifications to earnings from equity	(4,849)	2,444
Total activity	(4,744)	(11,269)
Ending balance	$ (17,481)	$ (12,737)	$ (1,468)

FINANCIAL INSTRUMENTS AND DERIVATIVES Summary of Notional Amounts and Fair Value of the Company's Fair Value Hedges (Details) $ in Thousands	Dec. 31, 2012 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative Assets (Liabilities), at Fair Value, Net	$ (90,678)
Interest Rate Contract
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative Assets (Liabilities), at Fair Value, Net	4,513
Interest Rate Contract \| Maturing In Year Two
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	45,000
Interest Rate Contract \| Maturing in Year Three
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	60,000
Interest Rate Contract \| Maturing in Year Four
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	45,000
Interest Rate Swap [Member] \| Maturing in the Next Twelve Months
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	1,246
Interest Rate Swap [Member] \| Maturing In Year Two
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	145,634
Interest Rate Swap [Member] \| Maturing in Year Three
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	953
Interest Rate Swap [Member] \| Maturing in Year Four
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	71,980
Interest Rate Swap [Member] \| Us Dollar Denominated [Member]
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Derivative Assets (Liabilities), at Fair Value, Net	4,513
Interest Rate Swap [Member] \| Us Dollar Denominated [Member] \| Maturing In Year Two
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	45,000
Interest Rate Swap [Member] \| Us Dollar Denominated [Member] \| Maturing in Year Three
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	60,000
Interest Rate Swap [Member] \| Us Dollar Denominated [Member] \| Maturing in Year Four
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Derivatives	$ 45,000

Fair Value Measurement - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Feb. 28, 2010
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Long-term debt	$ 1,472,913	$ 1,491,419
Probability-weighted average payout discount using market rate	5.00%
Corporate Bond Securities
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
DIO Corporation's stock volatility factor	40.00%
Discount rate	15.00%
Estimate of Fair Value, Fair Value Disclosure
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Long-term debt	$ 1,515,200	1,512,500
Carrying (Reported) Amount, Fair Value Disclosure
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Long-term debt	1,472,900	1,491,400
Tranche C \| Unsecured Senior Notes
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Senior Notes	450,000
Tranche B \| Unsecured Senior Notes
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Senior Notes	300,000
Tranche A \| Unsecured Senior Notes
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Senior Notes	$ 250,000
Fixed rate senior notes $450 million due August 2021 \| U.S. Dollar denominated due twenty twenty one [Domain]
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Debt, fixed rate	4.10%
Private Placement Notes
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Senior Notes			$ 250,000
Private Placement Notes \| U.S. Dollar Denominated Expiring March 2016
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Long-term debt	$ 254,560	$ 254,512
Debt, fixed rate	4.10%	4.10%
Fixed Rate Senior Notes \| U.S. Dollar Denominated Due August 2016
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Long-term debt	$ 299,689	$ 299,603
Debt, fixed rate	2.80%	2.80%

Financial Assets and Liabilities that are Recorded at Fair Value and Classified Based on the Lowest Level of Input (Detail) - USD ($) $ in Thousands	Dec. 31, 2012	Dec. 31, 2011
Assets	$ 97,668	$ 92,221
Liabilities	356,004	363,090
Money Market Funds
Assets		10,516
Interest Rate Swap [Member]
Assets	4,727	5,699
Liabilities	2,003	1,631
Commodity Contract [Member]
Assets	8,728	15
Liabilities	95	259
Cross Currency Interest Rate Swaps
Assets	9,070	19,838
Liabilities	194,753	199,454
Foreign Exchange Forward
Assets		8,303
Liabilities	4,440	3,898
Long-term Debt
Liabilities	154,560	154,512
Corporate Bond Securities
Assets	75,143	47,850
DIO Equity Option Contracts
Liabilities	153	419
Contingent Considerations On Acquisitions
Liabilities		2,917
Fair Value, Inputs, Level 1
Assets	0	10,516
Fair Value, Inputs, Level 1 \| Money Market Funds
Assets		10,516
Fair Value, Inputs, Level 2
Assets	22,525	33,855
Liabilities	355,851	359,754
Fair Value, Inputs, Level 2 \| Interest Rate Swap [Member]
Assets	4,727	5,699
Liabilities	2,003	1,631
Fair Value, Inputs, Level 2 \| Commodity Contract [Member]
Assets	8,728	15
Liabilities	95	259
Fair Value, Inputs, Level 2 \| Cross Currency Interest Rate Swaps
Assets	9,070	19,838
Liabilities	194,753	199,454
Fair Value, Inputs, Level 2 \| Foreign Exchange Forward
Assets		8,303
Liabilities	4,440	3,898
Fair Value, Inputs, Level 2 \| Long-term Debt
Liabilities	154,560	154,512
Fair Value, Inputs, Level 3
Assets	75,143	47,850
Liabilities	153	3,336
Fair Value, Inputs, Level 3 \| Corporate Bond Securities
Assets	75,143	47,850
Fair Value, Inputs, Level 3 \| DIO Equity Option Contracts
Liabilities	$ 153	419
Fair Value, Inputs, Level 3 \| Contingent Considerations On Acquisitions
Liabilities		$ 2,917

Reconciliation Assets Measured at Fair Value on a Recurring Basis Using Unobservable Inputs (Level 3) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2012 USD ($)
Corporate Bond Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning Balance	$ 47,850
Unrealized Loss Reported in AOCI	25,775
Effect of exchange rate changes	1,518
Ending Balance	75,143
DIO Equity Option Contracts
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning Balance	(419)
Unrealized Gain Reported in other expense (income), net	272
Effect of exchange rate changes	(6)
Ending Balance	(153)
Contingent Considerations On Acquisitions
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning Balance	2,917
Payments/sales, gross	(2,493)
Unrealized Gain Reported in other expense (income), net	(412)
Effect of exchange rate changes	(12)
Ending Balance	$ 0

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions	1 Months Ended		12 Months Ended
	Dec. 31, 2006	Jun. 30, 2004	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Commitments and Contingencies Disclosure [Line Items]
Operating leases, rent expense, total			$ 42.3	$ 39.0	$ 34.9
Liability for employees under contract, if terminated by the Company without cause			16.4
Other Purchase Commitments			$ 62.6
San Francisco County, California
Commitments and Contingencies Disclosure [Line Items]
Class action law suit filed		On June 18, 2004, Marvin Weinstat, DDS and Richard Nathan, DDS filed a class action suit in San Francisco County, California alleging that the Company misrepresented that its Cavitron® ultrasonic scalers are suitable for use in oral surgical procedures.
Name of plaintiff (s)		Marvin Weinstat, DDS and Richard Nathan, DDS
Eastern District of Pennsylvania
Commitments and Contingencies Disclosure [Line Items]
Class action law suit filed	On December 12, 2006, a Complaint was filed by Carole Hildebrand, DDS and Robert Jaffin, DDS in the Eastern District of Pennsylvania (the Plaintiffs subsequently added Dr. Mitchell Goldman as a named class representative). The case was filed by the same law firm that filed the Weinstat case in California. The Complaint asserts putative class action claims on behalf of dentists located in New Jersey and Pennsylvania.
Name of plaintiff (s)	Carole Hildebrand, DDS and Robert Jaffin, DDS and Dr. Mitchell Goldman

Commitments and Contingencies - Rental commitments (Detail) $ in Thousands	Dec. 31, 2012 USD ($)
Commitments and Contingencies Disclosure [Line Items]
2012	$ 37,778
2013	28,386
2014	23,424
2015	19,393
2016	17,160
2017 and thereafter	24,772
Operating Leases, Future Minimum Payments Due, Total	$ 150,913

Disclosure - Schedule II Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Allowance for doubtful accounts

Movement in Valuation Allowances and Reserves [Roll Forward]

Balance at beginning of period

$ 14,905

$ 8,820

$ 12,235

Additions - (credited) to costs and expenses

2,409

469

(233)

Additions - charged to other accounts

115

7,930

^[1]

111

Write-offs net of recoveries

(3,798)

(1,373)

(2,611)

Translation adjustment

(941)

(682)

Balance at end of period

13,647

14,905

8,820

Inventory valuation reserves

Movement in Valuation Allowances and Reserves [Roll Forward]

Balance at beginning of period

35,104

35,469

31,932

Additions - (credited) to costs and expenses

2,500

3,325

6,590

Additions - charged to other accounts

(78)

697

^[2]

760

Write-offs net of recoveries

(4,673)

(3,924)

(3,652)

Translation adjustment

(292)

(463)

(161)

Balance at end of period

32,561

35,104

35,469

Deferred tax asset valuation allowance

Movement in Valuation Allowances and Reserves [Roll Forward]

Balance at beginning of period

71,758

93,054

51,809

Additions - (credited) to costs and expenses

107,995

(22,400)

47,304

Additions - charged to other accounts

2,174

^[3]

Write-offs net of recoveries

Translation adjustment

(54)

(1,070)

(6,059)

Balance at end of period

$ 179,699

$ 71,758

$ 93,054

[1]	Amount includes $7.8 million allowance for Astra Tech opening balance at August 31, 2011.
[2]	Amount includes $1.1 million reserve for Astra Tech opening balance at August 31, 2011.
[3]	Amount related to opening balance sheet valuation allowance for Astra Tech at August 31, 2011.